,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2021,negative regulation of relaxation of muscle (GO:1901078),3/6,8.975829464588214e-06,0.0093438384726363,0,0,130.53947368421052,1516.9959874027893,PDE4D;PDE4B;NEUROG1
1,GO_Biological_Process_2021,transepithelial transport (GO:0070633),3/16,0.0002374000832195512,0.1235667433157764,0,0,30.10931174089069,251.28520171916048,SLC23A2;SLC1A1;GPLD1
2,GO_Biological_Process_2021,regulation of relaxation of cardiac muscle (GO:1901897),2/6,0.0008770408644773522,0.1929262602503268,0,0,64.83986928104575,456.4050498695137,PDE4D;PDE4B
3,GO_Biological_Process_2021,hydrogen sulfide metabolic process (GO:0070813),2/6,0.0008770408644773522,0.1929262602503268,0,0,64.83986928104575,456.4050498695137,MPST;ETHE1
4,GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),3/26,0.0010413400903819,0.1929262602503268,0,0,17.009725400457665,116.80998312208952,CACNA1C;SCN2A;SCN3A
5,GO_Biological_Process_2021,regulation of cardiac muscle cell contraction (GO:0086004),3/27,0.0011648833522799,0.1929262602503268,0,0,16.30016447368421,110.10980051937489,PDE4D;PDE4B;CACNA1C
6,GO_Biological_Process_2021,GPI anchor metabolic process (GO:0006505),3/28,0.0012972947375142,0.1929262602503268,0,0,15.647368421052631,104.01547715528795,PIGB;MPPE1;GPLD1
7,GO_Biological_Process_2021,GPI anchor biosynthetic process (GO:0006506),3/32,0.0019201623461608,0.2064418478680252,0,0,13.48638838475499,84.36201944980475,PIGB;PIGT;MPPE1
8,GO_Biological_Process_2021,maintenance of apical/basal cell polarity (GO:0035090),2/9,0.0020729611988468,0.2064418478680252,0,0,37.04575163398693,228.8974441857843,SLC9A3R1;ANK1
9,GO_Biological_Process_2021,maintenance of epithelial cell apical/basal polarity (GO:0045199),2/9,0.0020729611988468,0.2064418478680252,0,0,37.04575163398693,228.8974441857843,SLC9A3R1;ANK1
10,GO_Biological_Process_2021,endoplasmic reticulum organization (GO:0007029),4/73,0.0024944331205397,0.2064418478680252,0,0,7.592283328534409,45.50582137582752,REEP1;REEP5;RAB18;SPTSSB
11,GO_Biological_Process_2021,regulation of actin filament-based movement (GO:1903115),2/10,0.0025780442096871,0.2064418478680252,0,0,32.41339869281046,193.20733082812885,PDE4D;PDE4B
12,GO_Biological_Process_2021,protein localization to endosome (GO:0036010),2/10,0.0025780442096871,0.2064418478680252,0,0,32.41339869281046,193.20733082812885,MICALL1;WASHC2C
13,GO_Biological_Process_2021,cellular response to cholesterol (GO:0071397),2/11,0.0031349527155465,0.2331061269202832,0,0,28.81045751633987,166.0963552659853,OSBPL7;GPLD1
14,GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),3/43,0.004489766813554,0.3115898168606521,0,0,9.77220394736842,52.828090033158816,IMPACT;NEUROG1;BEND6
15,GO_Biological_Process_2021,endoplasmic reticulum tubular network organization (GO:0071786),2/15,0.0058645211069789,0.350246211804314,0,0,19.941679235796883,102.47698830558303,REEP1;RAB18
16,GO_Biological_Process_2021,cellular response to sterol (GO:0036315),2/16,0.0066683987625744,0.350246211804314,0,0,18.516339869281047,92.77381587987476,OSBPL7;GPLD1
17,GO_Biological_Process_2021,endocytic recycling (GO:0032456),3/52,0.0076431053932976,0.350246211804314,0,0,7.973684210526316,38.86334847023619,DENND1C;MICALL1;WASHC2C
18,GO_Biological_Process_2021,acidic amino acid transport (GO:0015800),2/18,0.0084164685042253,0.350246211804314,0,0,16.200163398692812,77.39733293925609,SLC9A3R1;SLC1A1
19,GO_Biological_Process_2021,cellular response to pH (GO:0071467),2/18,0.0084164685042253,0.350246211804314,0,0,16.200163398692812,77.39733293925609,IMPACT;GPLD1
20,GO_Biological_Process_2021,positive regulation of excitatory postsynaptic potential (GO:2000463),2/18,0.0084164685042253,0.350246211804314,0,0,16.200163398692812,77.39733293925609,RIMS1;STX1B
21,GO_Biological_Process_2021,"synaptic transmission, glutamatergic (GO:0035249)",2/18,0.0084164685042253,0.350246211804314,0,0,16.200163398692812,77.39733293925609,GRIK4;CDH8
22,GO_Biological_Process_2021,folic acid metabolic process (GO:0046655),2/19,0.0093591344240522,0.350246211804314,0,0,15.24644367550942,71.2222746266767,ALDH1L1;MTHFD2L
23,GO_Biological_Process_2021,response to cholesterol (GO:0070723),2/19,0.0093591344240522,0.350246211804314,0,0,15.24644367550942,71.2222746266767,OSBPL7;GPLD1
24,GO_Biological_Process_2021,carboxylic acid transport (GO:0046942),3/57,0.0098392946561788,0.350246211804314,0,0,7.233552631578948,33.428932179743015,SLC23A2;SLC1A1;SLC38A6
25,GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),7/306,0.009976781494706,0.350246211804314,0,0,3.091882852752418,14.245833968979277,CHRM3;RIMS1;SLC12A5;NOVA1;SLC1A1;GRIK4;CDH8
26,GO_Biological_Process_2021,folic acid-containing compound metabolic process (GO:0006760),2/20,0.0103465517369631,0.350246211804314,0,0,14.398692810457517,65.81789321952054,ALDH1L1;MTHFD2L
27,GO_Biological_Process_2021,cation transport (GO:0006812),5/174,0.0115462887414638,0.350246211804314,0,0,3.8808678500986193,17.314069731975135,PANX2;NDFIP2;SLC1A1;SCN2A;SCN3A
28,GO_Biological_Process_2021,protein lipidation (GO:0006497),3/61,0.0118341690506474,0.350246211804314,0,0,6.733325771324864,29.874179063557197,PIGB;MPPE1;GPLD1
29,GO_Biological_Process_2021,amino acid import (GO:0043090),2/22,0.0124526851651479,0.350246211804314,0,0,12.95751633986928,56.82932140040243,SLC9A3R1;SLC1A1
30,GO_Biological_Process_2021,neuronal action potential (GO:0019228),2/22,0.0124526851651479,0.350246211804314,0,0,12.95751633986928,56.82932140040243,SCN2A;SCN3A
31,GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),3/64,0.0134718225129174,0.350246211804314,0,0,6.401207937877481,27.57099475060908,ESPL1;E2F1;AURKB
32,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,0.0135699451738065,0.350246211804314,0,0,12.339869281045752,53.06017733400719,PDE4D;CACNA1C
33,GO_Biological_Process_2021,regulation of cellular catabolic process (GO:0031329),3/65,0.0140449342088807,0.350246211804314,0,0,6.297644312393888,26.862560897120517,OSBPL7;IFI16;GPR137
34,GO_Biological_Process_2021,anion transmembrane transport (GO:0098656),3/67,0.0152322518720205,0.350246211804314,0,0,6.100226151315789,25.52542191271736,SLC23A2;SLC1A1;SLC25A4
35,GO_Biological_Process_2021,cellular response to drug (GO:0035690),2/26,0.0171699400330277,0.350246211804314,0,0,10.795751633986928,43.88035915585627,PDE4B;GPLD1
36,GO_Biological_Process_2021,positive regulation of interleukin-2 production (GO:0032743),2/26,0.0171699400330277,0.350246211804314,0,0,10.795751633986928,43.88035915585627,PDE4D;PDE4B
37,GO_Biological_Process_2021,modulation of excitatory postsynaptic potential (GO:0098815),2/27,0.0184503480156957,0.350246211804314,0,0,10.363398692810458,41.37765226269128,RIMS1;STX1B
38,GO_Biological_Process_2021,insulin receptor signaling pathway (GO:0008286),3/73,0.019125238912683,0.350246211804314,0,0,5.5756578947368425,22.061464342671105,ATP6V1A;GPLD1;ATP6V0A1
39,GO_Biological_Process_2021,neutral amino acid transport (GO:0015804),2/28,0.0197698170931865,0.350246211804314,0,0,9.964303670186023,39.095930855617496,SLC1A1;SLC38A6
40,GO_Biological_Process_2021,phagosome acidification (GO:0090383),2/28,0.0197698170931865,0.350246211804314,0,0,9.964303670186023,39.095930855617496,ATP6V1A;ATP6V0A1
41,GO_Biological_Process_2021,gene expression (GO:0010467),7/356,0.0211886583715164,0.350246211804314,0,0,2.642143576240997,10.18358551134996,HHEX;NOVA1;RPL34;E2F1;RPL39;RPS24;THOC6
42,GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),3/76,0.0212590124795052,0.350246211804314,0,0,5.345710165825523,20.58619276769925,SLC23A2;ALDH1L1;MTHFD2L
43,GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),3/79,0.0235180249647346,0.350246211804314,0,0,5.13391620498615,19.252124839716394,IMPACT;NEUROG1;BEND6
44,GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),2/31,0.0239558897463325,0.350246211804314,0,0,8.932161370295244,33.330726969710895,IFI16;E2F1
45,GO_Biological_Process_2021,glycerophospholipid metabolic process (GO:0006650),3/80,0.0242988652116395,0.350246211804314,0,0,5.066985645933015,18.83563560256868,PIGB;PLCB3;GPLD1
46,GO_Biological_Process_2021,protein localization to organelle (GO:0033365),4/142,0.0247396472776259,0.350246211804314,0,0,3.7828966311546215,13.994251727071198,HHEX;MICALL1;WASHC2C;CD68
47,GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),2/32,0.0254249416366314,0.350246211804314,0,0,8.633986928104575,31.704212677211423,SLC9A3R1;ANK1
48,GO_Biological_Process_2021,membrane depolarization (GO:0051899),2/32,0.0254249416366314,0.350246211804314,0,0,8.633986928104575,31.704212677211423,SCN2A;SCN3A
49,GO_Biological_Process_2021,negative regulation of JNK cascade (GO:0046329),2/33,0.0269297631411036,0.350246211804314,0,0,8.3550495467004,30.19952015259173,HDAC3;ZMYND11
50,GO_Biological_Process_2021,regulation of neurotransmitter secretion (GO:0046928),2/33,0.0269297631411036,0.350246211804314,0,0,8.3550495467004,30.19952015259173,RIMS1;STX1B
51,GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),8/464,0.0284025679192767,0.350246211804314,0,0,2.313999283924096,8.240789461793625,HHEX;HDAC3;IFI16;NACC2;ZNF219;E2F1;ZMYND11;SMARCA2
52,GO_Biological_Process_2021,intracellular pH reduction (GO:0051452),2/35,0.0300441825997201,0.350246211804314,0,0,7.847890671420084,27.507533506798595,ATP6V1A;ATP6V0A1
53,GO_Biological_Process_2021,negative regulation of binding (GO:0051100),3/88,0.0310453354281075,0.350246211804314,0,0,4.588235294117647,15.931760197200118,IFI16;E2F1;AURKB
54,GO_Biological_Process_2021,regulation of cardiac muscle contraction (GO:0055117),2/36,0.0316525332277574,0.350246211804314,0,0,7.616685890042292,26.299937249191007,PDE4D;PDE4B
55,GO_Biological_Process_2021,embryonic limb morphogenesis (GO:0030326),2/36,0.0316525332277574,0.350246211804314,0,0,7.616685890042292,26.299937249191007,MYH3;CACNA1C
56,GO_Biological_Process_2021,membrane fusion (GO:0061025),2/36,0.0316525332277574,0.350246211804314,0,0,7.616685890042292,26.299937249191007,RIMS1;DNM1
57,GO_Biological_Process_2021,transferrin transport (GO:0033572),2/36,0.0316525332277574,0.350246211804314,0,0,7.616685890042292,26.299937249191007,ATP6V1A;ATP6V0A1
58,GO_Biological_Process_2021,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),3/90,0.0328701170985082,0.350246211804314,0,0,4.4823049001814885,15.30792882831114,RPL34;RPL39;RPS24
59,GO_Biological_Process_2021,negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.0332941586660862,0.350246211804314,0,0,7.398692810457517,25.173114968021835,HDAC3;ZMYND11
60,GO_Biological_Process_2021,phagosome maturation (GO:0090382),2/37,0.0332941586660862,0.350246211804314,0,0,7.398692810457517,25.173114968021835,ATP6V1A;ATP6V0A1
61,GO_Biological_Process_2021,regulation of autophagy (GO:0010506),5/231,0.034184640569076,0.350246211804314,0,0,2.8936578171091445,9.768927566430673,ATP6V1A;OSBPL7;IFI16;GPR137;ATP6V0A1
62,GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),2/38,0.0349684537869782,0.350246211804314,0,0,7.19281045751634,24.11971564183129,DNAJC6;DNM1
63,GO_Biological_Process_2021,cytoplasmic translation (GO:0002181),3/93,0.0357100658075632,0.350246211804314,0,0,4.332236842105263,14.436411060444716,RPL34;RPL39;RPS24
64,GO_Biological_Process_2021,regulation of intracellular transport (GO:0032386),2/39,0.0366748207263118,0.350246211804314,0,0,6.9980568804098215,23.133230599840196,REEP5;ATP9A
65,GO_Biological_Process_2021,cotranslational protein targeting to membrane (GO:0006613),3/94,0.036683987440569,0.350246211804314,0,0,4.284412955465587,14.161762543512785,RPL34;RPL39;RPS24
66,GO_Biological_Process_2021,ADP transport (GO:0015866),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC25A4
67,GO_Biological_Process_2021,regulation of barbed-end actin filament capping (GO:2000812),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,WASHC2C
68,GO_Biological_Process_2021,bile acid secretion (GO:0032782),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC9A3R1
69,GO_Biological_Process_2021,C-terminal protein lipidation (GO:0006501),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,GPLD1
70,GO_Biological_Process_2021,negative regulation of pinocytosis (GO:0048550),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,STX1B
71,GO_Biological_Process_2021,regulation of mitophagy (GO:1901524),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC25A4
72,GO_Biological_Process_2021,DNA protection (GO:0042262),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,NUDT1
73,GO_Biological_Process_2021,peristalsis (GO:0030432),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,NEUROG1
74,GO_Biological_Process_2021,regulation of sodium:proton antiporter activity (GO:0032415),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC9A3R1
75,GO_Biological_Process_2021,regulation of synaptic vesicle priming (GO:0010807),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,STX1B
76,GO_Biological_Process_2021,regulation of vascular associated smooth muscle contraction (GO:0003056),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,CHRM3
77,GO_Biological_Process_2021,glutathione transport (GO:0034635),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC9A3R1
78,GO_Biological_Process_2021,hematopoietic stem cell migration (GO:0035701),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,GPLD1
79,GO_Biological_Process_2021,homoserine metabolic process (GO:0009092),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,MPST
80,GO_Biological_Process_2021,positive regulation of neurotransmitter transport (GO:0051590),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,STX1B
81,GO_Biological_Process_2021,L-aspartate transmembrane transport (GO:0070778),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,SLC1A1
82,GO_Biological_Process_2021,sulfide oxidation (GO:0019418),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,ETHE1
83,GO_Biological_Process_2021,"sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)",1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,ETHE1
84,GO_Biological_Process_2021,thorax and anterior abdomen determination (GO:0007356),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,NEUROG1
85,GO_Biological_Process_2021,membrane depolarization during AV node cell action potential (GO:0086045),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,CACNA1C
86,GO_Biological_Process_2021,transsulfuration (GO:0019346),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,MPST
87,GO_Biological_Process_2021,positive regulation of translation in response to stress (GO:0032056),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,IMPACT
88,GO_Biological_Process_2021,mitochondrial RNA 3'-end processing (GO:0000965),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,TRNT1
89,GO_Biological_Process_2021,postsynaptic endocytosis (GO:0140239),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,DNM1
90,GO_Biological_Process_2021,postsynaptic neurotransmitter receptor internalization (GO:0098884),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,DNM1
91,GO_Biological_Process_2021,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,NEUROG1
92,GO_Biological_Process_2021,protein localization to microtubule end (GO:1905725),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,MAPRE2
93,GO_Biological_Process_2021,protein localization to microtubule plus-end (GO:1904825),1/5,0.0381575599921209,0.350246211804314,0,0,32.20941558441559,105.19696189979992,MAPRE2
94,GO_Biological_Process_2021,glycolipid biosynthetic process (GO:0009247),2/40,0.0384126688211,0.350246211804314,0,0,6.813553491572067,22.2078779208944,PIGB;MPPE1
95,GO_Biological_Process_2021,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.0384126688211,0.350246211804314,0,0,6.813553491572067,22.2078779208944,SLC9A3R1;NACC2
96,GO_Biological_Process_2021,synaptic vesicle exocytosis (GO:0016079),2/40,0.0384126688211,0.350246211804314,0,0,6.813553491572067,22.2078779208944,RIMS1;STX1B
97,GO_Biological_Process_2021,carboxylic acid transmembrane transport (GO:1905039),2/41,0.0401814145340901,0.350246211804314,0,0,6.638511814982404,21.33850520091635,SLC23A2;SLC38A6
98,GO_Biological_Process_2021,positive regulation of TOR signaling (GO:0032008),2/41,0.0401814145340901,0.350246211804314,0,0,6.638511814982404,21.33850520091635,HDAC3;GPR137
99,GO_Biological_Process_2021,membrane organization (GO:0061024),5/242,0.0404515402652276,0.350246211804314,0,0,2.757805907172996,8.846077656867392,REEP1;SLC9A3R1;RIMS1;DNAJC6;DNM1
100,GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),10/684,0.0405739302808632,0.350246211804314,0,0,1.9616289777959688,6.286294149001543,IMPACT;HHEX;TGIF2;HDAC3;IFI16;NACC2;ZNF219;E2F1;SMARCA2;AURKB
101,GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),5/244,0.0416611449171593,0.350246211804314,0,0,2.7344490934449093,8.690588813957913,CHRM3;SLC12A5;NOVA1;SLC1A1;GRIK4
102,GO_Biological_Process_2021,ATP-dependent chromatin remodeling (GO:0043044),2/42,0.0419804813758262,0.350246211804314,0,0,6.472222222222222,20.520507388964894,ACTL6A;SMARCA2
103,GO_Biological_Process_2021,cellular response to glucose starvation (GO:0042149),2/43,0.0438092998414484,0.350246211804314,0,0,6.314044316913757,19.749757049145234,IMPACT;IFI16
104,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),3/102,0.044960400647231,0.350246211804314,0,0,3.936602870813397,12.211236455674046,IFI16;E2F1;SCN2A
105,GO_Biological_Process_2021,negative regulation of cytokinesis (GO:0032466),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,AURKB
106,GO_Biological_Process_2021,negative regulation of fat cell proliferation (GO:0070345),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,E2F1
107,GO_Biological_Process_2021,attachment of GPI anchor to protein (GO:0016255),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,PIGT
108,GO_Biological_Process_2021,regulation of focal adhesion disassembly (GO:0120182),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,MAPRE2
109,GO_Biological_Process_2021,negative regulation of transporter activity (GO:0032410),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,NDFIP2
110,GO_Biological_Process_2021,negative regulation of triglyceride metabolic process (GO:0090209),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,GPLD1
111,GO_Biological_Process_2021,"regulation of retrograde transport, endosome to Golgi (GO:1905279)",1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,ATP9A
112,GO_Biological_Process_2021,regulation of saliva secretion (GO:0046877),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,NEUROG1
113,GO_Biological_Process_2021,gamma-aminobutyric acid transport (GO:0015812),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,SLC9A3R1
114,GO_Biological_Process_2021,positive regulation of focal adhesion disassembly (GO:0120183),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,MAPRE2
115,GO_Biological_Process_2021,positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,PDE4D
116,GO_Biological_Process_2021,histone-serine phosphorylation (GO:0035404),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,AURKB
117,GO_Biological_Process_2021,positive regulation of lipoprotein particle clearance (GO:0010986),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,GPLD1
118,GO_Biological_Process_2021,positive regulation of neurotransmitter secretion (GO:0001956),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,STX1B
119,GO_Biological_Process_2021,taurine metabolic process (GO:0019530),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,CSAD
120,GO_Biological_Process_2021,trigeminal nerve development (GO:0021559),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,NEUROG1
121,GO_Biological_Process_2021,tRNA 3'-end processing (GO:0042780),1/6,0.0456136829085219,0.350246211804314,0,0,25.766233766233768,79.55447177504013,TRNT1
122,GO_Biological_Process_2021,protein targeting to ER (GO:0045047),3/103,0.0460548820689252,0.350246211804314,0,0,3.8970394736842096,11.994781602675967,RPL34;RPL39;RPS24
123,GO_Biological_Process_2021,action potential (GO:0001508),2/45,0.0475539480307998,0.350246211804314,0,0,6.019759841921265,18.335529100477327,SCN2A;SCN3A
124,GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),2/47,0.0514109398314601,0.350246211804314,0,0,5.751633986928105,17.07029919570023,IFI16;E2F1
125,GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),3/109,0.0528958321826195,0.350246211804314,0,0,3.6753351539225423,10.803393094267529,RIMS1;STX1B;GRIK4
126,GO_Biological_Process_2021,negative regulation of digestive system process (GO:0060457),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,NEUROG1
127,GO_Biological_Process_2021,AV node cell action potential (GO:0086016),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,CACNA1C
128,GO_Biological_Process_2021,cellular ion homeostasis (GO:0006873),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,SLC12A5
129,GO_Biological_Process_2021,cellular nitrogen compound catabolic process (GO:0044270),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,MPST
130,GO_Biological_Process_2021,regulation of fat cell proliferation (GO:0070344),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,E2F1
131,GO_Biological_Process_2021,cleavage furrow formation (GO:0036089),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,AURKB
132,GO_Biological_Process_2021,creatine metabolic process (GO:0006600),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,CKB
133,GO_Biological_Process_2021,regulation of muscle organ development (GO:0048634),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,NEUROG1
134,GO_Biological_Process_2021,positive regulation of adenylate cyclase activity (GO:0045762),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,CACNA1C
135,GO_Biological_Process_2021,regulation of relaxation of muscle (GO:1901077),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,NEUROG1
136,GO_Biological_Process_2021,gland morphogenesis (GO:0022612),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,SLC9A3R1
137,GO_Biological_Process_2021,glutamine transport (GO:0006868),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,SLC38A6
138,GO_Biological_Process_2021,response to increased oxygen levels (GO:0036296),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,ATP6V1A
139,GO_Biological_Process_2021,positive regulation of interleukin-5 production (GO:0032754),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,PDE4D
140,GO_Biological_Process_2021,hypotonic response (GO:0006971),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,SLC12A5
141,GO_Biological_Process_2021,synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,DNM1
142,GO_Biological_Process_2021,synaptic vesicle docking (GO:0016081),1/7,0.0530123784483423,0.350246211804314,0,0,21.47077922077922,63.06461335243215,STX1B
143,GO_Biological_Process_2021,cellular response to alcohol (GO:0097306),2/48,0.0533802129066347,0.350246211804314,0,0,5.626314293833476,16.48687399421364,OSBPL7;GPLD1
144,GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),2/48,0.0533802129066347,0.350246211804314,0,0,5.626314293833476,16.48687399421364,PDE4D;PDE4B
145,GO_Biological_Process_2021,chloride transmembrane transport (GO:1902476),2/50,0.0573976675935087,0.350246211804314,0,0,5.391339869281046,15.407110195493528,SLC12A5;SLC1A1
146,GO_Biological_Process_2021,iron ion transport (GO:0006826),2/50,0.0573976675935087,0.350246211804314,0,0,5.391339869281046,15.407110195493528,ATP6V1A;ATP6V0A1
147,GO_Biological_Process_2021,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",3/113,0.0577130260866144,0.350246211804314,0,0,3.540968899521531,10.099807774774204,RPL34;RPL39;RPS24
148,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/51,0.0594448103118574,0.350246211804314,0,0,5.281045751633987,14.90684457102747,IFI16;E2F1
149,GO_Biological_Process_2021,negative regulation of B cell apoptotic process (GO:0002903),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,AURKB
150,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,CHRM3
151,GO_Biological_Process_2021,negative regulation of chromosome organization (GO:2001251),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,ESPL1
152,GO_Biological_Process_2021,aromatic compound catabolic process (GO:0019439),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,TET2
153,GO_Biological_Process_2021,cellular response to epinephrine stimulus (GO:0071872),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,PDE4B
154,GO_Biological_Process_2021,cysteine metabolic process (GO:0006534),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,MPST
155,GO_Biological_Process_2021,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,DNM1
156,GO_Biological_Process_2021,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,DNM1
157,GO_Biological_Process_2021,regulation of proton transport (GO:0010155),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,SLC9A3R1
158,GO_Biological_Process_2021,establishment of Golgi localization (GO:0051683),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,SLC9A3R1
159,GO_Biological_Process_2021,response to epinephrine (GO:0071871),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,PDE4B
160,GO_Biological_Process_2021,synaptic vesicle budding (GO:0070142),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,DNM1
161,GO_Biological_Process_2021,translocation of molecules into host (GO:0044417),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,THOC6
162,GO_Biological_Process_2021,mitochondrial tRNA processing (GO:0090646),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,TRNT1
163,GO_Biological_Process_2021,mitotic spindle elongation (GO:0000022),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,AURKB
164,GO_Biological_Process_2021,mitotic spindle midzone assembly (GO:0051256),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,AURKB
165,GO_Biological_Process_2021,viral mRNA export from host cell nucleus (GO:0046784),1/8,0.0603540856180015,0.350246211804314,0,0,18.4025974025974,51.66578236108292,THOC6
166,GO_Biological_Process_2021,ion transport (GO:0006811),3/116,0.061457637668942,0.350246211804314,0,0,3.4464368886818817,9.61351573345077,PANX2;SLC12A5;SLC1A1
167,GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),2/52,0.0615168813004335,0.350246211804314,0,0,5.175163398692811,14.430651512377356,IFI16;TET2
168,GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),8/547,0.0632325033515777,0.350246211804314,0,0,1.949288806431664,5.381863231659357,HHEX;HDAC3;IFI16;NACC2;ZNF219;E2F1;ZMYND11;SMARCA2
169,GO_Biological_Process_2021,acid secretion (GO:0046717),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,SLC9A3R1
170,GO_Biological_Process_2021,negative regulation of bone resorption (GO:0045779),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,GPR137
171,GO_Biological_Process_2021,negative regulation of exocytosis (GO:0045920),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,ATP9A
172,GO_Biological_Process_2021,negative regulation of necroptotic process (GO:0060546),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,SLC25A4
173,GO_Biological_Process_2021,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,CD68
174,GO_Biological_Process_2021,neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,STX1B
175,GO_Biological_Process_2021,organic acid catabolic process (GO:0016054),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,MPST
176,GO_Biological_Process_2021,embryonic forelimb morphogenesis (GO:0035115),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,CACNA1C
177,GO_Biological_Process_2021,positive regulation of autophagy of mitochondrion (GO:1903599),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,SLC25A4
178,GO_Biological_Process_2021,regulation of transmembrane transporter activity (GO:0022898),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,CHRM3
179,GO_Biological_Process_2021,histone phosphorylation (GO:0016572),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,NEK11
180,GO_Biological_Process_2021,response to UV-C (GO:0010225),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,IMPACT
181,GO_Biological_Process_2021,interleukin-23-mediated signaling pathway (GO:0038155),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,TYK2
182,GO_Biological_Process_2021,L-ascorbic acid metabolic process (GO:0019852),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,SLC23A2
183,GO_Biological_Process_2021,tetrahydrofolate interconversion (GO:0035999),1/9,0.0676392402357157,0.350246211804314,0,0,16.101461038961038,43.37036390482204,MTHFD2L
184,GO_Biological_Process_2021,endomembrane system organization (GO:0010256),4/199,0.0693584825285328,0.350246211804314,0,0,2.6693835965359143,7.12316157040096,SLC9A3R1;REEP5;SPTSSB;DNM1
185,GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),4/200,0.0703673025895698,0.350246211804314,0,0,2.655629139072848,7.0481103099362015,STX1B;ZNF827;NOVA1;HMG20B
186,GO_Biological_Process_2021,defense response to symbiont (GO:0140546),3/124,0.0719794284372953,0.350246211804314,0,0,3.2172683775554587,8.465839309761728,IFI16;ZMYND11;IFIT3
187,GO_Biological_Process_2021,dicarboxylic acid metabolic process (GO:0043648),2/57,0.072233750483877,0.350246211804314,0,0,4.703505644682116,12.36009735614786,ALDH1L1;MTHFD2L
188,GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),2/57,0.072233750483877,0.350246211804314,0,0,4.703505644682116,12.36009735614786,PDE4D;PDE4B
189,GO_Biological_Process_2021,eye development (GO:0001654),2/58,0.0744450307593925,0.350246211804314,0,0,4.619281045751634,11.999479895254678,RAB18;CACNA1C
190,GO_Biological_Process_2021,negative regulation of cAMP-mediated signaling (GO:0043951),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,PDE4D
191,GO_Biological_Process_2021,negative regulation of establishment of protein localization (GO:1904950),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,NDFIP2
192,GO_Biological_Process_2021,negative regulation of lymphocyte apoptotic process (GO:0070229),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,AURKB
193,GO_Biological_Process_2021,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,SLC9A3R1
194,GO_Biological_Process_2021,negative regulation of protein autophosphorylation (GO:0031953),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,IMPACT
195,GO_Biological_Process_2021,cellular response to acetylcholine (GO:1905145),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,CHRM3
196,GO_Biological_Process_2021,cellular response to acidic pH (GO:0071468),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,IMPACT
197,GO_Biological_Process_2021,cellular response to leucine starvation (GO:1990253),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,IMPACT
198,GO_Biological_Process_2021,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,CD68
199,GO_Biological_Process_2021,cellular response to oxygen levels (GO:0071453),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,ATP6V1A
200,GO_Biological_Process_2021,negative regulation of transcription by competitive promoter binding (GO:0010944),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,HHEX
201,GO_Biological_Process_2021,regulation of high voltage-gated calcium channel activity (GO:1901841),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,PDE4B
202,GO_Biological_Process_2021,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,IMPACT
203,GO_Biological_Process_2021,chloride ion homeostasis (GO:0055064),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,SLC12A5
204,GO_Biological_Process_2021,neuron remodeling (GO:0016322),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,ADGRB3
205,GO_Biological_Process_2021,regulation of macrophage migration (GO:1905521),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,MTUS1
206,GO_Biological_Process_2021,regulation of store-operated calcium entry (GO:2001256),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,SARAF
207,GO_Biological_Process_2021,forelimb morphogenesis (GO:0035136),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,CACNA1C
208,GO_Biological_Process_2021,removal of superoxide radicals (GO:0019430),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,PRDX1
209,GO_Biological_Process_2021,histone H4 deacetylation (GO:0070933),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,HDAC3
210,GO_Biological_Process_2021,positive regulation of keratinocyte migration (GO:0051549),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,MAPRE2
211,GO_Biological_Process_2021,L-glutamate transmembrane transport (GO:0015813),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,SLC1A1
212,GO_Biological_Process_2021,sulfur amino acid catabolic process (GO:0000098),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,MPST
213,GO_Biological_Process_2021,monovalent inorganic anion homeostasis (GO:0055083),1/10,0.0748682748782873,0.350246211804314,0,0,14.311688311688313,37.09625453392642,SLC12A5
214,GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),6/379,0.0750414864355766,0.350246211804314,0,0,2.1021645644781115,5.444005351690183,SLC9A3R1;NACC2;E2F1;SMARCA2;GPLD1;IFIT3
215,GO_Biological_Process_2021,regulation of gene expression (GO:0010468),13/1079,0.0763031241707767,0.350246211804314,0,0,1.6127619374785298,4.149703226458125,NDFIP2;TGIF2;SMARCA2;STX1B;RIMS1;NWD1;ZNF827;IFI16;NOVA1;ZNF219;E2F1;HMG20B;MYBL2
216,GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),3/128,0.0775235653242791,0.350246211804314,0,0,3.113684210526316,7.96223019050523,SLC9A3R1;MICALL1;FAM161B
217,GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),3/129,0.0789382325444093,0.350246211804314,0,0,3.088815789473684,7.842780043842932,ATP6V1A;GPLD1;ATP6V0A1
218,GO_Biological_Process_2021,negative regulation of bone remodeling (GO:0046851),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,GPR137
219,GO_Biological_Process_2021,regulation of cytoplasmic transport (GO:1903649),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,ATP9A
220,GO_Biological_Process_2021,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,SLC9A3R1
221,GO_Biological_Process_2021,negative regulation of programmed necrotic cell death (GO:0062099),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,SLC25A4
222,GO_Biological_Process_2021,regulation of endocytic recycling (GO:2001135),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,ATP9A
223,GO_Biological_Process_2021,cellular response to increased oxygen levels (GO:0036295),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,ATP6V1A
224,GO_Biological_Process_2021,negative regulation of steroid biosynthetic process (GO:0010894),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,DKKL1
225,GO_Biological_Process_2021,cellular response to superoxide (GO:0071451),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,PRDX1
226,GO_Biological_Process_2021,chromatin-mediated maintenance of transcription (GO:0048096),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,CDCA4
227,GO_Biological_Process_2021,complement receptor mediated signaling pathway (GO:0002430),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,GPLD1
228,GO_Biological_Process_2021,nucleus localization (GO:0051647),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,SLC9A3R1
229,GO_Biological_Process_2021,ER-associated misfolded protein catabolic process (GO:0071712),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,UGGT2
230,GO_Biological_Process_2021,establishment of epithelial cell apical/basal polarity (GO:0045198),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,SLC9A3R1
231,GO_Biological_Process_2021,tetrahydrofolate metabolic process (GO:0046653),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,MTHFD2L
232,GO_Biological_Process_2021,positive regulation of triglyceride biosynthetic process (GO:0010867),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,GPLD1
233,GO_Biological_Process_2021,monocyte differentiation (GO:0030224),1/11,0.082041618927272,0.350246211804314,0,0,12.87987012987013,32.20648378609581,IFI16
234,GO_Biological_Process_2021,defense response to virus (GO:0051607),3/133,0.0847089177458464,0.350246211804314,0,0,2.993168016194332,7.388738202810933,IFI16;ZMYND11;IFIT3
235,GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),2/63,0.0858152602117776,0.350246211804314,0,0,4.239579984999464,10.410536373337996,HHEX;NEUROG1
236,GO_Biological_Process_2021,plasma membrane organization (GO:0007009),2/64,0.0881489218191783,0.350246211804314,0,0,4.170988825637782,10.130195686037554,SLC9A3R1;MICALL1
237,GO_Biological_Process_2021,protein mono-ADP-ribosylation (GO:0140289),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,PARP8
238,GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,AURKB
239,GO_Biological_Process_2021,ATP transport (GO:0015867),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,SLC25A4
240,GO_Biological_Process_2021,regulation of B cell apoptotic process (GO:0002902),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,AURKB
241,GO_Biological_Process_2021,negative regulation of heart contraction (GO:0045822),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,PDE4D
242,GO_Biological_Process_2021,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,PDE4D
243,GO_Biological_Process_2021,C-terminal protein amino acid modification (GO:0018410),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,GPLD1
244,GO_Biological_Process_2021,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,RIMS1
245,GO_Biological_Process_2021,cellular response to fluid shear stress (GO:0071498),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,HDAC3
246,GO_Biological_Process_2021,regulation of keratinocyte migration (GO:0051547),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,MAPRE2
247,GO_Biological_Process_2021,cochlea morphogenesis (GO:0090103),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,NEUROG1
248,GO_Biological_Process_2021,dermatan sulfate biosynthetic process (GO:0030208),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,CHST12
249,GO_Biological_Process_2021,regulation of nucleobase-containing compound metabolic process (GO:0019219),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,NOVA1
250,GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,NEUROG1
251,GO_Biological_Process_2021,double-strand break repair via break-induced replication (GO:0000727),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,GINS2
252,GO_Biological_Process_2021,positive regulation of actin filament depolymerization (GO:0030836),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,WASHC2C
253,GO_Biological_Process_2021,regulation of sister chromatid cohesion (GO:0007063),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,ESPL1
254,GO_Biological_Process_2021,regulation of triglyceride catabolic process (GO:0010896),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,GPLD1
255,GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,CACNA1C
256,GO_Biological_Process_2021,Golgi localization (GO:0051645),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,SLC9A3R1
257,GO_Biological_Process_2021,homocysteine metabolic process (GO:0050667),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,MPST
258,GO_Biological_Process_2021,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,ESPL1
259,GO_Biological_Process_2021,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,ESPL1
260,GO_Biological_Process_2021,positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,ESPL1
261,GO_Biological_Process_2021,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,STX1B
262,GO_Biological_Process_2021,mitochondrial genome maintenance (GO:0000002),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,SLC25A4
263,GO_Biological_Process_2021,protein auto-ADP-ribosylation (GO:0070213),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,PARP8
264,GO_Biological_Process_2021,protein localization to condensed chromosome (GO:1903083),1/12,0.0891596984900511,0.350246211804314,0,0,11.708382526564344,28.302979280758237,AURKB
265,GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),2/65,0.0905014316563682,0.3515372774413409,0,0,4.104575163398692,9.86078872188386,TYK2;IFIT3
266,GO_Biological_Process_2021,inorganic anion transmembrane transport (GO:0098661),2/65,0.0905014316563682,0.3515372774413409,0,0,4.104575163398692,9.86078872188386,SLC12A5;SLC1A1
267,GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),2/65,0.0905014316563682,0.3515372774413409,0,0,4.104575163398692,9.86078872188386,TYK2;IFIT3
268,GO_Biological_Process_2021,atrial cardiac muscle cell action potential (GO:0086014),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,CACNA1C
269,GO_Biological_Process_2021,regulation of cell communication by electrical coupling (GO:0010649),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,PDE4D
270,GO_Biological_Process_2021,negative regulation of myotube differentiation (GO:0010832),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,HDAC3
271,GO_Biological_Process_2021,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,HHEX
272,GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,PDE4D
273,GO_Biological_Process_2021,chromatin organization involved in regulation of transcription (GO:0034401),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,CDCA4
274,GO_Biological_Process_2021,cranial nerve development (GO:0021545),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,NEUROG1
275,GO_Biological_Process_2021,dermatan sulfate metabolic process (GO:0030205),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,CHST12
276,GO_Biological_Process_2021,embryonic appendage morphogenesis (GO:0035113),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,MYH3
277,GO_Biological_Process_2021,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,SLC9A3R1
278,GO_Biological_Process_2021,plasma membrane tubulation (GO:0097320),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,MICALL1
279,GO_Biological_Process_2021,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,GPLD1
280,GO_Biological_Process_2021,homeostasis of number of cells (GO:0048872),1/13,0.0962229365001757,0.3529360390659491,0,0,10.732142857142858,25.12488575477612,OCIAD1
281,GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),5/314,0.0977353450006734,0.3529360390659491,0,0,2.1074433656957927,4.900842718195881,RPL34;MCM9;E2F1;RPL39;RPS24
282,GO_Biological_Process_2021,chromatin organization (GO:0006325),3/142,0.098324539514539,0.3529360390659491,0,0,2.7980878455130638,6.490113395897423,HDAC3;ACTL6A;SMARCA2
283,GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),3/143,0.0998892902439119,0.3529360390659491,0,0,2.7779605263157894,6.399567673825588,DNAJC6;MICALL1;DNM1
284,GO_Biological_Process_2021,establishment of protein localization to membrane (GO:0090150),2/70,0.1025319240658071,0.3529360390659491,0,0,3.801806997308728,8.658923666332969,REEP1;MICALL1
285,GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,IFI16
286,GO_Biological_Process_2021,C4-dicarboxylate transport (GO:0015740),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC1A1
287,GO_Biological_Process_2021,cAMP metabolic process (GO:0046058),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,PDE4D
288,GO_Biological_Process_2021,carbohydrate transport (GO:0008643),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC23A2
289,GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,NEUROG1
290,GO_Biological_Process_2021,neuromuscular process controlling balance (GO:0050885),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,NEUROG1
291,GO_Biological_Process_2021,nuclear migration (GO:0007097),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC9A3R1
292,GO_Biological_Process_2021,covalent chromatin modification (GO:0016569),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,AURKB
293,GO_Biological_Process_2021,polarized epithelial cell differentiation (GO:0030859),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC9A3R1
294,GO_Biological_Process_2021,positive regulation of cyclase activity (GO:0031281),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,CACNA1C
295,GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,NEUROG1
296,GO_Biological_Process_2021,renal absorption (GO:0070293),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC9A3R1
297,GO_Biological_Process_2021,positive regulation of glucose metabolic process (GO:0010907),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,GPLD1
298,GO_Biological_Process_2021,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,GPLD1
299,GO_Biological_Process_2021,histone H3-K4 trimethylation (GO:0080182),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,TET2
300,GO_Biological_Process_2021,secretion (GO:0046903),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,RIMS1
301,GO_Biological_Process_2021,microvillus organization (GO:0032528),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,SLC9A3R1
302,GO_Biological_Process_2021,protein localization to kinetochore (GO:0034501),1/14,0.1032317526957649,0.3529360390659491,0,0,9.906093906093906,22.49454795449228,AURKB
303,GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),2/71,0.1049887297550084,0.3529360390659491,0,0,3.746518897414038,8.444287448423836,IFI16;E2F1
304,GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),2/72,0.1074615017700934,0.3529360390659491,0,0,3.69281045751634,8.237266532829768,ESPL1;AURKB
305,GO_Biological_Process_2021,organelle organization (GO:0006996),6/420,0.1087839679268501,0.3529360390659491,0,0,1.8899912459877444,4.192740154244666,SLC9A3R1;REEP5;RAB18;SPTSSB;FAM161B;ANK1
306,GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),2/73,0.1099498491856705,0.3529360390659491,0,0,3.6406149314185767,8.037498201583205,RIMS1;SLC1A1
307,GO_Biological_Process_2021,positive regulation of synaptic transmission (GO:0050806),2/73,0.1099498491856705,0.3529360390659491,0,0,3.6406149314185767,8.037498201583205,RIMS1;STX1B
308,GO_Biological_Process_2021,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,NUDT1
309,GO_Biological_Process_2021,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,CHST12
310,GO_Biological_Process_2021,engulfment of apoptotic cell (GO:0043652),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,XKR7
311,GO_Biological_Process_2021,establishment of apical/basal cell polarity (GO:0035089),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,SLC9A3R1
312,GO_Biological_Process_2021,establishment of spindle localization (GO:0051293),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,ESPL1
313,GO_Biological_Process_2021,regulation of secretion (GO:0051046),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,GPLD1
314,GO_Biological_Process_2021,regulation of triglyceride biosynthetic process (GO:0010866),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,GPLD1
315,GO_Biological_Process_2021,response to acidic pH (GO:0010447),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,IMPACT
316,GO_Biological_Process_2021,histone H3 deacetylation (GO:0070932),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,HDAC3
317,GO_Biological_Process_2021,positive regulation of lyase activity (GO:0051349),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,CACNA1C
318,GO_Biological_Process_2021,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,GPLD1
319,GO_Biological_Process_2021,integrated stress response signaling (GO:0140467),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,IMPACT
320,GO_Biological_Process_2021,interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,TYK2
321,GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,GPLD1
322,GO_Biological_Process_2021,microvillus assembly (GO:0030033),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,SLC9A3R1
323,GO_Biological_Process_2021,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,NEK11
324,GO_Biological_Process_2021,myoblast fusion (GO:0007520),1/15,0.1101865635892732,0.3529360390659491,0,0,9.198051948051948,20.28704233319861,ADGRB3
325,GO_Biological_Process_2021,cellular response to amino acid starvation (GO:0034198),2/74,0.112453386079987,0.3590919475744371,0,0,3.589869281045752,7.844641546864164,ATP6V1A;IMPACT
326,GO_Biological_Process_2021,cellular protein localization (GO:0034613),5/329,0.1131211789899495,0.360119716601032,0,0,2.0083333333333333,4.376752105953986,REEP1;STX1B;RABGAP1L;HHEX;RAB18
327,GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),3/152,0.1144130430468834,0.3629738709737322,0,0,2.608972094666196,5.656095468758505,IMPACT;PRKRIP1;PDE4D
328,GO_Biological_Process_2021,response to amino acid starvation (GO:1990928),2/75,0.1149717315595245,0.3629738709737322,0,0,3.540513922463963,7.658375886246893,ATP6V1A;IMPACT
329,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,NACC2
330,GO_Biological_Process_2021,regulation of neurotransmitter transport (GO:0051588),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,RIMS1
331,GO_Biological_Process_2021,regulation of systemic arterial blood pressure (GO:0003073),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,PLCB3
332,GO_Biological_Process_2021,histone H2A acetylation (GO:0043968),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,ACTL6A
333,GO_Biological_Process_2021,positive regulation of small molecule metabolic process (GO:0062013),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,GPLD1
334,GO_Biological_Process_2021,positive regulation of TORC1 signaling (GO:1904263),1/16,0.1170877826276355,0.3629738709737322,0,0,8.584415584415584,18.41212363798959,GPR137
335,GO_Biological_Process_2021,actomyosin structure organization (GO:0031032),2/76,0.1175045096235809,0.3629738709737322,0,0,3.4924924924924925,7.478399317344772,MYH3;EPB41L1
336,GO_Biological_Process_2021,chloride transport (GO:0006821),2/76,0.1175045096235809,0.3629738709737322,0,0,3.4924924924924925,7.478399317344772,SLC12A5;SLC1A1
337,GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",11/948,0.1188455458797083,0.3644553351391861,0,0,1.5414739713032135,3.2832325230855384,IMPACT;HHEX;TGIF2;HDAC3;IFI16;NACC2;ZNF219;E2F1;ZMYND11;SMARCA2;AURKB
338,GO_Biological_Process_2021,cellular response to UV (GO:0034644),2/77,0.120051349101911,0.3644553351391861,0,0,3.4457516339869283,7.304427390958649,IMPACT;AURKB
339,GO_Biological_Process_2021,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),2/77,0.120051349101911,0.3644553351391861,0,0,3.4457516339869283,7.304427390958649,NDFIP2;HDAC3
340,GO_Biological_Process_2021,purine ribonucleotide transport (GO:0015868),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,SLC25A4
341,GO_Biological_Process_2021,pyrimidine-containing compound catabolic process (GO:0072529),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,TET2
342,GO_Biological_Process_2021,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,CACNA1C
343,GO_Biological_Process_2021,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,CACNA1C
344,GO_Biological_Process_2021,regulation of transferase activity (GO:0051338),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,SPTSSB
345,GO_Biological_Process_2021,positive regulation of dendrite extension (GO:1903861),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,RIMS1
346,GO_Biological_Process_2021,positive regulation of heart rate (GO:0010460),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,PDE4D
347,GO_Biological_Process_2021,synaptic vesicle membrane organization (GO:0048499),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,STX1B
348,GO_Biological_Process_2021,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,CACNA1C
349,GO_Biological_Process_2021,positive regulation of telomere capping (GO:1904355),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,AURKB
350,GO_Biological_Process_2021,modified amino acid transport (GO:0072337),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,SLC9A3R1
351,GO_Biological_Process_2021,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,PIGB
352,GO_Biological_Process_2021,monosaccharide transmembrane transport (GO:0015749),1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,SLC23A2
353,GO_Biological_Process_2021,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.1239358200185128,0.3644553351391861,0,0,8.047483766233766,16.803077119770684,AURKB
354,GO_Biological_Process_2021,cellular response to starvation (GO:0009267),3/158,0.1245140101866166,0.3651241819838534,0,0,2.507215619694397,5.223375162232867,ATP6V1A;IMPACT;IFI16
355,GO_Biological_Process_2021,negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/79,0.125185751947877,0.3660628308363483,0,0,3.355912061794415,6.973439715567481,NWD1;COMMD6
356,GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),2/80,0.1277725968955336,0.3667834604711975,0,0,3.3127199597787835,6.815931857716935,SLC9A3R1;HHEX
357,GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),2/80,0.1277725968955336,0.3667834604711975,0,0,3.3127199597787835,6.815931857716935,IMPACT;WASHC2C
358,GO_Biological_Process_2021,adenine nucleotide transport (GO:0051503),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,SLC25A4
359,GO_Biological_Process_2021,negative regulation of lipid catabolic process (GO:0050995),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,GPLD1
360,GO_Biological_Process_2021,regulation of chromosome segregation (GO:0051983),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,AURKB
361,GO_Biological_Process_2021,cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,GPLD1
362,GO_Biological_Process_2021,regulation of dendrite extension (GO:1903859),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,RIMS1
363,GO_Biological_Process_2021,neuron maturation (GO:0042551),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,ADGRB3
364,GO_Biological_Process_2021,DNA conformation change (GO:0071103),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,HHEX
365,GO_Biological_Process_2021,DNA strand elongation (GO:0022616),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,GINS2
366,GO_Biological_Process_2021,DNA strand elongation involved in DNA replication (GO:0006271),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,GINS2
367,GO_Biological_Process_2021,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,CHRM3
368,GO_Biological_Process_2021,glycoprotein catabolic process (GO:0006516),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,NCCRP1
369,GO_Biological_Process_2021,positive regulation of nervous system process (GO:0031646),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,RIMS1
370,GO_Biological_Process_2021,mitochondrial fission (GO:0000266),1/18,0.1307310829477655,0.3667834604711975,0,0,7.573720397249809,15.409588975790411,DNM1
371,GO_Biological_Process_2021,peptide biosynthetic process (GO:0043043),3/162,0.1314219315617259,0.3667834604711975,0,0,2.4436444885799404,4.958991077955887,RPL34;RPL39;RPS24
372,GO_Biological_Process_2021,rRNA metabolic process (GO:0016072),3/162,0.1314219315617259,0.3667834604711975,0,0,2.4436444885799404,4.958991077955887,RPL34;RPL39;RPS24
373,GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),2/82,0.1329838130022024,0.3701501319125475,0,0,3.229575163398693,6.5157578840027,NDFIP2;HDAC3
374,GO_Biological_Process_2021,carbohydrate derivative catabolic process (GO:1901136),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,NCCRP1
375,GO_Biological_Process_2021,cardiac muscle cell contraction (GO:0086003),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,CACNA1C
376,GO_Biological_Process_2021,regulation of exosomal secretion (GO:1903541),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,ATP9A
377,GO_Biological_Process_2021,negative regulation of striated muscle cell differentiation (GO:0051154),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,HDAC3
378,GO_Biological_Process_2021,neuromuscular process (GO:0050905),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,NEUROG1
379,GO_Biological_Process_2021,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,MTUS1
380,GO_Biological_Process_2021,regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,SLC25A4
381,GO_Biological_Process_2021,endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,UGGT2
382,GO_Biological_Process_2021,regulation of synaptic vesicle exocytosis (GO:2000300),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,RIMS1
383,GO_Biological_Process_2021,positive regulation of triglyceride metabolic process (GO:0090208),1/19,0.137473975435875,0.3726833552831924,0,0,7.152597402597403,14.19304672243636,GPLD1
384,GO_Biological_Process_2021,spindle assembly (GO:0051225),2/84,0.1382427697747157,0.3728257081230028,0,0,3.1504862107444604,6.234005491707501,HDAC3;MAPRE2
385,GO_Biological_Process_2021,vascular transport (GO:0010232),2/84,0.1382427697747157,0.3728257081230028,0,0,3.1504862107444604,6.234005491707501,SLC9A3R1;SLC1A1
386,GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),2/86,0.1435467772015938,0.3751891483510754,0,0,3.07516339869281,5.969182216637869,IMPACT;PRKRIP1
387,GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.1435467772015938,0.3751891483510754,0,0,3.07516339869281,5.969182216637869,PDE4D;PDE4B
388,GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),2/86,0.1435467772015938,0.3751891483510754,0,0,3.07516339869281,5.969182216637869,SLC9A3R1;SLC1A1
389,GO_Biological_Process_2021,adrenergic receptor signaling pathway (GO:0071875),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,PDE4D
390,GO_Biological_Process_2021,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,HHEX
391,GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,GPR137
392,GO_Biological_Process_2021,cellular response to interferon-beta (GO:0035458),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,IFI16
393,GO_Biological_Process_2021,cellular response to misfolded protein (GO:0071218),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,UGGT2
394,GO_Biological_Process_2021,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,SLC9A3R1
395,GO_Biological_Process_2021,establishment of epithelial cell polarity (GO:0090162),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,SLC9A3R1
396,GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,CHRM3
397,GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,E2F1
398,GO_Biological_Process_2021,skeletal muscle contraction (GO:0003009),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,MYH3
399,GO_Biological_Process_2021,mitochondrial cytochrome c oxidase assembly (GO:0033617),1/20,0.1441648985018541,0.3751891483510754,0,0,6.775803144224197,13.123358631426164,COX20
400,GO_Biological_Process_2021,ERAD pathway (GO:0036503),2/87,0.1462148536544539,0.3753581573327612,0,0,3.038831218762015,5.842694351341186,NCCRP1;UGGT2
401,GO_Biological_Process_2021,sodium ion transmembrane transport (GO:0035725),2/87,0.1462148536544539,0.3753581573327612,0,0,3.038831218762015,5.842694351341186,SCN2A;SCN3A
402,GO_Biological_Process_2021,nuclear-transcribed mRNA catabolic process (GO:0000956),3/171,0.1474379573930898,0.3753581573327612,0,0,2.311677631578948,4.425355033479668,RPL34;RPL39;RPS24
403,GO_Biological_Process_2021,metal ion transport (GO:0030001),2/88,0.148893215973102,0.3753581573327612,0,0,3.003343973248214,5.7199463875338346,NDFIP2;CACNA1C
404,GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,CHRM3
405,GO_Biological_Process_2021,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,CACNA1C
406,GO_Biological_Process_2021,calcium ion transport into cytosol (GO:0060402),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,CACNA1C
407,GO_Biological_Process_2021,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,PDE4D
408,GO_Biological_Process_2021,neuron apoptotic process (GO:0051402),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,SCN2A
409,GO_Biological_Process_2021,chondroitin sulfate biosynthetic process (GO:0030206),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,CHST12
410,GO_Biological_Process_2021,poly(A)+ mRNA export from nucleus (GO:0016973),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,HHEX
411,GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,PRDX1
412,GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,RPL39
413,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,IFI16
414,GO_Biological_Process_2021,positive regulation of phosphatase activity (GO:0010922),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,GPLD1
415,GO_Biological_Process_2021,vacuolar acidification (GO:0007035),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,ATP6V0A1
416,GO_Biological_Process_2021,myotube differentiation (GO:0014902),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,ADGRB3
417,GO_Biological_Process_2021,protein localization to chromatin (GO:0071168),1/21,0.1508042500591137,0.3753581573327612,0,0,6.436688311688312,12.17675084276717,MCM9
418,GO_Biological_Process_2021,rRNA processing (GO:0006364),3/173,0.1510807568899394,0.3753581573327612,0,0,2.284249226006192,4.317095744013317,RPL34;RPL39;RPS24
419,GO_Biological_Process_2021,sodium ion transport (GO:0006814),2/90,0.1542795358893855,0.3775242269124916,0,0,2.9347890671420083,5.485088935421072,SCN2A;SCN3A
420,GO_Biological_Process_2021,mitochondrial respiratory chain complex assembly (GO:0033108),2/90,0.1542795358893855,0.3775242269124916,0,0,2.9347890671420083,5.485088935421072,TIMMDC1;COX20
421,GO_Biological_Process_2021,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,HHEX
422,GO_Biological_Process_2021,regulation of adenylate cyclase activity (GO:0045761),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,CACNA1C
423,GO_Biological_Process_2021,negative regulation of phosphate metabolic process (GO:0045936),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,PRKRIP1
424,GO_Biological_Process_2021,negative regulation of small molecule metabolic process (GO:0062014),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,DKKL1
425,GO_Biological_Process_2021,cellular response to osmotic stress (GO:0071470),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,SCN2A
426,GO_Biological_Process_2021,regulation of macrophage chemotaxis (GO:0010758),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,MTUS1
427,GO_Biological_Process_2021,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,GPLD1
428,GO_Biological_Process_2021,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,MED30
429,GO_Biological_Process_2021,regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,PDE4B
430,GO_Biological_Process_2021,limb morphogenesis (GO:0035108),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,MYH3
431,GO_Biological_Process_2021,lipid droplet organization (GO:0034389),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,RAB18
432,GO_Biological_Process_2021,membrane lipid metabolic process (GO:0006643),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,TEX2
433,GO_Biological_Process_2021,metallo-sulfur cluster assembly (GO:0031163),1/22,0.1573924250528543,0.3775242269124916,0,0,6.12987012987013,11.334209985174065,LYRM4
434,GO_Biological_Process_2021,protein transport (GO:0015031),5/369,0.1593168441612333,0.3812616891306755,0,0,1.783974358974359,3.276911728027994,ATP6V1A;STX1B;RABGAP1L;RAB18;ATP6V0A1
435,GO_Biological_Process_2021,blood vessel endothelial cell migration (GO:0043534),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,GPLD1
436,GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,IFI16
437,GO_Biological_Process_2021,regulation of necroptotic process (GO:0060544),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,SLC25A4
438,GO_Biological_Process_2021,ear morphogenesis (GO:0042471),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,NEUROG1
439,GO_Biological_Process_2021,regulation of telomere capping (GO:1904353),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,AURKB
440,GO_Biological_Process_2021,respiratory chain complex IV assembly (GO:0008535),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,COX20
441,GO_Biological_Process_2021,response to nutrient levels (GO:0031667),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,CD68
442,GO_Biological_Process_2021,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,MED30
443,GO_Biological_Process_2021,mitotic cell cycle checkpoint signaling (GO:0007093),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,AURKB
444,GO_Biological_Process_2021,protein deacylation (GO:0035601),1/23,0.163929815349397,0.3827768568758386,0,0,5.850944510035419,10.580361826426786,HDAC3
445,GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),4/274,0.1639946956451719,0.3827768568758386,0,0,1.9205298013245036,3.472166534035242,ATP6V1A;CACNA1C;SCN2A;SCN3A
446,GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),2/94,0.1651619558469531,0.3831617691996171,0,0,2.8066211992043195,5.054244106312554,MAPRE2;GPLD1
447,GO_Biological_Process_2021,hemopoiesis (GO:0030097),2/94,0.1651619558469531,0.3831617691996171,0,0,2.8066211992043195,5.054244106312554,IFI16;TET2
448,GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),10/908,0.1677444535532471,0.3831617691996171,0,0,1.4551109745795254,2.597829365052036,HHEX;HDAC3;ZNF827;IFI16;MED30;E2F1;TET2;MYBL2;SMARCA2;NEUROG1
449,GO_Biological_Process_2021,purine ribonucleotide catabolic process (GO:0009154),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,PDE4D
450,GO_Biological_Process_2021,amino acid import across plasma membrane (GO:0089718),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,SLC1A1
451,GO_Biological_Process_2021,regulation of cell size (GO:0008361),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,SLC9A3R1
452,GO_Biological_Process_2021,cellular response to catecholamine stimulus (GO:0071870),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,PDE4B
453,GO_Biological_Process_2021,positive regulation of cell-substrate junction organization (GO:0150117),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,MAPRE2
454,GO_Biological_Process_2021,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,HHEX
455,GO_Biological_Process_2021,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,GPLD1
456,GO_Biological_Process_2021,inner ear morphogenesis (GO:0042472),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,NEUROG1
457,GO_Biological_Process_2021,iron-sulfur cluster assembly (GO:0016226),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,LYRM4
458,GO_Biological_Process_2021,lipid translocation (GO:0034204),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,ATP9A
459,GO_Biological_Process_2021,sulfur amino acid metabolic process (GO:0000096),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,MPST
460,GO_Biological_Process_2021,potassium ion homeostasis (GO:0055075),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,SLC12A5
461,GO_Biological_Process_2021,"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,UGGT2
462,GO_Biological_Process_2021,ncRNA 3'-end processing (GO:0043628),1/24,0.1704168099322024,0.3831617691996171,0,0,5.596273291925466,9.902650470022865,TRNT1
463,GO_Biological_Process_2021,double-strand break repair via homologous recombination (GO:0000724),2/97,0.1734104736664521,0.389052377342191,0,0,2.717578259373925,4.7614520591918525,GINS2;MCM9
464,GO_Biological_Process_2021,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,UGGT2
465,GO_Biological_Process_2021,regulation of cAMP-mediated signaling (GO:0043949),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,PDE4D
466,GO_Biological_Process_2021,regulation of cardiac muscle cell action potential (GO:0098901),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,CACNA1C
467,GO_Biological_Process_2021,cAMP-mediated signaling (GO:0019933),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,PDE4D
468,GO_Biological_Process_2021,regulation of myotube differentiation (GO:0010830),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,HDAC3
469,GO_Biological_Process_2021,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,PDE4D
470,GO_Biological_Process_2021,response to hexose (GO:0009746),1/25,0.1768537947593154,0.3908806801368308,0,0,5.362824675324675,9.290728574129565,GPLD1
471,GO_Biological_Process_2021,organic anion transport (GO:0015711),2/99,0.1789464822283736,0.3938335898514522,0,0,2.661276194326528,4.579174116871343,SLC9A3R1;SLC25A4
472,GO_Biological_Process_2021,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),2/99,0.1789464822283736,0.3938335898514522,0,0,2.661276194326528,4.579174116871343,HHEX;THOC6
473,GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),4/286,0.1821591493616123,0.3941199176050345,0,0,1.8376778920670709,3.1293348711761904,E2F1;DKKL1;GPLD1;CTNNBL1
474,GO_Biological_Process_2021,proteoglycan metabolic process (GO:0006029),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,CHST12
475,GO_Biological_Process_2021,negative regulation of protein transport (GO:0051224),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,NDFIP2
476,GO_Biological_Process_2021,clathrin-dependent endocytosis (GO:0072583),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,DNAJC6
477,GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,ESPL1
478,GO_Biological_Process_2021,organelle fission (GO:0048285),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,DNM1
479,GO_Biological_Process_2021,DNA geometric change (GO:0032392),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,MCM9
480,GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,E2F1
481,GO_Biological_Process_2021,endothelial cell development (GO:0001885),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,PDE4D
482,GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,E2F1
483,GO_Biological_Process_2021,mononuclear cell differentiation (GO:1903131),1/26,0.1832411528538297,0.3941199176050345,0,0,5.148051948051948,8.735998174132183,IFI16
484,GO_Biological_Process_2021,ribosome biogenesis (GO:0042254),3/192,0.1870139385466054,0.3998021868329297,0,0,2.0526315789473686,3.44138489272082,RPL34;RPL39;RPS24
485,GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),2/102,0.1873005010984672,0.3998021868329297,0,0,2.581045751633987,4.32335744178112,CHRM3;CACNA1C
486,GO_Biological_Process_2021,bile acid biosynthetic process (GO:0006699),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,OSBPL7
487,GO_Biological_Process_2021,calcium-ion regulated exocytosis (GO:0017156),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,RIMS1
488,GO_Biological_Process_2021,camera-type eye development (GO:0043010),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,CACNA1C
489,GO_Biological_Process_2021,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,CHST12
490,GO_Biological_Process_2021,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,ZMYND11
491,GO_Biological_Process_2021,L-alpha-amino acid transmembrane transport (GO:1902475),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,SLC1A1
492,GO_Biological_Process_2021,monovalent inorganic cation homeostasis (GO:0055067),1/27,0.1895792643766286,0.3998021868329297,0,0,4.9498001998002,8.231260640854018,SLC12A5
493,GO_Biological_Process_2021,chromatin remodeling (GO:0006338),2/103,0.1900974449740146,0.3998021868329297,0,0,2.555361418494791,4.242458224534349,ACTL6A;SMARCA2
494,GO_Biological_Process_2021,mRNA transport (GO:0051028),2/104,0.1929000916286438,0.3998021868329297,0,0,2.530180699730873,4.163622053067811,HHEX;THOC6
495,GO_Biological_Process_2021,regulation of JNK cascade (GO:0046328),2/105,0.1957081869256645,0.3998021868329297,0,0,2.5054889269623706,4.086779585058725,HDAC3;ZMYND11
496,GO_Biological_Process_2021,calcium ion import (GO:0070509),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,CACNA1C
497,GO_Biological_Process_2021,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,ZMYND11
498,GO_Biological_Process_2021,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,GPLD1
499,GO_Biological_Process_2021,cytosolic calcium ion transport (GO:0060401),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,CACNA1C
500,GO_Biological_Process_2021,regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,MAPRE2
501,GO_Biological_Process_2021,regulation of protein transport (GO:0051223),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,NDFIP2
502,GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,RIMS1
503,GO_Biological_Process_2021,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,E2F1
504,GO_Biological_Process_2021,response to interferon-beta (GO:0035456),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,IFI16
505,GO_Biological_Process_2021,sarcomere organization (GO:0045214),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,MYH3
506,GO_Biological_Process_2021,L-amino acid transport (GO:0015807),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,SLC1A1
507,GO_Biological_Process_2021,positive regulation of protein import into nucleus (GO:0042307),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,HDAC3
508,GO_Biological_Process_2021,sulfur compound transport (GO:0072348),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,SLC9A3R1
509,GO_Biological_Process_2021,mucosal immune response (GO:0002385),1/28,0.1958685065175736,0.3998021868329297,0,0,4.766233766233766,7.770446817061417,RPL39
510,GO_Biological_Process_2021,chromosome organization (GO:0051276),2/106,0.1985214802167605,0.4015185746144903,0,0,2.4812719959778784,4.01186440747303,HHEX;HDAC3
511,GO_Biological_Process_2021,RNA export from nucleus (GO:0006405),2/106,0.1985214802167605,0.4015185746144903,0,0,2.4812719959778784,4.01186440747303,HHEX;THOC6
512,GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),3/198,0.1987962079477091,0.4015185746144903,0,0,1.9888663967611333,3.21296406094616,SLC9A3R1;PDE4D;ZMYND11
513,GO_Biological_Process_2021,mRNA export from nucleus (GO:0006406),2/107,0.2013397243650939,0.4015185746144903,0,0,2.457516339869281,3.938812886491429,HHEX;THOC6
514,GO_Biological_Process_2021,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,PDE4D
515,GO_Biological_Process_2021,negative regulation of mRNA catabolic process (GO:1902373),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,E2F1
516,GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,GPR137
517,GO_Biological_Process_2021,dicarboxylic acid transport (GO:0006835),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,SLC1A1
518,GO_Biological_Process_2021,establishment of endothelial barrier (GO:0061028),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,PDE4D
519,GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,ESPL1
520,GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,PRDX1
521,GO_Biological_Process_2021,mismatch repair (GO:0006298),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,MCM9
522,GO_Biological_Process_2021,protein ADP-ribosylation (GO:0006471),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,PARP8
523,GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),1/29,0.2021092536964389,0.4015185746144903,0,0,4.595779220779221,7.348406790668775,ANAPC13
524,GO_Biological_Process_2021,mRNA processing (GO:0006397),4/300,0.2041464608869168,0.4015597303269524,0,0,1.749507785931627,2.7798237075286494,NOVA1;SNRPA;CTNNBL1;THOC6
525,GO_Biological_Process_2021,ncRNA processing (GO:0034470),3/201,0.204753940319104,0.4015597303269524,0,0,1.958433014354067,3.105969616210949,RPL34;RPL39;RPS24
526,GO_Biological_Process_2021,regulation of protein ubiquitination (GO:0031396),2/109,0.2069900940997461,0.4015597303269524,0,0,2.411337120517989,3.7980593404908847,NDFIP2;HDAC3
527,GO_Biological_Process_2021,protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,UGGT2
528,GO_Biological_Process_2021,cardiac muscle cell action potential (GO:0086001),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,CACNA1C
529,GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,BEND6
530,GO_Biological_Process_2021,chondroitin sulfate metabolic process (GO:0030204),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,CHST12
531,GO_Biological_Process_2021,peptidyl-lysine trimethylation (GO:0018023),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,TET2
532,GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,AURKB
533,GO_Biological_Process_2021,regulation of vasoconstriction (GO:0019229),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,CHRM3
534,GO_Biological_Process_2021,histone H3-K4 methylation (GO:0051568),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,TET2
535,GO_Biological_Process_2021,ion homeostasis (GO:0050801),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,SLC12A5
536,GO_Biological_Process_2021,positive regulation of protein import (GO:1904591),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,HDAC3
537,GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,RIMS1
538,GO_Biological_Process_2021,maintenance of blood-brain barrier (GO:0035633),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,SLC1A1
539,GO_Biological_Process_2021,morphogenesis of an epithelium (GO:0002009),1/30,0.2083018774030301,0.4015597303269524,0,0,4.437080161218092,6.960744568453372,SLC9A3R1
540,GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),2/110,0.2098217426497772,0.4037420223630649,0,0,2.388888888888889,3.73024272168158,SLC9A3R1;PRKRIP1
541,GO_Biological_Process_2021,proteoglycan biosynthetic process (GO:0030166),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,CHST12
542,GO_Biological_Process_2021,regulation of cellular component size (GO:0032535),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,SLC9A3R1
543,GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,CACNA1C
544,GO_Biological_Process_2021,negative regulation of response to biotic stimulus (GO:0002832),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,IFI16
545,GO_Biological_Process_2021,peptidyl-asparagine modification (GO:0018196),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,UGGT2
546,GO_Biological_Process_2021,phospholipid translocation (GO:0045332),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,ATP9A
547,GO_Biological_Process_2021,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.2144467463020621,0.4073705527380414,0,0,4.288961038961039,6.603686893515271,OSBPL7
548,GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),2/112,0.2154967996968651,0.4078766699717029,0,0,2.3452168746286395,3.599460482415453,RIMS1;SLC9A3R1
549,GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),2/112,0.2154967996968651,0.4078766699717029,0,0,2.3452168746286395,3.599460482415453,ATP6V1A;ATP6V0A1
550,GO_Biological_Process_2021,sulfur compound biosynthetic process (GO:0044272),2/113,0.2183397511824014,0.4099759636264062,0,0,2.3239710298533827,3.536393543300476,MPST;CHST12
551,GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),4/310,0.220310818842585,0.4099759636264062,0,0,1.691468640436307,2.558711535139301,E2F1;DKKL1;GPLD1;CTNNBL1
552,GO_Biological_Process_2021,regulation of dendrite morphogenesis (GO:0048814),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,ADGRB3
553,GO_Biological_Process_2021,chondrocyte differentiation (GO:0002062),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,GPLD1
554,GO_Biological_Process_2021,DNA damage checkpoint signaling (GO:0000077),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,E2F1
555,GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,E2F1
556,GO_Biological_Process_2021,superoxide metabolic process (GO:0006801),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,PRDX1
557,GO_Biological_Process_2021,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,OCIAD1
558,GO_Biological_Process_2021,positive regulation of telomere maintenance (GO:0032206),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,AURKB
559,GO_Biological_Process_2021,mitochondrial membrane organization (GO:0007006),1/32,0.2205442263504202,0.4099759636264062,0,0,4.150397989107667,6.273978302469515,SLC25A4
560,GO_Biological_Process_2021,histone modification (GO:0016570),2/114,0.2211860187526702,0.4104360882736715,0,0,2.3031045751633985,3.474811832253972,AURKB;NEK11
561,GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),5/417,0.2230391813056968,0.4121989811947381,0,0,1.5722491909385112,2.3590149842695287,CHRM3;RPL34;VWA1;RPL39;RPS24
562,GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),2/115,0.2240353819675974,0.4121989811947381,0,0,2.282607438255538,3.414669529012476,ALDH1L1;MTHFD2L
563,GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),2/115,0.2240353819675974,0.4121989811947381,0,0,2.282607438255538,3.414669529012476,PDE4B;CD68
564,GO_Biological_Process_2021,apoptotic cell clearance (GO:0043277),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,XKR7
565,GO_Biological_Process_2021,bile acid metabolic process (GO:0008206),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,OSBPL7
566,GO_Biological_Process_2021,neuron projection extension (GO:1990138),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,IMPACT
567,GO_Biological_Process_2021,RNA stabilization (GO:0043489),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,E2F1
568,GO_Biological_Process_2021,signal transduction by p53 class mediator (GO:0072331),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,IFI16
569,GO_Biological_Process_2021,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,OCIAD1
570,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.2265946805711609,0.4121989811947381,0,0,4.02049512987013,5.968796536704066,AURKB
571,GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),2/116,0.2268876236547405,0.4121989811947381,0,0,2.262469900240798,3.355922585069313,STX1B;IMPACT
572,GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),2/116,0.2268876236547405,0.4121989811947381,0,0,2.262469900240798,3.355922585069313,SPTSSB;TEX2
573,GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),3/214,0.2310153246947863,0.4160395302433088,0,0,1.8365552506859568,2.6910515711185226,RABGAP1L;MAPRE2;RGS6
574,GO_Biological_Process_2021,translation (GO:0006412),3/214,0.2310153246947863,0.4160395302433088,0,0,1.8365552506859568,2.6910515711185226,RPL34;RPL39;RPS24
575,GO_Biological_Process_2021,regulation of glucose metabolic process (GO:0010906),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,GPLD1
576,GO_Biological_Process_2021,female gamete generation (GO:0007292),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,MCM9
577,GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,E2F1
578,GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,ESPL1
579,GO_Biological_Process_2021,positive regulation of telomerase activity (GO:0051973),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,AURKB
580,GO_Biological_Process_2021,protein insertion into membrane (GO:0051205),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,REEP1
581,GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),1/34,0.2325984693579306,0.4160395302433088,0,0,3.898465171192444,5.685683857821177,MCM9
582,GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),2/120,0.2383211390650813,0.42162435352036,0,0,2.185332890218234,3.1340649873038147,PDE4B;CD68
583,GO_Biological_Process_2021,cellular response to hydrogen peroxide (GO:0070301),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,IMPACT
584,GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,CHRM3
585,GO_Biological_Process_2021,regulation of regulated secretory pathway (GO:1903305),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,RIMS1
586,GO_Biological_Process_2021,regulation of TORC1 signaling (GO:1903432),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,GPR137
587,GO_Biological_Process_2021,regulation of trans-synaptic signaling (GO:0099177),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,GRIK4
588,GO_Biological_Process_2021,positive regulation of lipid biosynthetic process (GO:0046889),1/35,0.2385559502627205,0.42162435352036,0,0,3.783613445378151,5.422490920943929,GPLD1
589,GO_Biological_Process_2021,cellular response to lipid (GO:0071396),3/219,0.2412806599234999,0.4220408703545891,0,0,1.7935855263157894,2.5501099631878934,PDE4B;CD68;GPLD1
590,GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),5/430,0.2415083715038352,0.4220408703545891,0,0,1.5231372549019608,2.164151307864616,TGIF2;ZNF219;E2F1;MYBL2;SMARCA2
591,GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),4/323,0.2418126199602439,0.4220408703545891,0,0,1.6214577840519837,2.301808742499778,IMPACT;PDE4B;CD68;GPLD1
592,GO_Biological_Process_2021,negative regulation of fat cell differentiation (GO:0045599),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,E2F1
593,GO_Biological_Process_2021,regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,E2F1
594,GO_Biological_Process_2021,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,CDH8
595,GO_Biological_Process_2021,cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,PDE4D
596,GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,GPR137
597,GO_Biological_Process_2021,regulation of protein import into nucleus (GO:0042306),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,HDAC3
598,GO_Biological_Process_2021,retina homeostasis (GO:0001895),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,PRDX1
599,GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,ESPL1
600,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,IFI16
601,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,AURKB
602,GO_Biological_Process_2021,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/36,0.2444674782169233,0.4220408703545891,0,0,3.675324675324675,5.177330608217989,PLCB3
603,GO_Biological_Process_2021,proton transmembrane transport (GO:1902600),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,ATP6V1A
604,GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,NACC2
605,GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,MAPRE2
606,GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,XKR7
607,GO_Biological_Process_2021,regulation of protein autophosphorylation (GO:0031952),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,IMPACT
608,GO_Biological_Process_2021,positive regulation of cytokinesis (GO:0032467),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,AURKB
609,GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,REEP5
610,GO_Biological_Process_2021,glutamate receptor signaling pathway (GO:0007215),1/37,0.2503334052868782,0.4265091242285438,0,0,3.573051948051948,4.948539844529104,GRIK4
611,GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),2/126,0.2555227625023401,0.4314828453405807,0,0,2.0789584651064725,2.836621953407555,PIGB;MPPE1
612,GO_Biological_Process_2021,actin-myosin filament sliding (GO:0033275),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,MYH3
613,GO_Biological_Process_2021,negative regulation of G0 to G1 transition (GO:0070317),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,E2F1
614,GO_Biological_Process_2021,negative regulation of innate immune response (GO:0045824),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,IFI16
615,GO_Biological_Process_2021,positive regulation of insulin secretion (GO:0032024),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,GPLD1
616,GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,RIMS1
617,GO_Biological_Process_2021,muscle filament sliding (GO:0030049),1/38,0.2561540810955608,0.4314828453405807,0,0,3.4763074763074764,4.734647825101587,MYH3
618,GO_Biological_Process_2021,cilium organization (GO:0044782),3/228,0.2599410499971909,0.4369695132882053,0,0,1.7210526315789474,2.3187749066128567,SLC9A3R1;TMEM138;FAM161B
619,GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/128,0.2612641495173021,0.4369695132882053,0,0,2.045751633986928,2.745855542573781,ESPL1;AURKB
620,GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),1/39,0.2619298523456677,0.4369695132882053,0,0,3.384654818865345,4.534349460692842,ADGRB3
621,GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.2619298523456677,0.4369695132882053,0,0,3.384654818865345,4.534349460692842,CACNA1C
622,GO_Biological_Process_2021,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.2619298523456677,0.4369695132882053,0,0,3.384654818865345,4.534349460692842,CHRM3
623,GO_Biological_Process_2021,DNA integrity checkpoint signaling (GO:0031570),1/39,0.2619298523456677,0.4369695132882053,0,0,3.384654818865345,4.534349460692842,E2F1
624,GO_Biological_Process_2021,nervous system development (GO:0007399),5/447,0.2662559960923727,0.4415771266004052,0,0,1.4632730015082955,1.936344834062267,CHRM3;ACTL6A;SCN2A;NEUROG1;THOC6
625,GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,ZMYND11
626,GO_Biological_Process_2021,carboxylic acid metabolic process (GO:0019752),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,SLC23A2
627,GO_Biological_Process_2021,negative regulation of protein kinase B signaling (GO:0051898),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,SLC9A3R1
628,GO_Biological_Process_2021,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,SLC9A3R1
629,GO_Biological_Process_2021,ribosomal small subunit biogenesis (GO:0042274),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,RPS24
630,GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),1/40,0.2676610632899671,0.4415771266004052,0,0,3.2977022977022976,4.346483051407713,MPST
631,GO_Biological_Process_2021,regulation of G0 to G1 transition (GO:0070316),1/41,0.273348055509039,0.4474140342530025,0,0,3.2150974025974026,4.170011447706375,E2F1
632,GO_Biological_Process_2021,nucleobase-containing compound catabolic process (GO:0034655),1/41,0.273348055509039,0.4474140342530025,0,0,3.2150974025974026,4.170011447706375,NUDT1
633,GO_Biological_Process_2021,endosome organization (GO:0007032),1/41,0.273348055509039,0.4474140342530025,0,0,3.2150974025974026,4.170011447706375,DNM1
634,GO_Biological_Process_2021,epithelial cell migration (GO:0010631),1/41,0.273348055509039,0.4474140342530025,0,0,3.2150974025974026,4.170011447706375,PKN3
635,GO_Biological_Process_2021,visual system development (GO:0150063),1/41,0.273348055509039,0.4474140342530025,0,0,3.2150974025974026,4.170011447706375,RAB18
636,GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),6/566,0.2758783445698338,0.4508467138103563,0,0,1.386744966442953,1.7858436375773488,SLC9A3R1;IMPACT;NACC2;SMARCA2;GPLD1;IFIT3
637,GO_Biological_Process_2021,ceramide biosynthetic process (GO:0046513),1/42,0.278991167899673,0.4537965715368119,0,0,3.136522014570795,4.004006073572531,SPTSSB
638,GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.278991167899673,0.4537965715368119,0,0,3.136522014570795,4.004006073572531,E2F1
639,GO_Biological_Process_2021,potassium ion import across plasma membrane (GO:1990573),1/42,0.278991167899673,0.4537965715368119,0,0,3.136522014570795,4.004006073572531,SLC12A5
640,GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.2842290391712582,0.457189748683145,0,0,1.9228367964101063,2.418880407245809,SLC9A3R1;ANK1
641,GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,WASHC2C
642,GO_Biological_Process_2021,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,MCM9
643,GO_Biological_Process_2021,glutathione metabolic process (GO:0006749),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,ETHE1
644,GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,RIMS1
645,GO_Biological_Process_2021,substantia nigra development (GO:0021762),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,CKB
646,GO_Biological_Process_2021,myofibril assembly (GO:0030239),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,MYH3
647,GO_Biological_Process_2021,natural killer cell activation (GO:0030101),1/43,0.2845907369324476,0.457189748683145,0,0,3.061688311688312,3.8476333196795687,PRDX1
648,GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,RPL39
649,GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,RIMS1
650,GO_Biological_Process_2021,positive regulation of cell division (GO:0051781),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,AURKB
651,GO_Biological_Process_2021,metal ion homeostasis (GO:0055065),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,SLC12A5
652,GO_Biological_Process_2021,mitotic spindle assembly (GO:0090307),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,AURKB
653,GO_Biological_Process_2021,mRNA stabilization (GO:0048255),1/44,0.2901470963848315,0.4618396442455804,0,0,2.9903352461492,3.700142917107279,E2F1
654,GO_Biological_Process_2021,amino acid transmembrane transport (GO:0003333),1/45,0.2956605775351539,0.4663877267109289,0,0,2.9222255017709564,3.560857955999816,SLC38A6
655,GO_Biological_Process_2021,cellular response to radiation (GO:0071478),1/45,0.2956605775351539,0.4663877267109289,0,0,2.9222255017709564,3.560857955999816,IFI16
656,GO_Biological_Process_2021,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.2956605775351539,0.4663877267109289,0,0,2.9222255017709564,3.560857955999816,OCIAD1
657,GO_Biological_Process_2021,zymogen activation (GO:0031638),1/45,0.2956605775351539,0.4663877267109289,0,0,2.9222255017709564,3.560857955999816,IFI16
658,GO_Biological_Process_2021,protein deacetylation (GO:0006476),1/45,0.2956605775351539,0.4663877267109289,0,0,2.9222255017709564,3.560857955999816,HDAC3
659,GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.2956925068484275,0.4663877267109289,0,0,1.8667235009946008,2.2744816088925184,SLC9A3R1;ANK1
660,GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),5/468,0.2975689963901505,0.4686374058126274,0,0,1.3953923686105112,1.6913678721311751,TGIF2;ZNF219;E2F1;MYBL2;SMARCA2
661,GO_Biological_Process_2021,regulation of fibroblast proliferation (GO:0048145),1/46,0.3011315091318221,0.4706875390483885,0,0,2.857142857142857,3.429166292099496,E2F1
662,GO_Biological_Process_2021,regulation of telomerase activity (GO:0051972),1/46,0.3011315091318221,0.4706875390483885,0,0,2.857142857142857,3.429166292099496,AURKB
663,GO_Biological_Process_2021,interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.3011315091318221,0.4706875390483885,0,0,2.857142857142857,3.429166292099496,TYK2
664,GO_Biological_Process_2021,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.3011315091318221,0.4706875390483885,0,0,2.857142857142857,3.429166292099496,HDAC3
665,GO_Biological_Process_2021,vesicle organization (GO:0016050),1/46,0.3011315091318221,0.4706875390483885,0,0,2.857142857142857,3.429166292099496,DNM1
666,GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.3042736554341249,0.4748858700253733,0,0,1.826727854262272,2.173491584305896,NWD1;COMMD6
667,GO_Biological_Process_2021,negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.3065602174785805,0.4763122185003019,0,0,2.79488989271598,3.3045131196563458,NOVA1
668,GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.3065602174785805,0.4763122185003019,0,0,2.79488989271598,3.3045131196563458,PLCB3
669,GO_Biological_Process_2021,histone deacetylation (GO:0016575),1/47,0.3065602174785805,0.4763122185003019,0,0,2.79488989271598,3.3045131196563458,HDAC3
670,GO_Biological_Process_2021,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",3/251,0.3083370116722549,0.4782575174357701,0,0,1.5596084465195246,1.8349758778122371,NOVA1;SNRPA;CTNNBL1
671,GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),3/252,0.3104544012898885,0.4782575174357701,0,0,1.553265694356373,1.816883220688721,STX1B;RIMS1;HHEX
672,GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",11/1183,0.310563457264132,0.4782575174357701,0,0,1.2170731418278349,1.4232052018275725,HHEX;HDAC3;ZNF827;IFI16;MED30;CDCA4;E2F1;TET2;MYBL2;SMARCA2;NEUROG1
673,GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,SLC9A3R1
674,GO_Biological_Process_2021,cellular response to interleukin-12 (GO:0071349),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,TYK2
675,GO_Biological_Process_2021,cellular response to ionizing radiation (GO:0071479),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,IFI16
676,GO_Biological_Process_2021,histone H4 acetylation (GO:0043967),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,ACTL6A
677,GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,PLCB3
678,GO_Biological_Process_2021,myelination (GO:0042552),1/48,0.3119470262621401,0.4782575174357701,0,0,2.7352859906051394,3.186394534645299,SCN2A
679,GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.3125723021731489,0.4785114214150706,0,0,1.5469736842105264,1.7990058163470806,SLC9A3R1;HHEX;DKKL1
680,GO_Biological_Process_2021,adherens junction organization (GO:0034332),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,CDH8
681,GO_Biological_Process_2021,negative regulation of cell projection organization (GO:0031345),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,STX1B
682,GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,DNM1
683,GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,REEP5
684,GO_Biological_Process_2021,positive regulation of actin filament polymerization (GO:0030838),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,WASHC2C
685,GO_Biological_Process_2021,response to glucose (GO:0009749),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,GPLD1
686,GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,IMPACT
687,GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),1/49,0.3172922568741916,0.4800890107645835,0,0,2.6781655844155843,3.0743519324254893,ESPL1
688,GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),2/148,0.3185327692110475,0.4812664916526858,0,0,1.7637210135195631,2.0177496156419243,HDAC3;E2F1
689,GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),2/149,0.321376948837597,0.484592602416881,0,0,1.7516339869281046,1.9883507661878144,MAPRE2;RGS6
690,GO_Biological_Process_2021,amino acid transport (GO:0006865),1/50,0.3225962281219006,0.484592602416881,0,0,2.623376623376624,2.9679671260643183,SLC38A6
691,GO_Biological_Process_2021,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.3225962281219006,0.484592602416881,0,0,2.623376623376624,2.9679671260643183,SLC9A3R1
692,GO_Biological_Process_2021,organic hydroxy compound biosynthetic process (GO:1901617),1/50,0.3225962281219006,0.484592602416881,0,0,2.623376623376624,2.9679671260643183,OSBPL7
693,GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),3/258,0.3231671228390543,0.4847506842585815,0,0,1.5162538699690402,1.7127386608820712,IMPACT;NEUROG1;BEND6
694,GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),2/150,0.324218276468499,0.4856276630269172,0,0,1.739710298533828,1.959502335297862,IMPACT;SLC1A1
695,GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.3278592564128742,0.4882710814389157,0,0,2.5707792207792206,2.866858071905812,NDFIP2
696,GO_Biological_Process_2021,DNA duplex unwinding (GO:0032508),1/51,0.3278592564128742,0.4882710814389157,0,0,2.5707792207792206,2.866858071905812,MCM9
697,GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.3278592564128742,0.4882710814389157,0,0,2.5707792207792206,2.866858071905812,WASHC2C
698,GO_Biological_Process_2021,inositol lipid-mediated signaling (GO:0048017),1/51,0.3278592564128742,0.4882710814389157,0,0,2.5707792207792206,2.866858071905812,PLCB3
699,GO_Biological_Process_2021,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,DKKL1
700,GO_Biological_Process_2021,ameboidal-type cell migration (GO:0001667),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,PKN3
701,GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,SPTSSB
702,GO_Biological_Process_2021,cartilage development (GO:0051216),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,GPLD1
703,GO_Biological_Process_2021,negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,IMPACT
704,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,SLC9A3R1
705,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,PDE4D
706,GO_Biological_Process_2021,regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,AURKB
707,GO_Biological_Process_2021,positive regulation of developmental growth (GO:0048639),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,RIMS1
708,GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,E2F1
709,GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),1/52,0.333081655717353,0.4883633853545978,0,0,2.520244461420932,2.7706751218434675,GPLD1
710,GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.3382637377900799,0.4938745456374098,0,0,2.471653346653347,2.6790977252069794,IFI16
711,GO_Biological_Process_2021,cellular macromolecule catabolic process (GO:0044265),1/53,0.3382637377900799,0.4938745456374098,0,0,2.471653346653347,2.6790977252069794,NCCRP1
712,GO_Biological_Process_2021,positive regulation of macroautophagy (GO:0016239),1/53,0.3382637377900799,0.4938745456374098,0,0,2.471653346653347,2.6790977252069794,SLC25A4
713,GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),3/266,0.3401214017500587,0.4958912874255057,0,0,1.4695317190314188,1.5848203930092823,SLC9A3R1;IMPACT;HDAC3
714,GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),3/267,0.3422395743188891,0.4971981224551166,0,0,1.4638905502392343,1.5696482653182438,SLC9A3R1;HHEX;BEND6
715,GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.3434058117629479,0.4971981224551166,0,0,2.424895858858123,2.5918315252533666,NOVA1
716,GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),1/54,0.3434058117629479,0.4971981224551166,0,0,2.424895858858123,2.5918315252533666,IFI16
717,GO_Biological_Process_2021,regulation of proteasomal protein catabolic process (GO:0061136),1/54,0.3434058117629479,0.4971981224551166,0,0,2.424895858858123,2.5918315252533666,OSBPL7
718,GO_Biological_Process_2021,striated muscle contraction (GO:0006941),1/54,0.3434058117629479,0.4971981224551166,0,0,2.424895858858123,2.5918315252533666,MYH3
719,GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),2/158,0.3468315288658418,0.5011008566021263,0,0,1.6498240321769733,1.7470252702985478,PDE4D;PDE4B
720,GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),1/55,0.3485081846108929,0.5011008566021263,0,0,2.3798701298701297,2.5086057865847664,SPTSSB
721,GO_Biological_Process_2021,glycoprotein metabolic process (GO:0009100),1/55,0.3485081846108929,0.5011008566021263,0,0,2.3798701298701297,2.5086057865847664,NCCRP1
722,GO_Biological_Process_2021,interstrand cross-link repair (GO:0036297),1/55,0.3485081846108929,0.5011008566021263,0,0,2.3798701298701297,2.5086057865847664,MCM9
723,GO_Biological_Process_2021,positive regulation of response to DNA damage stimulus (GO:2001022),1/55,0.3485081846108929,0.5011008566021263,0,0,2.3798701298701297,2.5086057865847664,NACC2
724,GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),2/159,0.3496417609327495,0.5020373422496445,0,0,1.6392323383705925,1.7225810554422958,PDE4B;CD68
725,GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),7/742,0.3527281191243219,0.5021385790238886,0,0,1.2297297297297298,1.2814493578702597,HDAC3;E2F1;DKKL1;GPLD1;IFIT3;CTNNBL1;THOC6
726,GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,SLC1A1
727,GO_Biological_Process_2021,negative regulation of metabolic process (GO:0009892),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,NOVA1
728,GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,E2F1
729,GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,E2F1
730,GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,IFI16
731,GO_Biological_Process_2021,sensory organ development (GO:0007423),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,RAB18
732,GO_Biological_Process_2021,mitochondrial transport (GO:0006839),1/56,0.3535711608304614,0.5021385790238886,0,0,2.336481700118064,2.429171121426597,SLC25A4
733,GO_Biological_Process_2021,"mRNA splicing, via spliceosome (GO:0000398)",3/274,0.3570507563689866,0.5063894242235899,0,0,1.4255680714701884,1.468160242893027,NOVA1;SNRPA;CTNNBL1
734,GO_Biological_Process_2021,"positive regulation of gene expression, epigenetic (GO:0045815)",1/57,0.3585950426235817,0.5065094157003373,0,0,2.294642857142857,2.3532974672725504,CDCA4
735,GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.3585950426235817,0.5065094157003373,0,0,2.294642857142857,2.3532974672725504,GPLD1
736,GO_Biological_Process_2021,monocarboxylic acid transport (GO:0015718),1/57,0.3585950426235817,0.5065094157003373,0,0,2.294642857142857,2.3532974672725504,SLC9A3R1
737,GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,DNM1
738,GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,SARAF
739,GO_Biological_Process_2021,negative regulation of neuron projection development (GO:0010977),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,STX1B
740,GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,ATP6V1A
741,GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,ESPL1
742,GO_Biological_Process_2021,membrane lipid biosynthetic process (GO:0046467),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,SPTSSB
743,GO_Biological_Process_2021,mitochondrial respiratory chain complex I assembly (GO:0032981),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,TIMMDC1
744,GO_Biological_Process_2021,muscle organ development (GO:0007517),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,MYH3
745,GO_Biological_Process_2021,NADH dehydrogenase complex assembly (GO:0010257),1/58,0.363580129986133,0.5073551143640275,0,0,2.254272043745728,2.2807722879324426,TIMMDC1
746,GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),2/165,0.3664150514948304,0.5106265978662897,0,0,1.5784113236296564,1.584706923923932,SLC9A3R1;DKKL1
747,GO_Biological_Process_2021,phospholipid transport (GO:0015914),1/59,0.368526720509172,0.5108339760985994,0,0,2.215293327362293,2.211398971117866,ATP9A
748,GO_Biological_Process_2021,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.368526720509172,0.5108339760985994,0,0,2.215293327362293,2.211398971117866,SLC9A3R1
749,GO_Biological_Process_2021,regulation of secretion by cell (GO:1903530),1/59,0.368526720509172,0.5108339760985994,0,0,2.215293327362293,2.211398971117866,RIMS1
750,GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.368526720509172,0.5108339760985994,0,0,2.215293327362293,2.211398971117866,NEK11
751,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.3734351095815957,0.5155781817963411,0,0,2.1776359233986358,2.1449953942099538,CHRM3
752,GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.3734351095815957,0.5155781817963411,0,0,2.1776359233986358,2.1449953942099538,SLC1A1
753,GO_Biological_Process_2021,ribonucleoprotein complex biogenesis (GO:0022613),1/60,0.3734351095815957,0.5155781817963411,0,0,2.1776359233986358,2.1449953942099538,RPS24
754,GO_Biological_Process_2021,phosphorylation (GO:0016310),4/400,0.3754481191292025,0.5176708503490064,0,0,1.3010234798314269,1.2745281133668156,PKN3;TYK2;AURKB;NEK11
755,GO_Biological_Process_2021,B cell differentiation (GO:0030183),1/61,0.3783055902922233,0.5188618175154209,0,0,2.1412337662337664,2.08139264203368,HHEX
756,GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/61,0.3783055902922233,0.5188618175154209,0,0,2.1412337662337664,2.08139264203368,MED30
757,GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.3783055902922233,0.5188618175154209,0,0,2.1412337662337664,2.08139264203368,AURKB
758,GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.3783055902922233,0.5188618175154209,0,0,2.1412337662337664,2.08139264203368,ATP6V1A
759,GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),7/764,0.3806633931451181,0.5213687976511723,0,0,1.1926166589310578,1.151876607806983,SLC9A3R1;HHEX;NACC2;NCCRP1;SMARCA2;GPLD1;IFIT3
760,GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),4/404,0.382478319270186,0.5213687976511723,0,0,1.2877483443708608,1.237633439926763,ATP6V1A;GPLD1;DNM1;ATP6V0A1
761,GO_Biological_Process_2021,negative regulation of kinase activity (GO:0033673),1/62,0.3831384536053283,0.5213687976511723,0,0,2.106025122418565,2.0204338552297143,PRKRIP1
762,GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.3831384536053283,0.5213687976511723,0,0,2.106025122418565,2.0204338552297143,IFI16
763,GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),1/62,0.3831384536053283,0.5213687976511723,0,0,2.106025122418565,2.0204338552297143,IFI16
764,GO_Biological_Process_2021,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.3831384536053283,0.5213687976511723,0,0,2.106025122418565,2.0204338552297143,TBKBP1
765,GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,IFI16
766,GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,E2F1
767,GO_Biological_Process_2021,cellular response to reactive oxygen species (GO:0034614),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,IMPACT
768,GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,MPST
769,GO_Biological_Process_2021,positive regulation of Ras protein signal transduction (GO:0046579),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,MAPRE2
770,GO_Biological_Process_2021,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.3879339880975881,0.5237863574702843,0,0,2.07195224130708,1.961973197846402,OSBPL7
771,GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,RPL39
772,GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,ZMYND11
773,GO_Biological_Process_2021,regulation of innate immune response (GO:0045088),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,IFI16
774,GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,MED30
775,GO_Biological_Process_2021,tRNA processing (GO:0008033),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,TRNT1
776,GO_Biological_Process_2021,protein catabolic process (GO:0030163),1/64,0.3926924802567047,0.5261169523130368,0,0,2.038961038961039,1.9058749250092195,NCCRP1
777,GO_Biological_Process_2021,mitochondrion organization (GO:0007005),2/175,0.3939906567805735,0.5271777297025413,0,0,1.4864180739733273,1.384491538248148,SLC25A4;DNM1
778,GO_Biological_Process_2021,regulation of RNA metabolic process (GO:0051252),1/65,0.3974142144717875,0.529038615428556,0,0,2.007000811688312,1.8520125439289237,NOVA1
779,GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.3974142144717875,0.529038615428556,0,0,2.007000811688312,1.8520125439289237,CHRM3
780,GO_Biological_Process_2021,steroid biosynthetic process (GO:0006694),1/65,0.3974142144717875,0.529038615428556,0,0,2.007000811688312,1.8520125439289237,OSBPL7
781,GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),1/65,0.3974142144717875,0.529038615428556,0,0,2.007000811688312,1.8520125439289237,E2F1
782,GO_Biological_Process_2021,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/66,0.4020994726804225,0.5319546325340503,0,0,1.976023976023976,1.8002680578468673,AURKB
783,GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),1/66,0.4020994726804225,0.5319546325340503,0,0,1.976023976023976,1.8002680578468673,CDH8
784,GO_Biological_Process_2021,cellular response to nutrient levels (GO:0031669),1/66,0.4020994726804225,0.5319546325340503,0,0,1.976023976023976,1.8002680578468673,CD68
785,GO_Biological_Process_2021,regulation of protein localization (GO:0032880),1/66,0.4020994726804225,0.5319546325340503,0,0,1.976023976023976,1.8002680578468673,RABGAP1L
786,GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),2/178,0.4021597462096998,0.5319546325340503,0,0,1.460858585858586,1.3307046912885878,SLC9A3R1;NEK11
787,GO_Biological_Process_2021,protein N-linked glycosylation (GO:0006487),1/67,0.4067485349917286,0.5366606146088586,0,0,1.9459858323494688,1.7505312773378598,UGGT2
788,GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),1/67,0.4067485349917286,0.5366606146088586,0,0,1.9459858323494688,1.7505312773378598,IFI16
789,GO_Biological_Process_2021,regulation of translational initiation (GO:0006446),1/68,0.4113616791408475,0.5413748520677905,0,0,1.9168443496801704,1.7026992020024727,IMPACT
790,GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.4113616791408475,0.5413748520677905,0,0,1.9168443496801704,1.7026992020024727,HDAC3
791,GO_Biological_Process_2021,negative regulation of cellular catabolic process (GO:0031330),1/69,0.4159391809029937,0.5446448897107125,0,0,1.8885599694423223,1.656675454939586,GPLD1
792,GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.4159391809029937,0.5446448897107125,0,0,1.8885599694423223,1.656675454939586,GPLD1
793,GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.4159391809029937,0.5446448897107125,0,0,1.8885599694423223,1.656675454939586,SCN2A
794,GO_Biological_Process_2021,RNA 3'-end processing (GO:0031123),1/69,0.4159391809029937,0.5446448897107125,0,0,1.8885599694423223,1.656675454939586,THOC6
795,GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),1/70,0.4204813138786264,0.5471640002982386,0,0,1.8610954263128177,1.61236977178465,AURKB
796,GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),1/70,0.4204813138786264,0.5471640002982386,0,0,1.8610954263128177,1.61236977178465,IFI16
797,GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),1/70,0.4204813138786264,0.5471640002982386,0,0,1.8610954263128177,1.61236977178465,PDE4B
798,GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),1/70,0.4204813138786264,0.5471640002982386,0,0,1.8610954263128177,1.61236977178465,RPL39
799,GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),2/185,0.4210166803447542,0.5471640002982386,0,0,1.4044787313832636,1.2149904290374027,PDE4D;PDE4B
800,GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.4210166803447542,0.5471640002982386,0,0,1.4044787313832636,1.2149904290374027,MPPE1;ANK1
801,GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.424988349541581,0.5488993447553174,0,0,1.8344155844155845,1.5696975345824375,E2F1
802,GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.424988349541581,0.5488993447553174,0,0,1.8344155844155845,1.5696975345824375,PLCB3
803,GO_Biological_Process_2021,regulation of TOR signaling (GO:0032006),1/71,0.424988349541581,0.5488993447553174,0,0,1.8344155844155845,1.5696975345824375,HDAC3
804,GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.424988349541581,0.5488993447553174,0,0,1.8344155844155845,1.5696975345824375,SLC9A3R1
805,GO_Biological_Process_2021,histone acetylation (GO:0016573),1/71,0.424988349541581,0.5488993447553174,0,0,1.8344155844155845,1.5696975345824375,ACTL6A
806,GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),2/188,0.4290061274814257,0.5526185910959851,0,0,1.3816150115960362,1.169238784833907,E2F1;NEK11
807,GO_Biological_Process_2021,response to ionizing radiation (GO:0010212),1/72,0.4294605573454869,0.5526185910959851,0,0,1.8084872873605269,1.5285793468391171,IFI16
808,GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.4294605573454869,0.5526185910959851,0,0,1.8084872873605269,1.5285793468391171,STX1B
809,GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),2/189,0.4316565199063786,0.5547585644722718,0,0,1.374156792841914,1.154463612728904,MAPRE2;RGS6
810,GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),1/73,0.4338982047853735,0.5562660482531697,0,0,1.7832792207792207,1.4889406460251045,PDE4B
811,GO_Biological_Process_2021,ubiquitin-dependent ERAD pathway (GO:0030433),1/73,0.4338982047853735,0.5562660482531697,0,0,1.7832792207792207,1.4889406460251045,NCCRP1
812,GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),2/191,0.436937805711537,0.5577896343791714,0,0,1.3594771241830066,1.1255986818863155,SLC9A3R1;DKKL1
813,GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.438301557081808,0.5577896343791714,0,0,1.7587617861590463,1.4507113511098748,AURKB
814,GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1/74,0.438301557081808,0.5577896343791714,0,0,1.7587617861590463,1.4507113511098748,E2F1
815,GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.438301557081808,0.5577896343791714,0,0,1.7587617861590463,1.4507113511098748,CACNA1C
816,GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.438301557081808,0.5577896343791714,0,0,1.7587617861590463,1.4507113511098748,SPTSSB
817,GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),1/74,0.438301557081808,0.5577896343791714,0,0,1.7587617861590463,1.4507113511098748,ESPL1
818,GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),18/2206,0.4457099178303186,0.5659356320668196,0,0,1.060282362988564,0.856800337688287,ZNF396;TGIF2;HDAC3;ACTL6A;TET2;SMARCA2;AURKB;MED29;IMPACT;HHEX;ZNF827;IFI16;MED30;NACC2;ZNF219;E2F1;MYBL2;NEUROG1
819,GO_Biological_Process_2021,regulation of cell division (GO:0051302),1/76,0.4470064278231222,0.5659356320668196,0,0,1.7116883116883117,1.3782211394841255,AURKB
820,GO_Biological_Process_2021,establishment of protein localization to organelle (GO:0072594),1/76,0.4470064278231222,0.5659356320668196,0,0,1.7116883116883117,1.3782211394841255,CD68
821,GO_Biological_Process_2021,RNA transport (GO:0050658),1/76,0.4470064278231222,0.5659356320668196,0,0,1.7116883116883117,1.3782211394841255,THOC6
822,GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.447420773478379,0.5659356320668196,0,0,1.331030512377663,1.0704890088213352,SLC9A3R1;ANK1
823,GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.4513084668329251,0.5680920362431379,0,0,1.6890806561859193,1.3438396833532529,PDE4B
824,GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),1/77,0.4513084668329251,0.5680920362431379,0,0,1.6890806561859193,1.3438396833532529,GPLD1
825,GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),1/77,0.4513084668329251,0.5680920362431379,0,0,1.6890806561859193,1.3438396833532529,SLC12A5
826,GO_Biological_Process_2021,positive regulation of type I interferon production (GO:0032481),1/77,0.4513084668329251,0.5680920362431379,0,0,1.6890806561859193,1.3438396833532529,IFI16
827,GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.4555772521262536,0.5707050775733213,0,0,1.667060212514758,1.3106260320374803,ZMYND11
828,GO_Biological_Process_2021,protein modification process (GO:0036211),1/78,0.4555772521262536,0.5707050775733213,0,0,1.667060212514758,1.3106260320374803,CHRM3
829,GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.4555772521262536,0.5707050775733213,0,0,1.667060212514758,1.3106260320374803,HHEX
830,GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.4555772521262536,0.5707050775733213,0,0,1.667060212514758,1.3106260320374803,HHEX
831,GO_Biological_Process_2021,recombinational repair (GO:0000725),1/79,0.459813039107101,0.5746282997724996,0,0,1.6456043956043955,1.2785281593281552,MCM9
832,GO_Biological_Process_2021,mRNA 3'-end processing (GO:0031124),1/79,0.459813039107101,0.5746282997724996,0,0,1.6456043956043955,1.2785281593281552,THOC6
833,GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),2/201,0.4629398097248122,0.5771096062269179,0,0,1.290504811639899,0.9938929066250386,NDFIP2;AURKB
834,GO_Biological_Process_2021,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.4640160810873489,0.5771096062269179,0,0,1.6246917639322702,1.2474969387201484,HHEX
835,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.4640160810873489,0.5771096062269179,0,0,1.6246917639322702,1.2474969387201484,ZMYND11
836,GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),1/80,0.4640160810873489,0.5771096062269179,0,0,1.6246917639322702,1.2474969387201484,E2F1
837,GO_Biological_Process_2021,negative regulation of protein modification process (GO:0031400),1/81,0.4681866297022675,0.5816017679236999,0,0,1.604301948051948,1.2174859477892066,IMPACT
838,GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.4723249344590365,0.5832624635490593,0,0,1.5844155844155845,1.1884512908284866,HHEX
839,GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),1/82,0.4723249344590365,0.5832624635490593,0,0,1.5844155844155845,1.1884512908284866,CDH8
840,GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.4723249344590365,0.5832624635490593,0,0,1.5844155844155845,1.1884512908284866,RGS6
841,GO_Biological_Process_2021,"regulation of gene expression, epigenetic (GO:0040029)",1/82,0.4723249344590365,0.5832624635490593,0,0,1.5844155844155845,1.1884512908284866,IFI16
842,GO_Biological_Process_2021,ephrin receptor signaling pathway (GO:0048013),1/82,0.4723249344590365,0.5832624635490593,0,0,1.5844155844155845,1.1884512908284866,DNM1
843,GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.4764312430429704,0.5855548099264842,0,0,1.5650142540386442,1.160351432611526,IFI16
844,GO_Biological_Process_2021,peptide metabolic process (GO:0006518),1/83,0.4764312430429704,0.5855548099264842,0,0,1.5650142540386442,1.160351432611526,ETHE1
845,GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.4764312430429704,0.5855548099264842,0,0,1.5650142540386442,1.160351432611526,BEND6
846,GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.4764312430429704,0.5855548099264842,0,0,1.5650142540386442,1.160351432611526,CHST12
847,GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.4805058013327256,0.5870968769804782,0,0,1.546080425598498,1.1331470458203732,AURKB
848,GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),1/84,0.4805058013327256,0.5870968769804782,0,0,1.546080425598498,1.1331470458203732,AURKB
849,GO_Biological_Process_2021,nuclear export (GO:0051168),1/84,0.4805058013327256,0.5870968769804782,0,0,1.546080425598498,1.1331470458203732,THOC6
850,GO_Biological_Process_2021,response to insulin (GO:0032868),1/84,0.4805058013327256,0.5870968769804782,0,0,1.546080425598498,1.1331470458203732,GPLD1
851,GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),1/84,0.4805058013327256,0.5870968769804782,0,0,1.546080425598498,1.1331470458203732,HHEX
852,GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),3/335,0.4824640266579405,0.5872122888467368,0,0,1.1600150602409638,0.845475720513311,IFI16;PDE4D;PDE4B
853,GO_Biological_Process_2021,intracellular protein transport (GO:0006886),3/336,0.4844341989568658,0.5872122888467368,0,0,1.1564722617354195,0.8381806443979651,STX1B;RABGAP1L;RAB18
854,GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.484548853140583,0.5872122888467368,0,0,1.5275974025974026,1.106800870844382,IFI16
855,GO_Biological_Process_2021,B cell activation (GO:0042113),1/85,0.484548853140583,0.5872122888467368,0,0,1.5275974025974026,1.106800870844382,HHEX
856,GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.484548853140583,0.5872122888467368,0,0,1.5275974025974026,1.106800870844382,E2F1
857,GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.484548853140583,0.5872122888467368,0,0,1.5275974025974026,1.106800870844382,ATP9A
858,GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.484548853140583,0.5872122888467368,0,0,1.5275974025974026,1.106800870844382,GPLD1
859,GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.4885606405437286,0.5906987535493862,0,0,1.5095492742551566,1.0812775841638456,GPLD1
860,GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.4885606405437286,0.5906987535493862,0,0,1.5095492742551566,1.0812775841638456,OSBPL7
861,GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),1/87,0.4925414037678645,0.5927579206038692,0,0,1.4919208698278466,1.0565436778339263,HHEX
862,GO_Biological_Process_2021,protein targeting to membrane (GO:0006612),1/87,0.4925414037678645,0.5927579206038692,0,0,1.4919208698278466,1.0565436778339263,MICALL1
863,GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.4925414037678645,0.5927579206038692,0,0,1.4919208698278466,1.0565436778339263,CACNA1C
864,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.4925414037678645,0.5927579206038692,0,0,1.4919208698278466,1.0565436778339263,IMPACT
865,GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.4956751183979345,0.5953458885311468,0,0,1.2105685041312122,0.8496188256680984,NOVA1;NEUROG1
866,GO_Biological_Process_2021,"retrograde transport, endosome to Golgi (GO:0042147)",1/88,0.4964913811934125,0.5953458885311468,0,0,1.4746977160770265,1.0325673473680734,WASHC2C
867,GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,PDE4D
868,GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,GPLD1
869,GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,IFI16
870,GO_Biological_Process_2021,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,NCCRP1
871,GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,CHRM3
872,GO_Biological_Process_2021,mitochondrial translational elongation (GO:0070125),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,MRPS25
873,GO_Biological_Process_2021,mitochondrial translational termination (GO:0070126),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,MRPS25
874,GO_Biological_Process_2021,post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.5004108092841051,0.5953458885311468,0,0,1.457865997638725,1.0093183879258836,DNAJC6
875,GO_Biological_Process_2021,regulation of cell growth (GO:0001558),2/217,0.5030497353643049,0.5972425707973459,0,0,1.1934944520443835,0.8200097412189727,OGFR;SMARCA2
876,GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.5042999228922834,0.5972425707973459,0,0,1.4414125200642054,0.9867680968127808,PRKRIP1
877,GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.5042999228922834,0.5972425707973459,0,0,1.4414125200642054,0.9867680968127808,NOVA1
878,GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.5042999228922834,0.5972425707973459,0,0,1.4414125200642054,0.9867680968127808,NACC2
879,GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),1/91,0.5081589549256513,0.6004466198383689,0,0,1.425324675324675,0.96488918467982,OCIAD1
880,GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.5081589549256513,0.6004466198383689,0,0,1.425324675324675,0.96488918467982,GPLD1
881,GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),3/350,0.511633870337411,0.6036009628977771,0,0,1.1090171393902624,0.7432034073726924,MCM9;E2F1;NUDT1
882,GO_Biological_Process_2021,regulation of lipid metabolic process (GO:0019216),1/92,0.5119881366366351,0.6036009628977771,0,0,1.4095904095904097,0.9436556911618096,HDAC3
883,GO_Biological_Process_2021,"transcription, DNA-templated (GO:0006351)",2/221,0.5127747061861684,0.6038444221038476,0,0,1.1714567105380964,0.7824378426256815,BTF3;E2F1
884,GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),4/481,0.5140375386148286,0.6046475454215103,0,0,1.075596651255779,0.715765454597713,RAB18;PLEKHO2;CD68;ATP6V0A1
885,GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),4/482,0.515671467021503,0.6053382106944822,0,0,1.073291030507911,0.7108249881432155,RIMS1;NWD1;IFI16;E2F1
886,GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),1/93,0.5157876972968355,0.6053382106944822,0,0,1.3941981931112366,0.9230429080306448,PDE4D
887,GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.5195578646566036,0.6075124993532232,0,0,1.379136992040218,0.9030273054750364,IMPACT
888,GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),1/94,0.5195578646566036,0.6075124993532232,0,0,1.379136992040218,0.9030273054750364,SLC9A3R1
889,GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.5195578646566036,0.6075124993532232,0,0,1.379136992040218,0.9030273054750364,SLC9A3R1
890,GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.5199865937356989,0.6075124993532232,0,0,1.155449567214273,0.7556088431049258,NDFIP2;ZMYND11
891,GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),4/485,0.5205582607330211,0.6075124993532232,0,0,1.0664316889482452,0.6962236232591676,RAB18;PLEKHO2;CD68;ATP6V0A1
892,GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),1/95,0.5232988646089584,0.6100270079036122,0,0,1.3643962420558164,0.8835864654839617,NEK11
893,GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),4/488,0.5254221953052427,0.6116146812954715,0,0,1.05965738054841,0.6819458536896053,RAB18;PLEKHO2;CD68;ATP6V0A1
894,GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.5270109213468184,0.6116146812954715,0,0,1.3499658236500345,0.8646990183859043,ATP6V1A
895,GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.5270109213468184,0.6116146812954715,0,0,1.3499658236500345,0.8646990183859043,ATP9A
896,GO_Biological_Process_2021,translational termination (GO:0006415),1/96,0.5270109213468184,0.6116146812954715,0,0,1.3499658236500345,0.8646990183859043,MRPS25
897,GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.5306942574187079,0.6145191568107619,0,0,1.3358360389610389,0.8463445838597365,HDAC3
898,GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.5306942574187079,0.6145191568107619,0,0,1.3358360389610389,0.8463445838597365,CHST12
899,GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.5343490934947801,0.6173778094651122,0,0,1.3219975900388272,0.8285037165324352,PDE4D
900,GO_Biological_Process_2021,RNA splicing (GO:0008380),1/98,0.5343490934947801,0.6173778094651122,0,0,1.3219975900388272,0.8285037165324352,NOVA1
901,GO_Biological_Process_2021,apoptotic process (GO:0006915),2/231,0.5365376831000831,0.6192192107618475,0,0,1.1197305705397151,0.6971649465198242,ESPL1;SCN2A
902,GO_Biological_Process_2021,response to UV (GO:0009411),1/99,0.5379756487839485,0.6198526628793111,0,0,1.3084415584415583,0.811157853500724,AURKB
903,GO_Biological_Process_2021,protein phosphorylation (GO:0006468),4/496,0.5382774325099877,0.6198526628793111,0,0,1.0419964464545308,0.6453929863976444,PKN3;TYK2;AURKB;NEK11
904,GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.5415741406288901,0.6229598678394194,0,0,1.295159386068477,0.7942892672270463,SLC23A2
905,GO_Biological_Process_2021,cellular protein modification process (GO:0006464),8/1025,0.5431596370232494,0.6240940200234025,0,0,1.0075251339473843,0.6149449920613188,CHRM3;PIGT;PKN3;VWA1;TYK2;AURKB;PARP8;NEK11
906,GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.5451447847938456,0.6243077238398166,0,0,1.2821428571428573,0.7778810197667608,PRDX1
907,GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.5451447847938456,0.6243077238398166,0,0,1.2821428571428573,0.7778810197667608,AURKB
908,GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.5451447847938456,0.6243077238398166,0,0,1.2821428571428573,0.7778810197667608,E2F1
909,GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),1/102,0.5486877954904755,0.6249277845794147,0,0,1.2693840812652697,0.7619169205092237,TET2
910,GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.5486877954904755,0.6249277845794147,0,0,1.2693840812652697,0.7619169205092237,IMPACT
911,GO_Biological_Process_2021,cell junction assembly (GO:0034329),1/102,0.5486877954904755,0.6249277845794147,0,0,1.2693840812652697,0.7619169205092237,CDH8
912,GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),1/102,0.5486877954904755,0.6249277845794147,0,0,1.2693840812652697,0.7619169205092237,RIMS1
913,GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),1/102,0.5486877954904755,0.6249277845794147,0,0,1.2693840812652697,0.7619169205092237,ESPL1
914,GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.5522033851102792,0.6282445069943177,0,0,1.2568754774637128,0.7463814872250639,IMPACT
915,GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.5556917645211323,0.630834380443292,0,0,1.244609759172866,0.7312599082361959,CACNA1C
916,GO_Biological_Process_2021,translational elongation (GO:0006414),1/104,0.5556917645211323,0.630834380443292,0,0,1.244609759172866,0.7312599082361959,MRPS25
917,GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),1/105,0.5591531429931211,0.633139270277556,0,0,1.23257992007992,0.7165380077419933,RABGAP1L
918,GO_Biological_Process_2021,mitochondrial translation (GO:0032543),1/105,0.5591531429931211,0.633139270277556,0,0,1.23257992007992,0.7165380077419933,MRPS25
919,GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),4/511,0.5619055888946157,0.633139270277556,0,0,1.010384419452173,0.5824072364482634,HHEX;MED30;E2F1;SMARCA2
920,GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),1/106,0.5625877281524873,0.633139270277556,0,0,1.2207792207792207,0.7022022131818262,AURKB
921,GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.5625877281524873,0.633139270277556,0,0,1.2207792207792207,0.7022022131818262,GPLD1
922,GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.5625877281524873,0.633139270277556,0,0,1.2207792207792207,0.7022022131818262,SLC9A3R1
923,GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),1/106,0.5625877281524873,0.633139270277556,0,0,1.2207792207792207,0.7022022131818262,RAB18
924,GO_Biological_Process_2021,protein localization to nucleus (GO:0034504),1/106,0.5625877281524873,0.633139270277556,0,0,1.2207792207792207,0.7022022131818262,HHEX
925,GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.5659957260383035,0.6362867719285896,0,0,1.2092011761823085,0.6882395243362479,GPLD1
926,GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),3/381,0.5690605308957751,0.6387088493983406,0,0,1.0164473684210529,0.5730409770454108,HDAC3;IFIT3;THOC6
927,GO_Biological_Process_2021,DNA replication (GO:0006260),1/108,0.569377341250394,0.6387088493983406,0,0,1.1978395436339362,0.6746374840803024,MCM9
928,GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),3/384,0.5743968451426331,0.6436459804020248,0,0,1.008288437629507,0.5590301515786094,RIMS1;NWD1;E2F1
929,GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.5793659116416887,0.6485160365795677,0,0,1.1649940968122787,0.6358782770177525,HHEX
930,GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),1/112,0.582644009595311,0.6514848700201061,0,0,1.1544401544401544,0.6236042096528597,PLCB3
931,GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.5858967239735873,0.6544189803181377,0,0,1.144074675324675,0.6116357573156603,HDAC3
932,GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.5923267818374698,0.660891939863672,0,0,1.1238892686261108,0.5885772135844056,CACNA1C
933,GO_Biological_Process_2021,cytosolic transport (GO:0016482),1/116,0.5955045114637109,0.6637261203787184,0,0,1.114059853190288,0.5774688187994799,WASHC2C
934,GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.6017863261475115,0.6685801126142578,0,0,1.094905094905095,0.5560506582922549,ADGRB3
935,GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.6017863261475115,0.6685801126142578,0,0,1.094905094905095,0.5560506582922549,IFI16
936,GO_Biological_Process_2021,regulation of protein binding (GO:0043393),1/118,0.6017863261475115,0.6685801126142578,0,0,1.094905094905095,0.5560506582922549,AURKB
937,GO_Biological_Process_2021,cellular component assembly (GO:0022607),2/261,0.6029711359100566,0.6691822521133997,0,0,0.9885179296944004,0.5000773328251953,SLC9A3R1;RIMS1
938,GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.6079712034798018,0.6740128038577995,0,0,1.076394194041253,0.5356436325568794,ANK1
939,GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.611027755968528,0.6766807382587635,0,0,1.06737012987013,0.5258002883512258,NACC2
940,GO_Biological_Process_2021,epithelium development (GO:0060429),1/122,0.6140606298452689,0.6793168072996013,0,0,1.05849522378448,0.516187485043715,SLC9A3R1
941,GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),2/267,0.6153702348120506,0.6800429028018521,0,0,0.9658404242200024,0.4689456451951918,SLC9A3R1;RIMS1
942,GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.6170700071393816,0.6801287295660311,0,0,1.0497658079625294,0.5067983760967132,ADGRB3
943,GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.6170700071393816,0.6801287295660311,0,0,1.0497658079625294,0.5067983760967132,SLC1A1
944,GO_Biological_Process_2021,central nervous system development (GO:0007417),2/268,0.6174079245340052,0.6801287295660311,0,0,0.9621603027175782,0.4639780710923079,RAB18;THOC6
945,GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),1/124,0.6200560688358586,0.6823238558754003,0,0,1.0411783338612608,0.4976263654976579,PLCB3
946,GO_Biological_Process_2021,protein targeting (GO:0006605),1/125,0.6230189944063451,0.6826976559757949,0,0,1.0327293674067868,0.4886650975604295,MICALL1
947,GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.6230189944063451,0.6826976559757949,0,0,1.0327293674067868,0.4886650975604295,PRDX1
948,GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),1/125,0.6230189944063451,0.6826976559757949,0,0,1.0327293674067868,0.4886650975604295,PRKRIP1
949,GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.6230189944063451,0.6826976559757949,0,0,1.0327293674067868,0.4886650975604295,CACNA1C
950,GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),1/126,0.6259589618952427,0.68375999930005,0,0,1.0244155844155844,0.4799084463203072,SMARCA2
951,GO_Biological_Process_2021,negative regulation of growth (GO:0045926),1/126,0.6259589618952427,0.68375999930005,0,0,1.0244155844155844,0.4799084463203072,SMARCA2
952,GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.6259589618952427,0.68375999930005,0,0,1.0244155844155844,0.4799084463203072,CACNA1C
953,GO_Biological_Process_2021,DNA-dependent DNA replication (GO:0006261),1/129,0.6346428769238629,0.6917939632227657,0,0,1.0002536525974026,0.4548081708590089,GINS2
954,GO_Biological_Process_2021,muscle contraction (GO:0006936),1/129,0.6346428769238629,0.6917939632227657,0,0,1.0002536525974026,0.4548081708590089,MYH3
955,GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.637333155985245,0.6920020538388558,0,0,0.926825802784882,0.4175005020295539,SLC9A3R1;TMEM138
956,GO_Biological_Process_2021,regulation of primary metabolic process (GO:0080090),1/130,0.6374927662165829,0.6920020538388558,0,0,0.9924494110540624,0.446812980738548,HDAC3
957,GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.6374927662165829,0.6920020538388558,0,0,0.9924494110540624,0.446812980738548,HHEX
958,GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.6374927662165829,0.6920020538388558,0,0,0.9924494110540624,0.446812980738548,TET2
959,GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.6403205677865307,0.6936250895585624,0,0,0.9847652347652348,0.4389948906161399,SCN2A
960,GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.6403205677865307,0.6936250895585624,0,0,0.9847652347652348,0.4389948906161399,GPLD1
961,GO_Biological_Process_2021,organelle assembly (GO:0070925),3/425,0.6431195628072428,0.6959329156781079,0,0,0.9084092042903468,0.4009941939513247,HDAC3;TMEM138;MAPRE2
962,GO_Biological_Process_2021,RNA metabolic process (GO:0016070),1/133,0.6459105867421241,0.698227332085723,0,0,0.9697461629279812,0.4238704188224676,NOVA1
963,GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.6621679608930106,0.7143179764659316,0,0,0.9273009599096556,0.3822668736214677,OGFR
964,GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.6621679608930106,0.7143179764659316,0,0,0.9273009599096556,0.3822668736214677,SLC12A5
965,GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),1/140,0.6648044725087627,0.7156788582022979,0,0,0.920583014108194,0.3758393459193833,IMPACT
966,GO_Biological_Process_2021,transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.6648044725087627,0.7156788582022979,0,0,0.920583014108194,0.3758393459193833,HDAC3
967,GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.6674205398181866,0.7177528739160457,0,0,0.913961038961039,0.3695463793506114,GPLD1
968,GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.6725919704563945,0.7218229291186666,0,0,0.9009968904335102,0.3573501591451499,MICALL1
969,GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.6725919704563945,0.7218229291186666,0,0,0.9009968904335102,0.3573501591451499,CKB
970,GO_Biological_Process_2021,regulation of mRNA stability (GO:0043488),1/146,0.6801996831192694,0.7292357055892476,0,0,0.8822212270488132,0.3399805993632853,E2F1
971,GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.6826963506241392,0.7311593631684455,0,0,0.87613413983277,0.3344248695253931,CACNA1C
972,GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.6851736513942092,0.7323057198166034,0,0,0.8701298701298701,0.3289812831150492,CACNA1C
973,GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.6851736513942092,0.7323057198166034,0,0,0.8701298701298701,0.3289812831150492,AURKB
974,GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.6900707486802138,0.7360283292787936,0,0,0.8583631133966705,0.318419369661449,RAB18
975,GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.6900707486802138,0.7360283292787936,0,0,0.8583631133966705,0.318419369661449,IFI16
976,GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.6972748387977963,0.7429509797221145,0,0,0.8412935748462064,0.3033499600592609,HHEX
977,GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.7043125292114396,0.7481523907235802,0,0,0.8248847926267281,0.2891494134341382,OCIAD1
978,GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.7043125292114396,0.7481523907235802,0,0,0.8248847926267281,0.2891494134341382,PKN3
979,GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.7043125292114396,0.7481523907235802,0,0,0.8248847926267281,0.2891494134341382,AURKB
980,GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),1/157,0.7066221109262841,0.7498405886587786,0,0,0.8195554445554446,0.2845982110979452,AURKB
981,GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.7089137681109071,0.7507418439506148,0,0,0.8142939862685086,0.2801345445576442,SPTSSB
982,GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.7089137681109071,0.7507418439506148,0,0,0.8142939862685086,0.2801345445576442,PRDX1
983,GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),1/159,0.7111876390217574,0.7523844839650908,0,0,0.8090991287193818,0.2757563360363151,AURKB
984,GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),2/320,0.7122374547448748,0.7527301425273244,0,0,0.8026883709458627,0.2723874177853811,BTF3;HDAC3
985,GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.7138531793949224,0.7536725758114748,0,0,0.8001311287315344,0.2697065757161478,NCCRP1;AURKB
986,GO_Biological_Process_2021,double-strand break repair (GO:0006302),1/164,0.7222949627775392,0.7610415549103425,0,0,0.7840809497251215,0.2550785379476446,MCM9
987,GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.7222949627775392,0.7610415549103425,0,0,0.7840809497251215,0.2550785379476446,CACNA1C
988,GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.7244649596363066,0.7617858817993891,0,0,0.7792603737725688,0.2511726712416007,ADGRB3
989,GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.7244649596363066,0.7617858817993891,0,0,0.7792603737725688,0.2511726712416007,STX1B
990,GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.7290446637553438,0.7658279464877022,0,0,0.7928723520419305,0.2505637440413621,HDAC3;IFIT3;THOC6
991,GO_Biological_Process_2021,"DNA-templated transcription, initiation (GO:0006352)",1/168,0.7308743811824205,0.7669760391238909,0,0,0.7651450346061125,0.2398834348958145,HDAC3
992,GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.7329777618405983,0.7684087110534369,0,0,0.760551948051948,0.2362577933392269,PKN3
993,GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.7350648084240426,0.7698213939330266,0,0,0.756013217551679,0.2326983046685702,CDH8
994,GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.7371356469711764,0.7704399683704765,0,0,0.751527883880825,0.2292034922834323,MICALL1
995,GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.7371356469711764,0.7704399683704765,0,0,0.751527883880825,0.2292034922834323,NDFIP2
996,GO_Biological_Process_2021,neuron differentiation (GO:0030182),1/174,0.7432521600380967,0.7760536595783939,0,0,0.7383830042789581,0.2190929392408325,NEUROG1
997,GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.7472510625502261,0.7794472506160174,0,0,0.7298701298701299,0.2126506225972366,RPL39
998,GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.7504107690957449,0.7812055819836791,0,0,0.7432306255835668,0.213407176546368,HDAC3;IFI16
999,GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.7511880764319527,0.7812055819836791,0,0,0.7215496368038741,0.2064347911010304,IFI16
1000,GO_Biological_Process_2021,regulation of translation (GO:0006417),1/178,0.7511880764319527,0.7812055819836791,0,0,0.7215496368038741,0.2064347911010304,IMPACT
1001,GO_Biological_Process_2021,RNA processing (GO:0006396),1/179,0.7531336731233035,0.782447259202953,0,0,0.7174595067853495,0.203408771556296,NOVA1
1002,GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.7550641533482444,0.7828902227445442,0,0,0.7134150765435682,0.2004357935391753,RIMS1
1003,GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.7550641533482444,0.7828902227445442,0,0,0.7134150765435682,0.2004357935391753,GPLD1
1004,GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.763056252761392,0.7903896110692626,0,0,0.7238933452168747,0.1957577898818783,NDFIP2;AURKB
1005,GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",15/2244,0.7653628106032174,0.7919907413896117,0,0,0.8467602384156893,0.2264281716492286,ZNF396;TGIF2;HDAC3;ACTL6A;SMARCA2;MED29;HHEX;IFI16;MED30;NACC2;ZNF219;E2F1;MYBL2;ZMYND11;NEUROG1
1006,GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.7753344951382731,0.8015126210913032,0,0,0.6717361585782639,0.1709304773862895,E2F1
1007,GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.7805674008452529,0.8061216907538773,0,0,0.6611937285512415,0.1638002906410217,NDFIP2
1008,GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.7873566863584465,0.8123273642211524,0,0,0.6476366273320588,0.1548330210276958,RGS6
1009,GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.793937221542376,0.8183055917085281,0,0,0.6346191122310525,0.1464389230090444,NEUROG1
1010,GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.7955504898858875,0.8183478853470443,0,0,0.6314452873858815,0.1444247747467937,HHEX
1011,GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.7955504898858875,0.8183478853470443,0,0,0.6314452873858815,0.1444247747467937,TNR
1012,GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),3/546,0.7990156685971387,0.8211009980351642,0,0,0.7015847630125036,0.1574178869664126,SLC9A3R1;NDFIP2;HDAC3
1013,GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.8018790336655394,0.8232308422542668,0,0,0.6190581263396797,0.1366864949042086,SLC9A3R1
1014,GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),1/209,0.8049699275523141,0.8255898468787772,0,0,0.6130432067932068,0.1329999440042646,E2F1
1015,GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.8095166582177842,0.8294358673274738,0,0,0.6042346279313104,0.1276856094024045,PLCB3
1016,GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.8124891440215583,0.8316629291312116,0,0,0.5985000914578379,0.124280175545407,HDAC3
1017,GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.8154155382993888,0.8338384826813987,0,0,0.5928722440350347,0.1209799880565517,TNR
1018,GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.8168616735490571,0.8344975487385363,0,0,0.5900974025974026,0.1193681532541001,TNR
1019,GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.8447593738735587,0.8621514786297789,0,0,0.5372349169817524,0.0906333876218008,SLC9A3R1
1020,GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.8471850669592539,0.86378026905444,0,0,0.5326848883334239,0.0883383903745038,TNR
1021,GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.8542384884092359,0.8701196344755523,0,0,0.5194805194805194,0.0818414876608536,NEUROG1
1022,GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.862059578045477,0.8772277817647521,0,0,0.5048701298701299,0.0749383250560651,HDAC3
1023,GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.8764725699944608,0.8910233841447595,0,0,0.4779562542720437,0.063018470010504,ACTL6A
1024,GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.8849373223873942,0.8979172583220775,0,0,0.4621015348288075,0.0564865793542005,ACTL6A
1025,GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.8852738928249398,0.8979172583220775,0,0,0.5365293009859311,0.0653804940264387,E2F1;NCCRP1
1026,GO_Biological_Process_2021,DNA metabolic process (GO:0006259),1/277,0.8858415218989178,0.8979172583220775,0,0,0.4604037267080745,0.0558088568663277,NUDT1
1027,GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),2/482,0.8908880613034429,0.902154155463895,0,0,0.5273692810457516,0.0609303967521457,IFI16;TYK2
1028,GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),1/296,0.901740328157586,0.9122562503518435,0,0,0.4303323794849218,0.0445087120766463,MYBL2
1029,GO_Biological_Process_2021,DNA repair (GO:0006281),1/298,0.903280161244626,0.9129268425783066,0,0,0.4273907910271546,0.0434752672622354,NUDT1
1030,GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.9047960162244522,0.9135719232683364,0,0,0.4244885549233375,0.0424682788681493,TNR
1031,GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.9062882640572922,0.9140500497017944,0,0,0.4216248867411658,0.0414869829084805,RPL39
1032,GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.907025649704086,0.9140500497017944,0,0,0.420207276167541,0.0410057377620294,RASAL2
1033,GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.9147660695806752,0.9200690612883892,0,0,0.4052114020165138,0.0360990309139155,ANAPC13
1034,GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.9147660695806752,0.9200690612883892,0,0,0.4052114020165138,0.0360990309139155,TMEM138
1035,GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.9199900018934196,0.9244301080801638,0,0,0.3949508435489744,0.0329359289413887,NDFIP2
1036,GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.93330230431577,0.9369023132041624,0,0,0.3681100875868318,0.0254092101276177,VWA1
1037,GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.9457177995566616,0.9484510879946864,0,0,0.3417865917865917,0.0190754732015756,HDAC3
1038,GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),2/621,0.955636575578784,0.9574761070043448,0,0,0.4060101154085759,0.0184237602583791,TYK2;IFIT3
1039,GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.967859514936864,0.9687901490858416,0,0,0.2890652925056595,0.0094432807820097,AURKB
1040,GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),1/625,0.9928458732556344,0.9928458732556344,0,0,0.2000187312687312,0.0014361025316786,NCCRP1
1041,GO_Cellular_Component_2021,endoplasmic reticulum tubular network (GO:0071782),3/23,0.0007214911228073286,0.0592912474040864,0,0,19.564144736842103,141.530749675572,REEP1;REEP5;RAB18
1042,GO_Cellular_Component_2021,sodium channel complex (GO:0034706),3/25,0.0009264257406888508,0.0592912474040864,0,0,17.783791866028707,124.20514418040852,GRIK4;SCN2A;SCN3A
1043,GO_Cellular_Component_2021,voltage-gated calcium channel complex (GO:0005891),3/31,0.0017500250965533,0.0746677374529441,0,0,13.96875,88.67537319272091,PDE4D;PDE4B;CACNA1C
1044,GO_Cellular_Component_2021,npBAF complex (GO:0071564),2/11,0.0031349527155465,0.1003184868974898,0,0,28.81045751633987,166.0963552659853,ACTL6A;SMARCA2
1045,GO_Cellular_Component_2021,calcium channel complex (GO:0034704),3/45,0.0051045975383244,0.1306776969811062,0,0,9.30592105263158,49.1130561335911,PDE4D;PDE4B;CACNA1C
1046,GO_Cellular_Component_2021,voltage-gated sodium channel complex (GO:0001518),2/17,0.0075193037455179,0.1497461507848361,0,0,17.281045751633986,84.50918235493056,SCN2A;SCN3A
1047,GO_Cellular_Component_2021,SWI/SNF complex (GO:0016514),2/19,0.0093591344240522,0.1497461507848361,0,0,15.24644367550942,71.2222746266767,ACTL6A;SMARCA2
1048,GO_Cellular_Component_2021,vacuolar proton-transporting V-type ATPase complex (GO:0016471),2/19,0.0093591344240522,0.1497461507848361,0,0,15.24644367550942,71.2222746266767,ATP6V1A;ATP6V0A1
1049,GO_Cellular_Component_2021,asymmetric synapse (GO:0032279),4/133,0.0200131973400989,0.2846321399480735,0,0,4.048667796088095,15.835810858397007,DNAJC6;SLC1A1;CACNA1C;DNM1
1050,GO_Cellular_Component_2021,polysomal ribosome (GO:0042788),2/30,0.0225232501267853,0.288297601622853,0,0,9.251633986928104,35.0933643209813,BTF3;RPL39
1051,GO_Cellular_Component_2021,neuron projection (GO:0043005),9/556,0.0294669005601043,0.3384401319697534,0,0,2.174776489444292,7.664972901344173,MPST;CHRM3;SLC12A5;SV2A;SLC1A1;SCN2A;ANK1;SCN3A;DNM1
1052,GO_Cellular_Component_2021,microtubule cytoskeleton (GO:0015630),6/331,0.0444137874710632,0.3384401319697534,0,0,2.4185854414042334,7.531971670554181,DCDC2B;MTUS1;FAM161B;MAPRE2;AURKB;DNM1
1053,GO_Cellular_Component_2021,THO complex part of transcription export complex (GO:0000445),1/6,0.0456136829085219,0.3384401319697534,0,0,25.766233766233768,79.55447177504013,THOC6
1054,GO_Cellular_Component_2021,cytoskeleton of presynaptic active zone (GO:0048788),1/7,0.0530123784483423,0.3384401319697534,0,0,21.47077922077922,63.06461335243215,RIMS1
1055,GO_Cellular_Component_2021,mitochondrial matrix (GO:0005759),6/348,0.0541600734838131,0.3384401319697534,0,0,2.296361709643236,6.695757407140349,MPST;LYRM4;ETHE1;MTHFD2L;NUDT1;TRNT1
1056,GO_Cellular_Component_2021,lytic vacuole membrane (GO:0098852),5/267,0.0571434931791298,0.3384401319697534,0,0,2.4914758269720103,7.131076575220626,ATP6V1A;GPR137;CD68;GPLD1;ATP6V0A1
1057,GO_Cellular_Component_2021,neuron to neuron synapse (GO:0098984),1/8,0.0603540856180015,0.3384401319697534,0,0,18.4025974025974,51.66578236108292,SLC1A1
1058,GO_Cellular_Component_2021,"proton-transporting V-type ATPase, V1 domain (GO:0033180)",1/8,0.0603540856180015,0.3384401319697534,0,0,18.4025974025974,51.66578236108292,ATP6V1A
1059,GO_Cellular_Component_2021,serine C-palmitoyltransferase complex (GO:0017059),1/8,0.0603540856180015,0.3384401319697534,0,0,18.4025974025974,51.66578236108292,SPTSSB
1060,GO_Cellular_Component_2021,spectrin-associated cytoskeleton (GO:0014731),1/8,0.0603540856180015,0.3384401319697534,0,0,18.4025974025974,51.66578236108292,ANK1
1061,GO_Cellular_Component_2021,"vacuolar proton-transporting V-type ATPase, V1 domain (GO:0000221)",1/8,0.0603540856180015,0.3384401319697534,0,0,18.4025974025974,51.66578236108292,ATP6V1A
1062,GO_Cellular_Component_2021,cytosolic large ribosomal subunit (GO:0022625),2/55,0.0678776589149193,0.3384401319697534,0,0,4.881489702799359,13.131443212163134,RPL34;RPL39
1063,GO_Cellular_Component_2021,cortical cytoskeleton (GO:0030863),2/58,0.0744450307593925,0.3384401319697534,0,0,4.619281045751634,11.999479895254678,RIMS1;DCDC2B
1064,GO_Cellular_Component_2021,recycling endosome membrane (GO:0055038),2/58,0.0744450307593925,0.3384401319697534,0,0,4.619281045751634,11.999479895254678,MICALL1;ATP9A
1065,GO_Cellular_Component_2021,axon (GO:0030424),4/204,0.0744778866174923,0.3384401319697534,0,0,2.601986754966888,6.758017961458882,SLC1A1;SCN2A;SCN3A;DNM1
1066,GO_Cellular_Component_2021,apical dendrite (GO:0097440),1/10,0.0748682748782873,0.3384401319697534,0,0,14.311688311688313,37.09625453392642,SLC1A1
1067,GO_Cellular_Component_2021,CMG complex (GO:0071162),1/10,0.0748682748782873,0.3384401319697534,0,0,14.311688311688313,37.09625453392642,GINS2
1068,GO_Cellular_Component_2021,"condensed chromosome, centromeric region (GO:0000779)",1/10,0.0748682748782873,0.3384401319697534,0,0,14.311688311688313,37.09625453392642,AURKB
1069,GO_Cellular_Component_2021,large ribosomal subunit (GO:0015934),2/59,0.0766778423993972,0.3384401319697534,0,0,4.538011695906433,11.654260696869702,RPL34;RPL39
1070,GO_Cellular_Component_2021,microvillus membrane (GO:0031528),1/11,0.082041618927272,0.341093174201492,0,0,12.87987012987013,32.20648378609581,SLC9A3R1
1071,GO_Cellular_Component_2021,ribosome (GO:0005840),2/62,0.0835008799733094,0.341093174201492,0,0,4.310457516339869,10.702426814427591,BTF3;RPL39
1072,GO_Cellular_Component_2021,integral component of organelle membrane (GO:0031301),4/214,0.085273293550373,0.341093174201492,0,0,2.4768211920529803,6.097671137702825,PIGT;CHST12;SARAF;SLC25A4
1073,GO_Cellular_Component_2021,intrinsic component of mitochondrial membrane (GO:0098573),1/12,0.0891596984900511,0.3439970765713896,0,0,11.708382526564344,28.302979280758237,SLC25A4
1074,GO_Cellular_Component_2021,postsynaptic density (GO:0014069),3/138,0.0921678406871915,0.3439970765713896,0,0,2.881578947368421,6.8700991831155855,DNAJC6;CACNA1C;DNM1
1075,GO_Cellular_Component_2021,cytoskeleton (GO:0005856),8/600,0.0954346721231404,0.3439970765713896,0,0,1.7699025556168413,4.158055661596866,SLC9A3R1;EPB41L1;MTUS1;FAM161B;SMARCA2;ANK1;MAPRE2;DNM1
1076,GO_Cellular_Component_2021,nBAF complex (GO:0071565),1/14,0.1032317526957649,0.3439970765713896,0,0,9.906093906093906,22.49454795449228,SMARCA2
1077,GO_Cellular_Component_2021,glial cell projection (GO:0097386),1/14,0.1032317526957649,0.3439970765713896,0,0,9.906093906093906,22.49454795449228,SLC1A1
1078,GO_Cellular_Component_2021,Ino80 complex (GO:0031011),1/14,0.1032317526957649,0.3439970765713896,0,0,9.906093906093906,22.49454795449228,ACTL6A
1079,GO_Cellular_Component_2021,cation channel complex (GO:0034703),2/73,0.1099498491856705,0.3439970765713896,0,0,3.6406149314185767,8.037498201583205,PDE4D;SCN2A
1080,GO_Cellular_Component_2021,muscle myosin complex (GO:0005859),1/15,0.1101865635892732,0.3439970765713896,0,0,9.198051948051948,20.28704233319861,MYH3
1081,GO_Cellular_Component_2021,proton-transporting V-type ATPase complex (GO:0033176),1/15,0.1101865635892732,0.3439970765713896,0,0,9.198051948051948,20.28704233319861,ATP6V0A1
1082,GO_Cellular_Component_2021,lysosomal membrane (GO:0005765),5/330,0.1141864649219446,0.3479968454764027,0,0,2.002051282051282,4.3442961423125865,ATP6V1A;GPR137;CD68;GPLD1;ATP6V0A1
1083,GO_Cellular_Component_2021,U1 snRNP (GO:0005685),1/18,0.1307310829477655,0.3825362794737392,0,0,7.573720397249809,15.409588975790411,SNRPA
1084,GO_Cellular_Component_2021,nuclear chromosome (GO:0000228),2/83,0.1356074936019886,0.3825362794737392,0,0,3.189542483660131,6.372676036053572,GINS2;ACTL6A
1085,GO_Cellular_Component_2021,anaphase-promoting complex (GO:0005680),1/19,0.137473975435875,0.3825362794737392,0,0,7.152597402597403,14.19304672243636,ANAPC13
1086,GO_Cellular_Component_2021,H4/H2A histone acetyltransferase complex (GO:0043189),1/19,0.137473975435875,0.3825362794737392,0,0,7.152597402597403,14.19304672243636,ACTL6A
1087,GO_Cellular_Component_2021,NuA4 histone acetyltransferase complex (GO:0035267),1/20,0.1441648985018541,0.3926192980476028,0,0,6.775803144224197,13.123358631426164,ACTL6A
1088,GO_Cellular_Component_2021,early endosome (GO:0005769),4/266,0.1522753157382912,0.4060675086354433,0,0,1.9799807896466304,3.726452760263425,RABGAP1L;MICALL1;WASHC2C;ATP9A
1089,GO_Cellular_Component_2021,"preribosome, large subunit precursor (GO:0030687)",1/23,0.163929815349397,0.4177413499443379,0,0,5.850944510035419,10.580361826426786,WDR37
1090,GO_Cellular_Component_2021,intracellular membrane-bounded organelle (GO:0043231),46/5192,0.1662761403899757,0.4177413499443379,0,0,1.205450389899343,2.1627050254752977,ATP6V1A;DENND1C;HDAC3;CDCA4;MCM9;NUDT1;WASHC2C;AURKB;SLC9A3R1;HHEX;ZNF827;IFI16;MED30;NACC2;PRDX1;E2F1;PDE4B;HMG20B;MYBL2;CTNNBL1;ATP6V0A1;BEND6;BTF3;RABGAP1L;NDFIP2;OSBPL7;TGIF2;WDR37;PDE4D;ACTL6A;MTUS1;TET2;TYK2;SMARCA2;THOC6;DPPA4;ESPL1;DNAJC6;NOVA1;ZNF219;MPPE1;ZMYND11;NEUROG1;GPLD1;RPS24;NEK11
1091,GO_Cellular_Component_2021,lysosome (GO:0005764),6/477,0.1664438191184471,0.4177413499443379,0,0,1.6563929380583935,2.970073952127793,ATP6V1A;OCIAD1;GPR137;CD68;GPLD1;ATP6V0A1
1092,GO_Cellular_Component_2021,INO80-type complex (GO:0097346),1/24,0.1704168099322024,0.4194875321408059,0,0,5.596273291925466,9.902650470022865,ACTL6A
1093,GO_Cellular_Component_2021,spindle (GO:0005819),3/192,0.1870139385466054,0.4451990221364208,0,0,2.0526315789473686,3.44138489272082,HDAC3;ESPL1;AURKB
1094,GO_Cellular_Component_2021,intracellular non-membrane-bounded organelle (GO:0043232),12/1158,0.1878183374638025,0.4451990221364208,0,0,1.3692380917511808,2.28974957657242,NWD1;IFI16;EPB41L1;NOVA1;NACC2;PRKRIP1;MTUS1;RAB18;WASHC2C;ANK1;AURKB;NEK11
1095,GO_Cellular_Component_2021,nucleolus (GO:0005730),8/733,0.209444958324401,0.4810445442824588,0,0,1.43523340370631,2.2436922033472877,NWD1;IFI16;NOVA1;NACC2;PRKRIP1;MTUS1;WASHC2C;NEK11
1096,GO_Cellular_Component_2021,intracellular organelle lumen (GO:0070013),9/848,0.2125624696248007,0.4810445442824588,0,0,1.3964275801263737,2.162395141427548,MPST;LYRM4;ETHE1;MTHFD2L;NUDT1;VWA1;TRNT1;PLEKHO2;UGGT2
1097,GO_Cellular_Component_2021,catenin complex (GO:0016342),1/31,0.2144467463020621,0.4810445442824588,0,0,4.288961038961039,6.603686893515271,CDH8
1098,GO_Cellular_Component_2021,ionotropic glutamate receptor complex (GO:0008328),1/32,0.2205442263504202,0.4810445442824588,0,0,4.150397989107667,6.273978302469515,GRIK4
1099,GO_Cellular_Component_2021,nuclear lumen (GO:0031981),8/745,0.2217314696301958,0.4810445442824588,0,0,1.4109785026629376,2.125340305026209,NWD1;IFI16;NOVA1;NACC2;PRKRIP1;MTUS1;WASHC2C;NEK11
1100,GO_Cellular_Component_2021,heterotrimeric G-protein complex (GO:0005834),1/33,0.2265946805711609,0.4834019852184767,0,0,4.02049512987013,5.968796536704066,GNG5
1101,GO_Cellular_Component_2021,mitotic spindle (GO:0072686),2/120,0.2383211390650813,0.4979295442626829,0,0,2.185332890218234,3.1340649873038147,HDAC3;ESPL1
1102,GO_Cellular_Component_2021,intrinsic component of endoplasmic reticulum membrane (GO:0031227),2/121,0.241184623002237,0.4979295442626829,0,0,2.1668589004229144,3.0816906245737723,PIGT;SARAF
1103,GO_Cellular_Component_2021,endosome membrane (GO:0010008),4/325,0.2451639119373877,0.4981108052061211,0,0,1.6111901961997896,2.265056716209316,MICALL1;CD68;ATP9A;ATP6V0A1
1104,GO_Cellular_Component_2021,mitochondrial inner membrane (GO:0005743),4/328,0.2502104921478059,0.5004209842956119,0,0,1.596026490066225,2.2112192846044905,TIMMDC1;MRPS25;SLC25A4;COX20
1105,GO_Cellular_Component_2021,cytosolic small ribosomal subunit (GO:0022627),1/40,0.2676610632899671,0.5076465397132958,0,0,3.2977022977022976,4.346483051407713,RPS24
1106,GO_Cellular_Component_2021,exocytic vesicle membrane (GO:0099501),1/41,0.273348055509039,0.5076465397132958,0,0,3.2150974025974026,4.170011447706375,SV2A
1107,GO_Cellular_Component_2021,synaptic vesicle membrane (GO:0030672),1/41,0.273348055509039,0.5076465397132958,0,0,3.2150974025974026,4.170011447706375,SV2A
1108,GO_Cellular_Component_2021,cilium (GO:0005929),3/237,0.2787862959795574,0.5076465397132958,0,0,1.6540991902834008,2.112797031308333,TMEM138;FAM161B;GPR19
1109,GO_Cellular_Component_2021,cortical actin cytoskeleton (GO:0030864),1/42,0.278991167899673,0.5076465397132958,0,0,3.136522014570795,4.004006073572531,DCDC2B
1110,GO_Cellular_Component_2021,organelle inner membrane (GO:0019866),4/346,0.2809209530079498,0.5076465397132958,0,0,1.5106308818403624,1.9180207717068625,TIMMDC1;MRPS25;SLC25A4;COX20
1111,GO_Cellular_Component_2021,trans-Golgi network (GO:0005802),3/239,0.2829935134428249,0.5076465397132958,0,0,1.639914139161463,2.070114950945108,MICALL1;GOLGA1;ATP9A
1112,GO_Cellular_Component_2021,phagocytic vesicle membrane (GO:0030670),1/45,0.2956605775351539,0.5076465397132958,0,0,2.9222255017709564,3.560857955999816,ATP6V0A1
1113,GO_Cellular_Component_2021,small ribosomal subunit (GO:0015935),1/45,0.2956605775351539,0.5076465397132958,0,0,2.9222255017709564,3.560857955999816,RPS24
1114,GO_Cellular_Component_2021,vacuolar membrane (GO:0005774),1/45,0.2956605775351539,0.5076465397132958,0,0,2.9222255017709564,3.560857955999816,ATP6V0A1
1115,GO_Cellular_Component_2021,mitochondrial membrane (GO:0031966),5/469,0.2990765966334427,0.5076465397132958,0,0,1.392313218390805,1.6805994148162025,TIMMDC1;MRPS25;SLC25A4;DNM1;COX20
1116,GO_Cellular_Component_2021,integral component of endoplasmic reticulum membrane (GO:0030176),2/142,0.3014151329547693,0.5076465397132958,0,0,1.8398692810457515,2.206494117823232,PIGT;SARAF
1117,GO_Cellular_Component_2021,recycling endosome (GO:0055037),2/145,0.3099844116353092,0.511913068737871,0,0,1.8009963892316834,2.1093868862822456,MICALL1;ATP9A
1118,GO_Cellular_Component_2021,acrosomal vesicle (GO:0001669),1/48,0.3119470262621401,0.511913068737871,0,0,2.7352859906051394,3.186394534645299,DKKL1
1119,GO_Cellular_Component_2021,basolateral plasma membrane (GO:0016323),2/151,0.3270566260426559,0.5170917404247226,0,0,1.7279466596481994,1.9311911234608288,SLC23A2;ANK1
1120,GO_Cellular_Component_2021,spliceosomal snRNP complex (GO:0097525),1/51,0.3278592564128742,0.5170917404247226,0,0,2.5707792207792206,2.866858071905812,SNRPA
1121,GO_Cellular_Component_2021,condensed chromosome (GO:0000793),1/54,0.3434058117629479,0.5170917404247226,0,0,2.424895858858123,2.5918315252533666,AURKB
1122,GO_Cellular_Component_2021,cullin-RING ubiquitin ligase complex (GO:0031461),2/157,0.344017383463199,0.5170917404247226,0,0,1.6605523930002108,1.7719141668547946,ANAPC13;NCCRP1
1123,GO_Cellular_Component_2021,cytoplasmic side of plasma membrane (GO:0009898),1/55,0.3485081846108929,0.5170917404247226,0,0,2.3798701298701297,2.5086057865847664,ANK1
1124,GO_Cellular_Component_2021,integral component of Golgi membrane (GO:0030173),1/55,0.3485081846108929,0.5170917404247226,0,0,2.3798701298701297,2.5086057865847664,CHST12
1125,GO_Cellular_Component_2021,secretory granule membrane (GO:0030667),3/274,0.3570507563689866,0.5170917404247226,0,0,1.4255680714701884,1.468160242893027,RAB18;CD68;ATP6V0A1
1126,GO_Cellular_Component_2021,microvillus (GO:0005902),1/57,0.3585950426235817,0.5170917404247226,0,0,2.294642857142857,2.3532974672725504,SLC9A3R1
1127,GO_Cellular_Component_2021,cis-Golgi network (GO:0005801),1/57,0.3585950426235817,0.5170917404247226,0,0,2.294642857142857,2.3532974672725504,MPPE1
1128,GO_Cellular_Component_2021,nucleus (GO:0005634),37/4484,0.361856875604528,0.5170917404247226,0,0,1.0857176614971815,1.103639078093517,HDAC3;CDCA4;MCM9;NUDT1;AURKB;SLC9A3R1;HHEX;ZNF827;IFI16;MED30;NACC2;PRDX1;E2F1;PDE4B;HMG20B;MYBL2;CTNNBL1;BEND6;BTF3;RABGAP1L;TGIF2;WDR37;PDE4D;ACTL6A;MTUS1;TET2;TYK2;SMARCA2;THOC6;DPPA4;ESPL1;NOVA1;ZNF219;ZMYND11;NEUROG1;RPS24;NEK11
1129,GO_Cellular_Component_2021,azurophil granule membrane (GO:0035577),1/58,0.363580129986133,0.5170917404247226,0,0,2.254272043745728,2.2807722879324426,CD68
1130,GO_Cellular_Component_2021,SCF ubiquitin ligase complex (GO:0019005),1/58,0.363580129986133,0.5170917404247226,0,0,2.254272043745728,2.2807722879324426,NCCRP1
1131,GO_Cellular_Component_2021,intrinsic component of Golgi membrane (GO:0031228),1/60,0.3734351095815957,0.5206786619075763,0,0,2.1776359233986358,2.1449953942099538,CHST12
1132,GO_Cellular_Component_2021,ficolin-1-rich granule membrane (GO:0101003),1/61,0.3783055902922233,0.5206786619075763,0,0,2.1412337662337664,2.08139264203368,ATP6V0A1
1133,GO_Cellular_Component_2021,spindle microtubule (GO:0005876),1/61,0.3783055902922233,0.5206786619075763,0,0,2.1412337662337664,2.08139264203368,AURKB
1134,GO_Cellular_Component_2021,integral component of mitochondrial membrane (GO:0032592),1/66,0.4020994726804225,0.5464045514419504,0,0,1.976023976023976,1.8002680578468673,SLC25A4
1135,GO_Cellular_Component_2021,late endosome membrane (GO:0031902),1/68,0.4113616791408475,0.5464045514419504,0,0,1.9168443496801704,1.7026992020024727,CD68
1136,GO_Cellular_Component_2021,microtubule (GO:0005874),2/182,0.4129711656995561,0.5464045514419504,0,0,1.4281045751633987,1.262983561299872,DCDC2B;AURKB
1137,GO_Cellular_Component_2021,autophagosome (GO:0005776),1/69,0.4159391809029937,0.5464045514419504,0,0,1.8885599694423223,1.656675454939586,OSBPL7
1138,GO_Cellular_Component_2021,ficolin-1-rich granule (GO:0101002),2/184,0.4183409846977433,0.5464045514419504,0,0,1.4122674710910006,1.2307323876421463,PLEKHO2;ATP6V0A1
1139,GO_Cellular_Component_2021,late endosome (GO:0005770),2/189,0.4316565199063786,0.5581013590708734,0,0,1.374156792841914,1.154463612728904,MICALL1;CD68
1140,GO_Cellular_Component_2021,lipid droplet (GO:0005811),1/77,0.4513084668329251,0.5776748375461441,0,0,1.6890806561859193,1.3438396833532529,RAB18
1141,GO_Cellular_Component_2021,potassium channel complex (GO:0034705),1/80,0.4640160810873489,0.5880599839522838,0,0,1.6246917639322702,1.2474969387201484,GRIK4
1142,GO_Cellular_Component_2021,actin-based cell projection (GO:0098858),1/83,0.4764312430429704,0.5971334230154259,0,0,1.5650142540386442,1.160351432611526,SLC9A3R1
1143,GO_Cellular_Component_2021,intermediate filament cytoskeleton (GO:0045111),1/84,0.4805058013327256,0.5971334230154259,0,0,1.546080425598498,1.1331470458203732,SMARCA2
1144,GO_Cellular_Component_2021,lytic vacuole (GO:0000323),2/219,0.5079277225098271,0.6241379189475171,0,0,1.1823740248787686,0.800959224381475,OCIAD1;CD68
1145,GO_Cellular_Component_2021,cell projection membrane (GO:0031253),1/92,0.5119881366366351,0.6241379189475171,0,0,1.4095904095904097,0.9436556911618096,SLC9A3R1
1146,GO_Cellular_Component_2021,vesicle (GO:0031982),2/226,0.524755178370694,0.6336666304853663,0,0,1.145016339869281,0.7383333889484172,SLC9A3R1;DNAJC6
1147,GO_Cellular_Component_2021,early endosome membrane (GO:0031901),1/97,0.5306942574187079,0.6348492051363982,0,0,1.3358360389610389,0.8463445838597365,ATP9A
1148,GO_Cellular_Component_2021,trans-Golgi network membrane (GO:0032588),1/99,0.5379756487839485,0.6359769724816324,0,0,1.3084415584415583,0.811157853500724,ATP9A
1149,GO_Cellular_Component_2021,phagocytic vesicle (GO:0045335),1/100,0.5415741406288901,0.6359769724816324,0,0,1.295159386068477,0.7942892672270463,ATP6V0A1
1150,GO_Cellular_Component_2021,integral component of plasma membrane (GO:0005887),11/1454,0.5779029520300349,0.6724688896349498,0,0,0.9741568491568492,0.5341782530847511,CHRM3;ADGRB3;TSPAN18;SLC1A1;SLC38A6;GRIK4;CACNA1C;SCN2A;SLC25A4;SCN3A;GPR19
1151,GO_Cellular_Component_2021,ficolin-1-rich granule lumen (GO:1904813),1/123,0.6170700071393816,0.710238429730689,0,0,1.0497658079625294,0.5067983760967132,PLEKHO2
1152,GO_Cellular_Component_2021,dendrite (GO:0030425),2/270,0.6214586260143529,0.710238429730689,0,0,0.9548824504926348,0.4542241574108416,CHRM3;SLC1A1
1153,GO_Cellular_Component_2021,mitochondrial envelope (GO:0005740),1/127,0.62887614813842,0.7123552828470597,0,0,1.0162337662337662,0.4713505052570561,DNM1
1154,GO_Cellular_Component_2021,adherens junction (GO:0005912),1/132,0.6431264517211345,0.7181181658725491,0,0,0.977198374144939,0.4313489601646135,CDH8
1155,GO_Cellular_Component_2021,endoplasmic reticulum membrane (GO:0005789),5/712,0.6504592025526026,0.7181181658725491,0,0,0.9023102310231024,0.3880626065853365,REEP1;PIGB;PIGT;RAB18;SPTSSB
1156,GO_Cellular_Component_2021,endoplasmic reticulum lumen (GO:0005788),2/285,0.6507945878219976,0.7181181658725491,0,0,0.903577449825631,0.3881418315888957,VWA1;UGGT2
1157,GO_Cellular_Component_2021,azurophil granule (GO:0042582),1/155,0.7019848836980487,0.7625290951108916,0,0,0.8302833530106257,0.293790291551975,CD68
1158,GO_Cellular_Component_2021,actin cytoskeleton (GO:0015629),2/316,0.7056986589799846,0.7625290951108916,0,0,0.813080221472878,0.283412902048364,SLC9A3R1;DCDC2B
1159,GO_Cellular_Component_2021,endocytic vesicle membrane (GO:0030666),1/158,0.7089137681109071,0.7625290951108916,0,0,0.8142939862685086,0.2801345445576442,ATP6V0A1
1160,GO_Cellular_Component_2021,tertiary granule (GO:0070820),1/164,0.7222949627775392,0.7704479602960419,0,0,0.7840809497251215,0.2550785379476446,ATP6V0A1
1161,GO_Cellular_Component_2021,collagen-containing extracellular matrix (GO:0062023),2/380,0.7965280756748654,0.8357015875933015,0,0,0.673202614379085,0.1531488160062287,TNR;VWA1
1162,GO_Cellular_Component_2021,cytoplasmic vesicle membrane (GO:0030659),2/380,0.7965280756748654,0.8357015875933015,0,0,0.673202614379085,0.1531488160062287,RAB18;ATP6V0A1
1163,GO_Cellular_Component_2021,polymeric cytoskeletal fiber (GO:0099513),1/256,0.8652824740559977,0.9004565583672172,0,0,0.4988540870893812,0.0721838201216769,DCDC2B
1164,GO_Cellular_Component_2021,cell-cell junction (GO:0005911),1/271,0.8803084757936134,0.9050413366893364,0,0,0.4707792207792208,0.06001629668101,CDH8
1165,GO_Cellular_Component_2021,Golgi membrane (GO:0000139),2/472,0.8838294303606802,0.9050413366893364,0,0,0.5388680294812961,0.0665454526200704,CHST12;ATP9A
1166,GO_Cellular_Component_2021,bounding membrane of organelle (GO:0098588),3/767,0.9396871493435224,0.9546028183807213,0,0,0.4929302149352438,0.0306643403195992,CHST12;RAB18;ATP6V0A1
1167,GO_Cellular_Component_2021,focal adhesion (GO:0005925),1/387,0.9521865075139888,0.9547699484419412,0,0,0.3273501110288675,0.0160383066078031,MAPRE2
1168,GO_Cellular_Component_2021,cell-substrate junction (GO:0030055),1/394,0.9547699484419412,0.9547699484419412,0,0,0.321403787052642,0.0148761290314603,MAPRE2
1169,GO_Molecular_Function_2021,beta-2 adrenergic receptor binding (GO:0031698),2/5,0.0005876843981730204,0.1263521456071993,0,0,86.45751633986929,643.1851729913229,SLC9A3R1;PDE4D
1170,GO_Molecular_Function_2021,phosphoric diester hydrolase activity (GO:0008081),3/36,0.002702278311826,0.1609431344451147,0,0,11.849282296650715,70.07262725109973,PLCB3;MPPE1;GPLD1
1171,GO_Molecular_Function_2021,sodium channel activity (GO:0005272),3/38,0.0031569053012106,0.1609431344451147,0,0,11.171052631578949,64.32474267490886,GRIK4;SCN2A;SCN3A
1172,GO_Molecular_Function_2021,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",2/12,0.0037428635917468,0.1609431344451147,0,0,25.9281045751634,144.88376689825418,PDE4D;PDE4B
1173,GO_Molecular_Function_2021,cAMP binding (GO:0030552),2/12,0.0037428635917468,0.1609431344451147,0,0,25.9281045751634,144.88376689825418,PDE4D;PDE4B
1174,GO_Molecular_Function_2021,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",2/16,0.0066683987625744,0.1792132167441891,0,0,18.516339869281047,92.77381587987476,ATP6V1A;ATP6V0A1
1175,GO_Molecular_Function_2021,chloride transmembrane transporter activity (GO:0015108),2/16,0.0066683987625744,0.1792132167441891,0,0,18.516339869281047,92.77381587987476,SLC12A5;SLC1A1
1176,GO_Molecular_Function_2021,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",2/16,0.0066683987625744,0.1792132167441891,0,0,18.516339869281047,92.77381587987476,ATP6V1A;ATP6V0A1
1177,GO_Molecular_Function_2021,adrenergic receptor binding (GO:0031690),2/17,0.0075193037455179,0.1796278116984837,0,0,17.281045751633986,84.50918235493056,SLC9A3R1;PDE4D
1178,GO_Molecular_Function_2021,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",2/21,0.0113779794334332,0.1945025474912273,0,0,13.640178878568973,61.05446940588135,PDE4D;PDE4B
1179,GO_Molecular_Function_2021,voltage-gated sodium channel activity (GO:0005248),2/22,0.0124526851651479,0.1945025474912273,0,0,12.95751633986928,56.82932140040243,SCN2A;SCN3A
1180,GO_Molecular_Function_2021,cyclic nucleotide binding (GO:0030551),2/23,0.0135699451738065,0.1945025474912273,0,0,12.339869281045752,53.06017733400719,PDE4D;PDE4B
1181,GO_Molecular_Function_2021,cyclic-nucleotide phosphodiesterase activity (GO:0004112),2/23,0.0135699451738065,0.1945025474912273,0,0,12.339869281045752,53.06017733400719,PDE4D;PDE4B
1182,GO_Molecular_Function_2021,phosphatidylinositol phospholipase C activity (GO:0004435),2/23,0.0135699451738065,0.1945025474912273,0,0,12.339869281045752,53.06017733400719,CHRM3;PLCB3
1183,GO_Molecular_Function_2021,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),2/23,0.0135699451738065,0.1945025474912273,0,0,12.339869281045752,53.06017733400719,ATP6V1A;ATP6V0A1
1184,GO_Molecular_Function_2021,NF-kappaB binding (GO:0051059),2/25,0.015929275316928,0.2014584819493839,0,0,11.265700483091788,46.63545595507459,HDAC3;COMMD6
1185,GO_Molecular_Function_2021,phospholipase C activity (GO:0004629),2/25,0.015929275316928,0.2014584819493839,0,0,11.265700483091788,46.63545595507459,CHRM3;PLCB3
1186,GO_Molecular_Function_2021,ATPase binding (GO:0051117),3/73,0.019125238912683,0.2237110881597426,0,0,5.5756578947368425,22.061464342671105,PDE4D;ANK1;ATP6V0A1
1187,GO_Molecular_Function_2021,thyroid hormone receptor binding (GO:0046966),2/28,0.0197698170931865,0.2237110881597426,0,0,9.964303670186023,39.095930855617496,MED30;TACC1
1188,GO_Molecular_Function_2021,neutral amino acid transmembrane transporter activity (GO:0015175),2/32,0.0254249416366314,0.2555028428385995,0,0,8.633986928104575,31.704212677211423,SLC1A1;SLC38A6
1189,GO_Molecular_Function_2021,organic anion transmembrane transporter activity (GO:0008514),4/144,0.0258738275966776,0.2555028428385995,0,0,3.728476821192053,13.62580556083519,SLC23A2;SLC9A3R1;SLC1A1;SLC38A6
1190,GO_Molecular_Function_2021,serine C-palmitoyltransferase activity (GO:0004758),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,SPTSSB
1191,GO_Molecular_Function_2021,kainate selective glutamate receptor activity (GO:0015277),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,GRIK4
1192,GO_Molecular_Function_2021,C-palmitoyltransferase activity (GO:0016454),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,SPTSSB
1193,GO_Molecular_Function_2021,voltage-gated calcium channel activity involved in cardiac muscle cell action potential (GO:0086007),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,CACNA1C
1194,GO_Molecular_Function_2021,chondroitin sulfotransferase activity (GO:0034481),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,CHST12
1195,GO_Molecular_Function_2021,creatine kinase activity (GO:0004111),1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,CKB
1196,GO_Molecular_Function_2021,"phosphotransferase activity, nitrogenous group as acceptor (GO:0016775)",1/5,0.0381575599921209,0.2555028428385995,0,0,32.20941558441559,105.19696189979992,CKB
1197,GO_Molecular_Function_2021,RNA binding (GO:0003723),17/1406,0.0451902503487804,0.2555028428385995,0,0,1.6368360096409678,5.069074742468176,LRRC47;BTF3;ZCCHC24;PNISR;RPL34;PRKRIP1;NUDT1;TRNT1;IFIT3;DNM1;RIMS1;IFI16;NOVA1;PRDX1;RPL39;SNRPA;RPS24
1198,GO_Molecular_Function_2021,histone serine kinase activity (GO:0035174),1/6,0.0456136829085219,0.2555028428385995,0,0,25.766233766233768,79.55447177504013,AURKB
1199,GO_Molecular_Function_2021,sulfur amino acid transmembrane transporter activity (GO:0000099),1/6,0.0456136829085219,0.2555028428385995,0,0,25.766233766233768,79.55447177504013,SLC1A1
1200,GO_Molecular_Function_2021,olfactory receptor binding (GO:0031849),1/6,0.0456136829085219,0.2555028428385995,0,0,25.766233766233768,79.55447177504013,REEP1
1201,GO_Molecular_Function_2021,gap junction hemi-channel activity (GO:0055077),1/6,0.0456136829085219,0.2555028428385995,0,0,25.766233766233768,79.55447177504013,PANX2
1202,GO_Molecular_Function_2021,purine nucleobase transmembrane transporter activity (GO:0005345),1/6,0.0456136829085219,0.2555028428385995,0,0,25.766233766233768,79.55447177504013,SLC25A4
1203,GO_Molecular_Function_2021,ADP transmembrane transporter activity (GO:0015217),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,SLC25A4
1204,GO_Molecular_Function_2021,MutSalpha complex binding (GO:0032407),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,MCM9
1205,GO_Molecular_Function_2021,organic acid:sodium symporter activity (GO:0005343),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,SLC23A2
1206,GO_Molecular_Function_2021,peroxisome proliferator activated receptor binding (GO:0042975),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,TACC1
1207,GO_Molecular_Function_2021,G protein-coupled acetylcholine receptor activity (GO:0016907),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,CHRM3
1208,GO_Molecular_Function_2021,G protein-coupled neurotransmitter receptor activity (GO:0099528),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,CHRM3
1209,GO_Molecular_Function_2021,gamma-aminobutyric acid transmembrane transporter activity (GO:0015185),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,SLC9A3R1
1210,GO_Molecular_Function_2021,GPI anchor binding (GO:0034235),1/7,0.0530123784483423,0.2555028428385995,0,0,21.47077922077922,63.06461335243215,MPPE1
1211,GO_Molecular_Function_2021,cation transmembrane transporter activity (GO:0008324),2/48,0.0533802129066347,0.2555028428385995,0,0,5.626314293833476,16.48687399421364,SLC1A1;SLC38A6
1212,GO_Molecular_Function_2021,amino acid transmembrane transporter activity (GO:0015171),2/49,0.0553759630417246,0.2555028428385995,0,0,5.50632735363649,15.9331620188262,SLC9A3R1;SLC38A6
1213,GO_Molecular_Function_2021,histone kinase activity (GO:0035173),1/8,0.0603540856180015,0.2555028428385995,0,0,18.4025974025974,51.66578236108292,AURKB
1214,GO_Molecular_Function_2021,L-glutamine transmembrane transporter activity (GO:0015186),1/8,0.0603540856180015,0.2555028428385995,0,0,18.4025974025974,51.66578236108292,SLC38A6
1215,GO_Molecular_Function_2021,sulfurtransferase activity (GO:0016783),1/8,0.0603540856180015,0.2555028428385995,0,0,18.4025974025974,51.66578236108292,MPST
1216,GO_Molecular_Function_2021,U1 snRNA binding (GO:0030619),1/8,0.0603540856180015,0.2555028428385995,0,0,18.4025974025974,51.66578236108292,SNRPA
1217,GO_Molecular_Function_2021,G protein-coupled glutamate receptor binding (GO:0035256),1/8,0.0603540856180015,0.2555028428385995,0,0,18.4025974025974,51.66578236108292,SLC9A3R1
1218,GO_Molecular_Function_2021,L-amino acid transmembrane transporter activity (GO:0015179),2/53,0.0636133769720255,0.2555028428385995,0,0,5.073433294886582,13.97696120232268,SLC1A1;SLC38A6
1219,GO_Molecular_Function_2021,nuclear receptor coactivator activity (GO:0030374),2/53,0.0636133769720255,0.2555028428385995,0,0,5.073433294886582,13.97696120232268,MED30;TACC1
1220,GO_Molecular_Function_2021,iron ion binding (GO:0005506),2/54,0.0657337999208766,0.2555028428385995,0,0,4.975615887380593,13.544333118835452,ETHE1;TET2
1221,GO_Molecular_Function_2021,L-aspartate transmembrane transporter activity (GO:0015183),1/9,0.0676392402357157,0.2555028428385995,0,0,16.101461038961038,43.37036390482204,SLC1A1
1222,GO_Molecular_Function_2021,potassium:chloride symporter activity (GO:0015379),1/9,0.0676392402357157,0.2555028428385995,0,0,16.101461038961038,43.37036390482204,SLC12A5
1223,GO_Molecular_Function_2021,glucocorticoid receptor binding (GO:0035259),1/9,0.0676392402357157,0.2555028428385995,0,0,16.101461038961038,43.37036390482204,TACC1
1224,GO_Molecular_Function_2021,growth hormone receptor binding (GO:0005131),1/9,0.0676392402357157,0.2555028428385995,0,0,16.101461038961038,43.37036390482204,TYK2
1225,GO_Molecular_Function_2021,carboxylic acid transmembrane transporter activity (GO:0046943),2/57,0.072233750483877,0.2555028428385995,0,0,4.703505644682116,12.36009735614786,SLC23A2;SLC38A6
1226,GO_Molecular_Function_2021,ATP transmembrane transporter activity (GO:0005347),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,SLC25A4
1227,GO_Molecular_Function_2021,UDP-glucosyltransferase activity (GO:0035251),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,UGGT2
1228,GO_Molecular_Function_2021,cation:chloride symporter activity (GO:0015377),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,SLC12A5
1229,GO_Molecular_Function_2021,nucleoside-triphosphate diphosphatase activity (GO:0047429),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,NUDT1
1230,GO_Molecular_Function_2021,eukaryotic initiation factor 4E binding (GO:0008190),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,HHEX
1231,GO_Molecular_Function_2021,high voltage-gated calcium channel activity (GO:0008331),1/10,0.0748682748782873,0.2555028428385995,0,0,14.311688311688313,37.09625453392642,CACNA1C
1232,GO_Molecular_Function_2021,amino acid:sodium symporter activity (GO:0005283),1/11,0.082041618927272,0.2713684318363614,0,0,12.87987012987013,32.20648378609581,SLC1A1
1233,GO_Molecular_Function_2021,retinoid X receptor binding (GO:0046965),1/11,0.082041618927272,0.2713684318363614,0,0,12.87987012987013,32.20648378609581,TACC1
1234,GO_Molecular_Function_2021,PDZ domain binding (GO:0030165),2/63,0.0858152602117776,0.2795497112959423,0,0,4.239579984999464,10.410536373337996,SLC9A3R1;GNG5
1235,GO_Molecular_Function_2021,m7G(5')pppN diphosphatase activity (GO:0050072),1/12,0.0891596984900511,0.2819019878729558,0,0,11.708382526564344,28.302979280758237,NUDT1
1236,GO_Molecular_Function_2021,carbohydrate:cation symporter activity (GO:0005402),1/12,0.0891596984900511,0.2819019878729558,0,0,11.708382526564344,28.302979280758237,SLC23A2
1237,GO_Molecular_Function_2021,aldehyde dehydrogenase (NAD+) activity (GO:0004029),1/13,0.0962229365001757,0.2998250919933012,0,0,10.732142857142858,25.12488575477612,ALDH1L1
1238,GO_Molecular_Function_2021,L-glutamate transmembrane transporter activity (GO:0005313),1/14,0.1032317526957649,0.2998748249581487,0,0,9.906093906093906,22.49454795449228,SLC1A1
1239,GO_Molecular_Function_2021,vitamin D receptor binding (GO:0042809),1/14,0.1032317526957649,0.2998748249581487,0,0,9.906093906093906,22.49454795449228,MED30
1240,GO_Molecular_Function_2021,cadherin binding (GO:0045296),5/322,0.1058013975439107,0.2998748249581487,0,0,2.0534174553102,4.612368937449641,PLCB3;RPL34;PRDX1;MICALL1;CDH8
1241,GO_Molecular_Function_2021,microtubule binding (GO:0008017),4/232,0.1064999129884624,0.2998748249581487,0,0,2.2791913558731265,5.104502284350169,REEP1;MTUS1;MAPRE2;DNM1
1242,GO_Molecular_Function_2021,GTPase regulator activity (GO:0030695),4/233,0.1077440031939728,0.2998748249581487,0,0,2.26912287804737,5.055599433175703,RIMS1;RABGAP1L;ADGRB3;RGS6
1243,GO_Molecular_Function_2021,phospholipase activity (GO:0004620),2/73,0.1099498491856705,0.2998748249581487,0,0,3.6406149314185767,8.037498201583205,PLCB3;GPLD1
1244,GO_Molecular_Function_2021,acidic amino acid transmembrane transporter activity (GO:0015172),1/15,0.1101865635892732,0.2998748249581487,0,0,9.198051948051948,20.28704233319861,SLC1A1
1245,GO_Molecular_Function_2021,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),1/15,0.1101865635892732,0.2998748249581487,0,0,9.198051948051948,20.28704233319861,ALDH1L1
1246,GO_Molecular_Function_2021,chloride channel regulator activity (GO:0017081),1/15,0.1101865635892732,0.2998748249581487,0,0,9.198051948051948,20.28704233319861,SLC9A3R1
1247,GO_Molecular_Function_2021,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",1/15,0.1101865635892732,0.2998748249581487,0,0,9.198051948051948,20.28704233319861,ALDH1L1
1248,GO_Molecular_Function_2021,C4-dicarboxylate transmembrane transporter activity (GO:0015556),1/16,0.1170877826276355,0.3069984544505079,0,0,8.584415584415584,18.41212363798959,SLC1A1
1249,GO_Molecular_Function_2021,"DNA binding, bending (GO:0008301)",1/16,0.1170877826276355,0.3069984544505079,0,0,8.584415584415584,18.41212363798959,HHEX
1250,GO_Molecular_Function_2021,phosphatidylinositol-5-phosphate binding (GO:0010314),1/16,0.1170877826276355,0.3069984544505079,0,0,8.584415584415584,18.41212363798959,WASHC2C
1251,GO_Molecular_Function_2021,ionotropic glutamate receptor activity (GO:0004970),1/17,0.1239358200185128,0.321038569927473,0,0,8.047483766233766,16.803077119770684,GRIK4
1252,GO_Molecular_Function_2021,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",1/18,0.1307310829477655,0.3299161995329618,0,0,7.573720397249809,15.409588975790411,ETHE1
1253,GO_Molecular_Function_2021,retinoic acid receptor binding (GO:0042974),1/18,0.1307310829477655,0.3299161995329618,0,0,7.573720397249809,15.409588975790411,TACC1
1254,GO_Molecular_Function_2021,histone deacetylase activity (GO:0004407),1/19,0.137473975435875,0.3299161995329618,0,0,7.152597402597403,14.19304672243636,HDAC3
1255,GO_Molecular_Function_2021,anion:anion antiporter activity (GO:0015301),1/19,0.137473975435875,0.3299161995329618,0,0,7.152597402597403,14.19304672243636,SLC25A4
1256,GO_Molecular_Function_2021,phosphatidic acid binding (GO:0070300),1/19,0.137473975435875,0.3299161995329618,0,0,7.152597402597403,14.19304672243636,MICALL1
1257,GO_Molecular_Function_2021,glutamate receptor activity (GO:0008066),1/19,0.137473975435875,0.3299161995329618,0,0,7.152597402597403,14.19304672243636,GRIK4
1258,GO_Molecular_Function_2021,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",4/256,0.1381044556184491,0.3299161995329618,0,0,2.0596026490066226,4.07748795445123,HHEX;IFI16;NACC2;ZNF219
1259,GO_Molecular_Function_2021,microtubule plus-end binding (GO:0051010),1/20,0.1441648985018541,0.3406093755813038,0,0,6.775803144224197,13.123358631426164,MAPRE2
1260,GO_Molecular_Function_2021,hormone receptor binding (GO:0051427),1/21,0.1508042500591137,0.3449246144969091,0,0,6.436688311688312,12.17675084276717,TYK2
1261,GO_Molecular_Function_2021,actinin binding (GO:0042805),1/21,0.1508042500591137,0.3449246144969091,0,0,6.436688311688312,12.17675084276717,CACNA1C
1262,GO_Molecular_Function_2021,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),1/21,0.1508042500591137,0.3449246144969091,0,0,6.436688311688312,12.17675084276717,GRIK4
1263,GO_Molecular_Function_2021,small GTPase binding (GO:0031267),3/175,0.1547523187231373,0.3452997080241192,0,0,2.2574586903304774,4.212258503134052,RIMS1;RABGAP1L;MICALL1
1264,GO_Molecular_Function_2021,acetylcholine receptor activity (GO:0015464),1/22,0.1573924250528543,0.3452997080241192,0,0,6.12987012987013,11.334209985174065,CHRM3
1265,GO_Molecular_Function_2021,TBP-class protein binding (GO:0017025),1/22,0.1573924250528543,0.3452997080241192,0,0,6.12987012987013,11.334209985174065,HHEX
1266,GO_Molecular_Function_2021,mannosyltransferase activity (GO:0000030),1/22,0.1573924250528543,0.3452997080241192,0,0,6.12987012987013,11.334209985174065,PIGB
1267,GO_Molecular_Function_2021,phosphatidylinositol binding (GO:0035091),2/92,0.1597032545933523,0.3455383362756897,0,0,2.869281045751634,5.263517736973824,DENND1C;MPPE1
1268,GO_Molecular_Function_2021,histone deacetylase binding (GO:0042826),2/93,0.1624283808635174,0.3455383362756897,0,0,2.8376068376068377,5.157401809348388,HDAC3;NACC2
1269,GO_Molecular_Function_2021,carboxy-lyase activity (GO:0016831),1/23,0.163929815349397,0.3455383362756897,0,0,5.850944510035419,10.580361826426786,CSAD
1270,GO_Molecular_Function_2021,DNA replication origin binding (GO:0003688),1/23,0.163929815349397,0.3455383362756897,0,0,5.850944510035419,10.580361826426786,MCM9
1271,GO_Molecular_Function_2021,alpha-actinin binding (GO:0051393),1/24,0.1704168099322024,0.3456567371266369,0,0,5.596273291925466,9.902650470022865,CACNA1C
1272,GO_Molecular_Function_2021,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",1/24,0.1704168099322024,0.3456567371266369,0,0,5.596273291925466,9.902650470022865,WASHC2C
1273,GO_Molecular_Function_2021,ferrous iron binding (GO:0008198),1/24,0.1704168099322024,0.3456567371266369,0,0,5.596273291925466,9.902650470022865,TET2
1274,GO_Molecular_Function_2021,gap junction channel activity (GO:0005243),1/24,0.1704168099322024,0.3456567371266369,0,0,5.596273291925466,9.902650470022865,PANX2
1275,GO_Molecular_Function_2021,wide pore channel activity (GO:0022829),1/25,0.1768537947593154,0.3517575702104766,0,0,5.362824675324675,9.290728574129565,PANX2
1276,GO_Molecular_Function_2021,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),3/190,0.1831286710681448,0.3517575702104766,0,0,2.074795947086969,3.522103580854302,HDAC3;TACC1;COMMD6
1277,GO_Molecular_Function_2021,NAD+ ADP-ribosyltransferase activity (GO:0003950),1/26,0.1832411528538297,0.3517575702104766,0,0,5.148051948051948,8.735998174132183,PARP8
1278,GO_Molecular_Function_2021,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",1/26,0.1832411528538297,0.3517575702104766,0,0,5.148051948051948,8.735998174132183,WASHC2C
1279,GO_Molecular_Function_2021,phosphatidylinositol-4-phosphate binding (GO:0070273),1/26,0.1832411528538297,0.3517575702104766,0,0,5.148051948051948,8.735998174132183,WASHC2C
1280,GO_Molecular_Function_2021,general transcription initiation factor binding (GO:0140296),1/26,0.1832411528538297,0.3517575702104766,0,0,5.148051948051948,8.735998174132183,HHEX
1281,GO_Molecular_Function_2021,phosphatidylinositol phosphate binding (GO:1901981),2/102,0.1873005010984672,0.3557550607802173,0,0,2.581045751633987,4.32335744178112,DENND1C;WASHC2C
1282,GO_Molecular_Function_2021,sequence-specific double-stranded DNA binding (GO:1990837),8/712,0.1886329159485803,0.3557550607802173,0,0,1.479669140383426,2.4680176882588376,ZNF396;HHEX;TGIF2;MCM9;E2F1;MYBL2;SMARCA2;NEUROG1
1283,GO_Molecular_Function_2021,monocarboxylic acid transmembrane transporter activity (GO:0008028),1/28,0.1958685065175736,0.3599293068485327,0,0,4.766233766233766,7.770446817061417,SLC9A3R1
1284,GO_Molecular_Function_2021,protein serine/threonine/tyrosine kinase activity (GO:0004712),1/28,0.1958685065175736,0.3599293068485327,0,0,4.766233766233766,7.770446817061417,AURKB
1285,GO_Molecular_Function_2021,receptor antagonist activity (GO:0048019),1/28,0.1958685065175736,0.3599293068485327,0,0,4.766233766233766,7.770446817061417,DKKL1
1286,GO_Molecular_Function_2021,transcription corepressor binding (GO:0001222),1/29,0.2021092536964389,0.3611685777552538,0,0,4.595779220779221,7.348406790668775,HDAC3
1287,GO_Molecular_Function_2021,dicarboxylic acid transmembrane transporter activity (GO:0005310),1/29,0.2021092536964389,0.3611685777552538,0,0,4.595779220779221,7.348406790668775,SLC1A1
1288,GO_Molecular_Function_2021,GTPase binding (GO:0051020),3/201,0.204753940319104,0.3611685777552538,0,0,1.958433014354067,3.105969616210949,RIMS1;RABGAP1L;MICALL1
1289,GO_Molecular_Function_2021,snoRNA binding (GO:0030515),1/30,0.2083018774030301,0.3611685777552538,0,0,4.437080161218092,6.960744568453372,NUDT1
1290,GO_Molecular_Function_2021,ligand-gated channel activity (GO:0022834),1/30,0.2083018774030301,0.3611685777552538,0,0,4.437080161218092,6.960744568453372,GRIK4
1291,GO_Molecular_Function_2021,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),1/30,0.2083018774030301,0.3611685777552538,0,0,4.437080161218092,6.960744568453372,GRIK4
1292,GO_Molecular_Function_2021,WW domain binding (GO:0050699),1/30,0.2083018774030301,0.3611685777552538,0,0,4.437080161218092,6.960744568453372,NDFIP2
1293,GO_Molecular_Function_2021,adenyl ribonucleotide binding (GO:0032559),4/306,0.2138028056780525,0.3635660919611911,0,0,1.714223060392088,2.6445338995962744,PDE4D;PDE4B;TRNT1;NEK11
1294,GO_Molecular_Function_2021,ligand-gated ion channel activity (GO:0015276),1/31,0.2144467463020621,0.3635660919611911,0,0,4.288961038961039,6.603686893515271,GRIK4
1295,GO_Molecular_Function_2021,tubulin binding (GO:0015631),4/307,0.2154246845903054,0.3635660919611911,0,0,1.70847813258147,2.62275982107674,REEP1;MTUS1;MAPRE2;DNM1
1296,GO_Molecular_Function_2021,potassium ion transmembrane transporter activity (GO:0015079),1/32,0.2205442263504202,0.3635660919611911,0,0,4.150397989107667,6.273978302469515,SLC12A5
1297,GO_Molecular_Function_2021,phosphatase binding (GO:0019902),2/114,0.2211860187526702,0.3635660919611911,0,0,2.3031045751633985,3.474811832253972,SLC9A3R1;ANK1
1298,GO_Molecular_Function_2021,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),1/33,0.2265946805711609,0.3635660919611911,0,0,4.02049512987013,5.968796536704066,TET2
1299,GO_Molecular_Function_2021,serotonin receptor activity (GO:0099589),1/33,0.2265946805711609,0.3635660919611911,0,0,4.02049512987013,5.968796536704066,CHRM3
1300,GO_Molecular_Function_2021,kinase inhibitor activity (GO:0019210),1/33,0.2265946805711609,0.3635660919611911,0,0,4.02049512987013,5.968796536704066,PRKRIP1
1301,GO_Molecular_Function_2021,nucleosomal DNA binding (GO:0031492),1/33,0.2265946805711609,0.3635660919611911,0,0,4.02049512987013,5.968796536704066,ACTL6A
1302,GO_Molecular_Function_2021,G protein-coupled serotonin receptor activity (GO:0004993),1/33,0.2265946805711609,0.3635660919611911,0,0,4.02049512987013,5.968796536704066,CHRM3
1303,GO_Molecular_Function_2021,transmitter-gated ion channel activity (GO:0022824),1/34,0.2325984693579306,0.3689894194711144,0,0,3.898465171192444,5.685683857821177,GRIK4
1304,GO_Molecular_Function_2021,GTPase activity (GO:0003924),3/216,0.2351117582959941,0.3689894194711144,0,0,1.819125277983692,2.633537315327936,GNG5;RAB18;DNM1
1305,GO_Molecular_Function_2021,nuclear receptor binding (GO:0016922),2/120,0.2383211390650813,0.3689894194711144,0,0,2.185332890218234,3.1340649873038147,MED30;TACC1
1306,GO_Molecular_Function_2021,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",1/35,0.2385559502627205,0.3689894194711144,0,0,3.783613445378151,5.422490920943929,WASHC2C
1307,GO_Molecular_Function_2021,estrogen receptor binding (GO:0030331),1/35,0.2385559502627205,0.3689894194711144,0,0,3.783613445378151,5.422490920943929,TACC1
1308,GO_Molecular_Function_2021,double-stranded DNA binding (GO:0003690),7/651,0.24152398662155,0.3709118365973803,0,0,1.4101792009400704,2.003563553419455,ZNF396;TGIF2;IFI16;E2F1;MYBL2;ZMYND11;NEUROG1
1309,GO_Molecular_Function_2021,sodium channel regulator activity (GO:0017080),1/37,0.2503334052868782,0.3763753995571945,0,0,3.573051948051948,4.948539844529104,GPLD1
1310,GO_Molecular_Function_2021,voltage-gated calcium channel activity (GO:0005245),1/37,0.2503334052868782,0.3763753995571945,0,0,3.573051948051948,4.948539844529104,CACNA1C
1311,GO_Molecular_Function_2021,protein serine/threonine kinase activator activity (GO:0043539),1/37,0.2503334052868782,0.3763753995571945,0,0,3.573051948051948,4.948539844529104,CAB39L
1312,GO_Molecular_Function_2021,pentosyltransferase activity (GO:0016763),1/38,0.2561540810955608,0.3824522738579555,0,0,3.4763074763074764,4.734647825101587,PARP8
1313,GO_Molecular_Function_2021,phosphatidylinositol-3-phosphate binding (GO:0032266),1/39,0.2619298523456677,0.3857186181802641,0,0,3.384654818865345,4.534349460692842,WASHC2C
1314,GO_Molecular_Function_2021,G protein-coupled amine receptor activity (GO:0008227),1/39,0.2619298523456677,0.3857186181802641,0,0,3.384654818865345,4.534349460692842,CHRM3
1315,GO_Molecular_Function_2021,GTPase activator activity (GO:0005096),4/336,0.2637748083121147,0.3857930869871066,0,0,1.556929705577276,2.0748572231670064,DENND1C;RABGAP1L;ADGRB3;RGS6
1316,GO_Molecular_Function_2021,sulfotransferase activity (GO:0008146),1/40,0.2676610632899671,0.3888319500496143,0,0,3.2977022977022976,4.346483051407713,CHST12
1317,GO_Molecular_Function_2021,E-box binding (GO:0070888),1/41,0.273348055509039,0.3944284022445865,0,0,3.2150974025974026,4.170011447706375,NEUROG1
1318,GO_Molecular_Function_2021,snRNA binding (GO:0017069),1/43,0.2845907369324476,0.4052119764269949,0,0,3.061688311688312,3.8476333196795687,SNRPA
1319,GO_Molecular_Function_2021,protein kinase inhibitor activity (GO:0004860),1/43,0.2845907369324476,0.4052119764269949,0,0,3.061688311688312,3.8476333196795687,PRKRIP1
1320,GO_Molecular_Function_2021,kinase binding (GO:0019900),5/461,0.2870542171066531,0.4060306360390159,0,0,1.4173245614035088,1.7689403506603838,STX1B;SV2A;PRKRIP1;AURKB;DNM1
1321,GO_Molecular_Function_2021,channel activity (GO:0015267),1/46,0.3011315091318221,0.4231586566231486,0,0,2.857142857142857,3.429166292099496,PANX2
1322,GO_Molecular_Function_2021,manganese ion binding (GO:0030145),1/48,0.3119470262621401,0.4355104587425982,0,0,2.7352859906051394,3.186394534645299,MPPE1
1323,GO_Molecular_Function_2021,tRNA binding (GO:0000049),1/49,0.3172922568741916,0.440115065986782,0,0,2.6781655844155843,3.0743519324254893,TRNT1
1324,GO_Molecular_Function_2021,cholesterol binding (GO:0015485),1/50,0.3225962281219006,0.4446037759372347,0,0,2.623376623376624,2.9679671260643183,OSBPL7
1325,GO_Molecular_Function_2021,transcription coregulator binding (GO:0001221),1/53,0.3382637377900799,0.4632274116233579,0,0,2.471653346653347,2.6790977252069794,HDAC3
1326,GO_Molecular_Function_2021,pyrophosphatase activity (GO:0016462),1/54,0.3434058117629479,0.4672927185381886,0,0,2.424895858858123,2.5918315252533666,NUDT1
1327,GO_Molecular_Function_2021,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",1/57,0.3585950426235817,0.4848926676985539,0,0,2.294642857142857,2.3532974672725504,HDAC3
1328,GO_Molecular_Function_2021,nucleoside-triphosphatase activity (GO:0017111),3/278,0.3654965465866159,0.4911359844757652,0,0,1.4045454545454543,1.4136728205673403,GNG5;RAB18;DNM1
1329,GO_Molecular_Function_2021,serine-type endopeptidase inhibitor activity (GO:0004867),1/60,0.3734351095815957,0.4956083244447103,0,0,2.1776359233986358,2.1449953942099538,TFPI2
1330,GO_Molecular_Function_2021,sterol binding (GO:0032934),1/60,0.3734351095815957,0.4956083244447103,0,0,2.1776359233986358,2.1449953942099538,OSBPL7
1331,GO_Molecular_Function_2021,methylation-dependent protein binding (GO:0140034),1/63,0.3879339880975881,0.5085719965913503,0,0,2.07195224130708,1.961973197846402,ZMYND11
1332,GO_Molecular_Function_2021,protein kinase activator activity (GO:0030295),1/63,0.3879339880975881,0.5085719965913503,0,0,2.07195224130708,1.961973197846402,CAB39L
1333,GO_Molecular_Function_2021,GDP binding (GO:0019003),1/67,0.4067485349917286,0.5300056668074039,0,0,1.9459858323494688,1.7505312773378598,RAB18
1334,GO_Molecular_Function_2021,methylated histone binding (GO:0035064),1/68,0.4113616791408475,0.5327877169595313,0,0,1.9168443496801704,1.7026992020024727,ZMYND11
1335,GO_Molecular_Function_2021,double-stranded RNA binding (GO:0003725),1/73,0.4338982047853735,0.5586114612506305,0,0,1.7832792207792207,1.4889406460251045,PRKRIP1
1336,GO_Molecular_Function_2021,DNA binding (GO:0003677),7/811,0.4404972398348138,0.5631611757265512,0,0,1.1201341266639775,0.9183431954536796,HHEX;IFI16;MCM9;ZNF219;E2F1;ZMYND11;SMARCA2
1337,GO_Molecular_Function_2021,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",1/75,0.4426708776641263,0.5631611757265512,0,0,1.734906984906985,1.4138255369672852,WASHC2C
1338,GO_Molecular_Function_2021,transition metal ion binding (GO:0046914),4/445,0.4537270586506406,0.5738312800581632,0,0,1.1655629139072847,0.9210971120972288,ETHE1;TET2;MPPE1;ZMYND11
1339,GO_Molecular_Function_2021,ligand-gated cation channel activity (GO:0099094),1/80,0.4640160810873489,0.5834120317764914,0,0,1.6246917639322702,1.2474969387201484,GRIK4
1340,GO_Molecular_Function_2021,sequence-specific DNA binding (GO:0043565),6/707,0.4692984521920421,0.5866230652400526,0,0,1.0997137358902431,0.8319514262578088,ZNF396;HHEX;TGIF2;E2F1;MYBL2;NEUROG1
1341,GO_Molecular_Function_2021,ion channel activity (GO:0005216),1/84,0.4805058013327256,0.5937284326812414,0,0,1.546080425598498,1.1331470458203732,GRIK4
1342,GO_Molecular_Function_2021,calcium channel activity (GO:0005262),1/84,0.4805058013327256,0.5937284326812414,0,0,1.546080425598498,1.1331470458203732,CACNA1C
1343,GO_Molecular_Function_2021,transcription regulatory region nucleic acid binding (GO:0001067),2/212,0.4907206368630299,0.602885353860294,0,0,1.2222222222222223,0.8700758987599063,HHEX;SMARCA2
1344,GO_Molecular_Function_2021,protein serine/threonine kinase activity (GO:0004674),3/344,0.5000663349579597,0.6108764887270531,0,0,1.128877913258219,0.7823287845674782,PKN3;AURKB;NEK11
1345,GO_Molecular_Function_2021,potassium channel activity (GO:0005267),1/91,0.5081589549256513,0.6172552277345482,0,0,1.425324675324675,0.96488918467982,GRIK4
1346,GO_Molecular_Function_2021,phosphatidylinositol bisphosphate binding (GO:1902936),1/94,0.5195578646566036,0.6260208782474618,0,0,1.379136992040218,0.9030273054750364,WASHC2C
1347,GO_Molecular_Function_2021,single-stranded DNA binding (GO:0003697),1/97,0.5306942574187079,0.6260208782474618,0,0,1.3358360389610389,0.8463445838597365,MCM9
1348,GO_Molecular_Function_2021,voltage-gated cation channel activity (GO:0022843),1/97,0.5306942574187079,0.6260208782474618,0,0,1.3358360389610389,0.8463445838597365,CACNA1C
1349,GO_Molecular_Function_2021,cysteine-type peptidase activity (GO:0008234),1/98,0.5343490934947801,0.6260208782474618,0,0,1.3219975900388272,0.8285037165324352,ESPL1
1350,GO_Molecular_Function_2021,protein kinase regulator activity (GO:0019887),1/98,0.5343490934947801,0.6260208782474618,0,0,1.3219975900388272,0.8285037165324352,PRKRIP1
1351,GO_Molecular_Function_2021,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),9/1149,0.5357574027792231,0.6260208782474618,0,0,1.0114455659697188,0.6312167052821908,ZNF396;HHEX;TGIF2;IFI16;NACC2;ZNF219;E2F1;MYBL2;NEUROG1
1352,GO_Molecular_Function_2021,cis-regulatory region sequence-specific DNA binding (GO:0000987),9/1149,0.5357574027792231,0.6260208782474618,0,0,1.0114455659697188,0.6312167052821908,ZNF396;HHEX;TGIF2;IFI16;NACC2;ZNF219;E2F1;MYBL2;NEUROG1
1353,GO_Molecular_Function_2021,protein kinase binding (GO:0019901),4/506,0.5541006642709455,0.6394570518272396,0,0,1.020711854568481,0.6026373676423213,STX1B;SV2A;PRKRIP1;DNM1
1354,GO_Molecular_Function_2021,cysteine-type endopeptidase activity (GO:0004197),1/105,0.5591531429931211,0.6394570518272396,0,0,1.23257992007992,0.7165380077419933,ESPL1
1355,GO_Molecular_Function_2021,cytokine receptor binding (GO:0005126),1/105,0.5591531429931211,0.6394570518272396,0,0,1.23257992007992,0.7165380077419933,TYK2
1356,GO_Molecular_Function_2021,growth factor receptor binding (GO:0070851),1/105,0.5591531429931211,0.6394570518272396,0,0,1.23257992007992,0.7165380077419933,SLC9A3R1
1357,GO_Molecular_Function_2021,protein tyrosine kinase activity (GO:0004713),1/108,0.569377341250394,0.6477043829038873,0,0,1.1978395436339362,0.6746374840803024,TYK2
1358,GO_Molecular_Function_2021,kinase activity (GO:0016301),1/112,0.582644009595311,0.6593076950683783,0,0,1.1544401544401544,0.6236042096528597,CKB
1359,GO_Molecular_Function_2021,endopeptidase inhibitor activity (GO:0004866),1/115,0.5923267818374698,0.6667552779845863,0,0,1.1238892686261108,0.5885772135844056,TFPI2
1360,GO_Molecular_Function_2021,protease binding (GO:0002020),1/118,0.6017863261475115,0.6738420700885884,0,0,1.094905094905095,0.5560506582922549,ATP9A
1361,GO_Molecular_Function_2021,hexosyltransferase activity (GO:0016758),1/119,0.6048907884981283,0.6738420700885884,0,0,1.0855712084525644,0.5457246277445359,PIGB
1362,GO_Molecular_Function_2021,protein phosphatase binding (GO:0019903),1/123,0.6170700071393816,0.6838662450256034,0,0,1.0497658079625294,0.5067983760967132,ANK1
1363,GO_Molecular_Function_2021,ATP binding (GO:0005524),2/278,0.637333155985245,0.7027006591632189,0,0,0.926825802784882,0.4175005020295539,TRNT1;NEK11
1364,GO_Molecular_Function_2021,G protein-coupled receptor binding (GO:0001664),1/143,0.6725919704563945,0.7377922124904327,0,0,0.9009968904335102,0.3573501591451499,REEP1
1365,GO_Molecular_Function_2021,guanyl-nucleotide exchange factor activity (GO:0005085),1/149,0.6876317347448913,0.7504610303053382,0,0,0.8642067392067392,0.3236470257461311,DENND1C
1366,GO_Molecular_Function_2021,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",2/333,0.7326583947171675,0.7924833218219339,0,0,0.7706494480974666,0.2397303342043648,HHEX;MYBL2
1367,GO_Molecular_Function_2021,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),9/1359,0.7337445111685489,0.7924833218219339,0,0,0.8445205479452055,0.2614588225219203,ZNF396;HHEX;TGIF2;IFI16;NACC2;ZNF219;E2F1;MYBL2;NEUROG1
1368,GO_Molecular_Function_2021,zinc ion binding (GO:0008270),2/336,0.7371937877413339,0.7924833218219339,0,0,0.7636100348322962,0.2328281206325869,TET2;ZMYND11
1369,GO_Molecular_Function_2021,transcription cis-regulatory region binding (GO:0000976),3/549,0.8020334132856697,0.8551364409775221,0,0,0.6976214574898786,0.1538987882796442,HHEX;E2F1;SMARCA2
1370,GO_Molecular_Function_2021,DNA-binding transcription factor binding (GO:0140297),1/208,0.8034305166393463,0.8551364409775221,0,0,0.6160361377752682,0.134828486501,HHEX
1371,GO_Molecular_Function_2021,guanyl ribonucleotide binding (GO:0032561),1/214,0.8124891440215583,0.8605180589390887,0,0,0.5985000914578379,0.124280175545407,RAB18
1372,GO_Molecular_Function_2021,ubiquitin protein ligase activity (GO:0061630),1/263,0.8725145460567305,0.904246949650072,0,0,0.4853524338257162,0.0661904008719132,NCCRP1
1373,GO_Molecular_Function_2021,mRNA binding (GO:0003729),1/263,0.8725145460567305,0.904246949650072,0,0,0.4853524338257162,0.0661904008719132,NOVA1
1374,GO_Molecular_Function_2021,protein homodimerization activity (GO:0042803),3/636,0.8743470184902101,0.904246949650072,0,0,0.5990271888251434,0.080436134404215,HHEX;NACC2;NEUROG1
1375,GO_Molecular_Function_2021,ubiquitin protein ligase binding (GO:0031625),1/265,0.8745090613558362,0.904246949650072,0,0,0.4816263282172373,0.0645825375702576,CKB
1376,GO_Molecular_Function_2021,purine ribonucleoside triphosphate binding (GO:0035639),2/460,0.874806351289372,0.904246949650072,0,0,0.5533293375574393,0.0740093094486455,TRNT1;NEK11
1377,GO_Molecular_Function_2021,ubiquitin-like protein ligase activity (GO:0061659),1/270,0.8793607411703486,0.9046055471369614,0,0,0.4725534688359967,0.0607515051310275,NCCRP1
1378,GO_Molecular_Function_2021,ubiquitin-like protein ligase binding (GO:0044389),1/282,0.8902577062854,0.9080136350234714,0,0,0.4520959467578684,0.0525535771103803,CKB
1379,GO_Molecular_Function_2021,G protein-coupled receptor activity (GO:0004930),1/283,0.8911203580928022,0.9080136350234714,0,0,0.4504697430229345,0.0519282503624917,ADGRB3
1380,GO_Molecular_Function_2021,endopeptidase activity (GO:0004175),1/315,0.915437153384406,0.9283914527247514,0,0,0.403900239887501,0.0356860259116115,ESPL1
1381,GO_Molecular_Function_2021,calcium ion binding (GO:0005509),1/348,0.9348678651935036,0.9436459672140995,0,0,0.3648714397993937,0.0245741207801788,CDH8
1382,GO_Molecular_Function_2021,ubiquitin-protein transferase activity (GO:0004842),1/392,0.9540463139413105,0.9585044742868304,0,0,0.3230810110605507,0.0151987199063819,NCCRP1
1383,GO_Molecular_Function_2021,metal ion binding (GO:0046872),1/517,0.9830118670945112,0.9830118670945112,0,0,0.2432422228933856,0.0041677333078963,CDH8
1384,KEGG_2021_Human,Synaptic vesicle cycle,6/78,3.188298313837749e-05,0.00349738300035,0,0,11.058724832214764,114.49582339616768,ATP6V1A;RIMS1;STX1B;SLC1A1;DNM1;ATP6V0A1
1385,KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,4/26,4.5420558446104927e-05,0.00349738300035,0,0,23.8687537627935,238.67669467855305,PIGB;PIGT;MPPE1;GPLD1
1386,KEGG_2021_Human,Taste transduction,5/86,0.0005507999762828362,0.0282743987825189,0,0,8.133333333333333,61.03366251790997,CHRM3;PLCB3;CACNA1C;SCN2A;SCN3A
1387,KEGG_2021_Human,Glutamatergic synapse,5/114,0.0019527625608295,0.0751813585919362,0,0,6.035474006116208,37.65236621607408,PLCB3;GNG5;SLC1A1;GRIK4;CACNA1C
1388,KEGG_2021_Human,Sulfur metabolism,2/10,0.0025780442096871,0.0794037616583643,0,0,32.41339869281046,193.20733082812885,MPST;ETHE1
1389,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",4/106,0.0093578287743992,0.2240172641486437,0,0,5.127386053759252,23.95279921804882,SLC9A3R1;PLCB3;PDE4D;PDE4B
1390,KEGG_2021_Human,One carbon pool by folate,2/20,0.0103465517369631,0.2240172641486437,0,0,14.398692810457517,65.81789321952054,ALDH1L1;MTHFD2L
1391,KEGG_2021_Human,Cholinergic synapse,4/113,0.0116372604752542,0.2240172641486437,0,0,4.7964031836685095,21.360988872963272,CHRM3;PLCB3;GNG5;CACNA1C
1392,KEGG_2021_Human,Collecting duct acid secretion,2/27,0.0184503480156957,0.3157059549352389,0,0,10.363398692810458,41.37765226269128,ATP6V1A;ATP6V0A1
1393,KEGG_2021_Human,Retrograde endocannabinoid signaling,4/148,0.028234886888426,0.4004366679152815,0,0,3.624172185430464,12.928135936938816,RIMS1;PLCB3;GNG5;CACNA1C
1394,KEGG_2021_Human,Insulin secretion,3/86,0.02927564272608,0.4004366679152815,0,0,4.6992707672796445,16.59312233001681,CHRM3;PLCB3;CACNA1C
1395,KEGG_2021_Human,GABAergic synapse,3/89,0.0319508537818508,0.4004366679152815,0,0,4.534654222766218,15.615337462120102,SLC12A5;GNG5;CACNA1C
1396,KEGG_2021_Human,Morphine addiction,3/91,0.0338030953434977,0.4004366679152815,0,0,4.43114533492823,15.009188339762767,GNG5;PDE4D;PDE4B
1397,KEGG_2021_Human,Circadian entrainment,3/97,0.0396870323740168,0.4365573561141848,0,0,4.14704647256439,13.381402520266294,PLCB3;GNG5;CACNA1C
1398,KEGG_2021_Human,Human papillomavirus infection,6/331,0.0444137874710632,0.4559815513695828,0,0,2.4185854414042334,7.531971670554181,ATP6V1A;SLC9A3R1;E2F1;TNR;TYK2;ATP6V0A1
1399,KEGG_2021_Human,Vibrio cholerae infection,2/50,0.0573976675935087,0.5156031607206282,0,0,5.391339869281046,15.407110195493528,ATP6V1A;ATP6V0A1
1400,KEGG_2021_Human,Serotonergic synapse,3/113,0.0577130260866144,0.5156031607206282,0,0,3.540968899521531,10.099807774774204,PLCB3;GNG5;CACNA1C
1401,KEGG_2021_Human,Sulfur relay system,1/8,0.0603540856180015,0.5156031607206282,0,0,18.4025974025974,51.66578236108292,MPST
1402,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,2/53,0.0636133769720255,0.5156031607206282,0,0,5.073433294886582,13.97696120232268,PLCB3;DNM1
1403,KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.0679438670022829,0.5231677759175787,0,0,3.299565120428189,8.872772796802854,PLCB3;HDAC3;MED30
1404,KEGG_2021_Human,Cell cycle,3/124,0.0719794284372953,0.5278491418734994,0,0,3.2172683775554587,8.465839309761728,ANAPC13;ESPL1;E2F1
1405,KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.082041618927272,0.5574104629496571,0,0,12.87987012987013,32.20648378609581,CSAD
1406,KEGG_2021_Human,Dopaminergic synapse,3/132,0.0832496145963773,0.5574104629496571,0,0,3.0165238678090573,7.498812216446909,PLCB3;GNG5;CACNA1C
1407,KEGG_2021_Human,GnRH secretion,2/64,0.0881489218191783,0.5574888190032286,0,0,4.170988825637782,10.130195686037554,PLCB3;CACNA1C
1408,KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.0905014316563682,0.5574888190032286,0,0,4.104575163398692,9.86078872188386,PLCB3;CACNA1C
1409,KEGG_2021_Human,Long-term potentiation,2/67,0.0952612907182658,0.5639255823619393,0,0,3.9778783308195074,9.35251597867776,PLCB3;CACNA1C
1410,KEGG_2021_Human,Renin secretion,2/69,0.1000914806928523,0.5639255823619393,0,0,3.858745488245049,8.88156144543646,PLCB3;CACNA1C
1411,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.1025319240658071,0.5639255823619393,0,0,3.801806997308728,8.658923666332969,ATP6V1A;ATP6V0A1
1412,KEGG_2021_Human,Coronavirus disease,4/232,0.1064999129884624,0.5639752226099696,0,0,2.2791913558731265,5.104502284350169,RPL34;TYK2;RPL39;RPS24
1413,KEGG_2021_Human,Calcium signaling pathway,4/240,0.1166354134914306,0.5639752226099696,0,0,2.201032663598608,4.72936402019339,CHRM3;PLCB3;CACNA1C;SLC25A4
1414,KEGG_2021_Human,Gastric acid secretion,2/76,0.1175045096235809,0.5639752226099696,0,0,3.4924924924924925,7.478399317344772,CHRM3;PLCB3
1415,KEGG_2021_Human,Cushing syndrome,3/155,0.1194233852097304,0.5639752226099696,0,0,2.557089681440443,5.434020756936524,PLCB3;E2F1;CACNA1C
1416,KEGG_2021_Human,Cellular senescence,3/156,0.1211114671094161,0.5639752226099696,0,0,2.540247678018576,5.362574471007007,E2F1;MYBL2;SLC25A4
1417,KEGG_2021_Human,Ribosome,3/158,0.1245140101866166,0.5639752226099696,0,0,2.507215619694397,5.223375162232867,RPL34;RPL39;RPS24
1418,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.140241722644036,0.6075700834264615,0,0,2.3685413992297817,4.652733721625065,PLCB3;CACNA1C;SLC25A4
1419,KEGG_2021_Human,Hepatocellular carcinoma,3/168,0.1420293701516403,0.6075700834264615,0,0,2.354066985645933,4.594482938139831,ACTL6A;E2F1;SMARCA2
1420,KEGG_2021_Human,ECM-receptor interaction,2/88,0.148893215973102,0.6191609554523633,0,0,3.003343973248214,5.7199463875338346,SV2A;TNR
1421,KEGG_2021_Human,Salivary secretion,2/93,0.1624283808635174,0.6191609554523633,0,0,2.8376068376068377,5.157401809348388,CHRM3;PLCB3
1422,KEGG_2021_Human,GnRH signaling pathway,2/93,0.1624283808635174,0.6191609554523633,0,0,2.8376068376068377,5.157401809348388,PLCB3;CACNA1C
1423,KEGG_2021_Human,Rheumatoid arthritis,2/93,0.1624283808635174,0.6191609554523633,0,0,2.8376068376068377,5.157401809348388,ATP6V1A;ATP6V0A1
1424,KEGG_2021_Human,NOD-like receptor signaling pathway,3/181,0.1659319091227021,0.6191609554523633,0,0,2.1806992903607334,3.916923568300577,PLCB3;IFI16;TYK2
1425,KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.1761749637730325,0.6191609554523633,0,0,2.689133986928105,4.669083280770389,PLCB3;CACNA1C
1426,KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.1811943580433992,0.6191609554523633,0,0,2.0860568760611207,3.563371111737044,PLCB3;HDAC3;SLC25A4
1427,KEGG_2021_Human,Maturity onset diabetes of the young,1/26,0.1832411528538297,0.6191609554523633,0,0,5.148051948051948,8.735998174132183,HHEX
1428,KEGG_2021_Human,Amoebiasis,2/102,0.1873005010984672,0.6191609554523633,0,0,2.581045751633987,4.32335744178112,PLCB3;PRDX1
1429,KEGG_2021_Human,Pancreatic secretion,2/102,0.1873005010984672,0.6191609554523633,0,0,2.581045751633987,4.32335744178112,CHRM3;PLCB3
1430,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,3/193,0.1889647071835134,0.6191609554523633,0,0,2.041724376731302,3.4019109802252814,GNG5;E2F1;TYK2
1431,KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.2265946805711609,0.6854291528904252,0,0,4.02049512987013,5.968796536704066,STX1B
1432,KEGG_2021_Human,cAMP signaling pathway,3/216,0.2351117582959941,0.6854291528904252,0,0,1.819125277983692,2.633537315327936,PDE4D;PDE4B;CACNA1C
1433,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",2/119,0.2354594937439973,0.6854291528904252,0,0,2.20412267471091,3.187638318796667,PLCB3;CACNA1C
1434,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,3/219,0.2412806599234999,0.6854291528904252,0,0,1.7935855263157894,2.5501099631878934,ESPL1;E2F1;SLC25A4
1435,KEGG_2021_Human,African trypanosomiasis,1/37,0.2503334052868782,0.6854291528904252,0,0,3.573051948051948,4.948539844529104,PLCB3
1436,KEGG_2021_Human,Human cytomegalovirus infection,3/225,0.2536975161205618,0.6854291528904252,0,0,1.7445768136557611,2.392883544584147,PLCB3;GNG5;E2F1
1437,KEGG_2021_Human,Lysosome,2/128,0.2612641495173021,0.6854291528904252,0,0,2.045751633986928,2.745855542573781,CD68;ATP6V0A1
1438,KEGG_2021_Human,Oocyte meiosis,2/129,0.2641354239769125,0.6854291528904252,0,0,2.029540425093922,2.701913646622323,ANAPC13;ESPL1
1439,KEGG_2021_Human,Purine metabolism,2/129,0.2641354239769125,0.6854291528904252,0,0,2.029540425093922,2.701913646622323,PDE4D;PDE4B
1440,KEGG_2021_Human,Relaxin signaling pathway,2/129,0.2641354239769125,0.6854291528904252,0,0,2.029540425093922,2.701913646622323,PLCB3;GNG5
1441,KEGG_2021_Human,Thermogenesis,3/232,0.268297306979676,0.6854291528904252,0,0,1.690645828545162,2.224314345121672,ACTL6A;SMARCA2;COX20
1442,KEGG_2021_Human,Bladder cancer,1/41,0.273348055509039,0.6854291528904252,0,0,3.2150974025974026,4.170011447706375,E2F1
1443,KEGG_2021_Human,Vascular smooth muscle contraction,2/133,0.2756203112102912,0.6854291528904252,0,0,1.967170583246021,2.535153800274671,PLCB3;CACNA1C
1444,KEGG_2021_Human,Oxidative phosphorylation,2/133,0.2756203112102912,0.6854291528904252,0,0,1.967170583246021,2.535153800274671,ATP6V1A;ATP6V0A1
1445,KEGG_2021_Human,Apelin signaling pathway,2/137,0.2870968072689402,0.6854291528904252,0,0,1.908496732026144,2.3816814200121974,PLCB3;GNG5
1446,KEGG_2021_Human,Type II diabetes mellitus,1/46,0.3011315091318221,0.6854291528904252,0,0,2.857142857142857,3.429166292099496,CACNA1C
1447,KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.3042736554341249,0.6854291528904252,0,0,1.826727854262272,2.173491584305896,PLCB3;SLC25A4
1448,KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.3065602174785805,0.6854291528904252,0,0,2.79488989271598,3.3045131196563458,PLCB3
1449,KEGG_2021_Human,Endocytosis,3/252,0.3104544012898885,0.6854291528904252,0,0,1.553265694356373,1.816883220688721,DNAJC6;WASHC2C;DNM1
1450,KEGG_2021_Human,Phospholipase D signaling pathway,2/148,0.3185327692110475,0.6854291528904252,0,0,1.7637210135195631,2.0177496156419243,PLCB3;DNM1
1451,KEGG_2021_Human,Alzheimer disease,4/369,0.3209401934069268,0.6854291528904252,0,0,1.4137712056608909,1.606751663153003,CHRM3;PLCB3;CACNA1C;SLC25A4
1452,KEGG_2021_Human,Arginine and proline metabolism,1/50,0.3225962281219006,0.6854291528904252,0,0,2.623376623376624,2.9679671260643183,CKB
1453,KEGG_2021_Human,Cysteine and methionine metabolism,1/50,0.3225962281219006,0.6854291528904252,0,0,2.623376623376624,2.9679671260643183,MPST
1454,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,2/150,0.324218276468499,0.6854291528904252,0,0,1.739710298533828,1.959502335297862,PLCB3;CACNA1C
1455,KEGG_2021_Human,Spliceosome,2/150,0.324218276468499,0.6854291528904252,0,0,1.739710298533828,1.959502335297862,SNRPA;CTNNBL1
1456,KEGG_2021_Human,Phagosome,2/152,0.3298918735144678,0.6854291528904252,0,0,1.7163398692810456,1.9034043252851225,ATP6V1A;ATP6V0A1
1457,KEGG_2021_Human,mTOR signaling pathway,2/154,0.3355525765775424,0.6854291528904252,0,0,1.6935844513243894,1.8493546311722011,ATP6V1A;CAB39L
1458,KEGG_2021_Human,Oxytocin signaling pathway,2/154,0.3355525765775424,0.6854291528904252,0,0,1.6935844513243894,1.8493546311722011,PLCB3;CACNA1C
1459,KEGG_2021_Human,Glycosaminoglycan biosynthesis,1/53,0.3382637377900799,0.6854291528904252,0,0,2.471653346653347,2.6790977252069794,CHST12
1460,KEGG_2021_Human,Hepatitis C,2/157,0.344017383463199,0.688034766926398,0,0,1.6605523930002108,1.7719141668547946,E2F1;TYK2
1461,KEGG_2021_Human,Necroptosis,2/159,0.3496417609327495,0.690318348508249,0,0,1.6392323383705925,1.7225810554422958,TYK2;SLC25A4
1462,KEGG_2021_Human,Hepatitis B,2/162,0.3580479056048186,0.6979668033309122,0,0,1.6082516339869282,1.651816737459199,E2F1;TYK2
1463,KEGG_2021_Human,Long-term depression,1/60,0.3734351095815957,0.7188625859445719,0,0,2.1776359233986358,2.1449953942099538,PLCB3
1464,KEGG_2021_Human,Influenza A,2/172,0.3857719988658003,0.7239739988778173,0,0,1.5128796616685891,1.4410311313955486,TYK2;SLC25A4
1465,KEGG_2021_Human,Mitophagy,1/68,0.4113616791408475,0.7239739988778173,0,0,1.9168443496801704,1.7026992020024727,E2F1
1466,KEGG_2021_Human,Amphetamine addiction,1/69,0.4159391809029937,0.7239739988778173,0,0,1.8885599694423223,1.656675454939586,CACNA1C
1467,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.4204813138786264,0.7239739988778173,0,0,1.8610954263128177,1.61236977178465,TBKBP1
1468,KEGG_2021_Human,Alcoholism,2/186,0.4236861454024682,0.7239739988778173,0,0,1.3967746518897417,1.199497441912084,HDAC3;GNG5
1469,KEGG_2021_Human,RNA transport,2/186,0.4236861454024682,0.7239739988778173,0,0,1.3967746518897417,1.199497441912084,TRNT1;THOC6
1470,KEGG_2021_Human,Melanoma,1/72,0.4294605573454869,0.7239739988778173,0,0,1.8084872873605269,1.5285793468391171,E2F1
1471,KEGG_2021_Human,Non-small cell lung cancer,1/72,0.4294605573454869,0.7239739988778173,0,0,1.8084872873605269,1.5285793468391171,E2F1
1472,KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.4338982047853735,0.7239739988778173,0,0,1.7832792207792207,1.4889406460251045,PLCB3
1473,KEGG_2021_Human,Chemokine signaling pathway,2/192,0.4395685823774682,0.7239739988778173,0,0,1.3522531819745442,1.111500091246678,PLCB3;GNG5
1474,KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.4426708776641263,0.7239739988778173,0,0,1.734906984906985,1.4138255369672852,PLCB3
1475,KEGG_2021_Human,Glioma,1/75,0.4426708776641263,0.7239739988778173,0,0,1.734906984906985,1.4138255369672852,E2F1
1476,KEGG_2021_Human,Chronic myeloid leukemia,1/76,0.4470064278231222,0.7239739988778173,0,0,1.7116883116883117,1.3782211394841255,E2F1
1477,KEGG_2021_Human,Pancreatic cancer,1/76,0.4470064278231222,0.7239739988778173,0,0,1.7116883116883117,1.3782211394841255,E2F1
1478,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.4513084668329251,0.7239739988778173,0,0,1.6890806561859193,1.3438396833532529,CACNA1C
1479,KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.4513084668329251,0.7239739988778173,0,0,1.6890806561859193,1.3438396833532529,DNM1
1480,KEGG_2021_Human,Epstein-Barr virus infection,2/202,0.4655017156774246,0.724285573602222,0,0,1.2839869281045753,0.9817871183545908,E2F1;TYK2
1481,KEGG_2021_Human,Diabetic cardiomyopathy,2/203,0.4680564704095102,0.724285573602222,0,0,1.277533899131792,0.9698607179183664,PLCB3;SLC25A4
1482,KEGG_2021_Human,Peroxisome,1/82,0.4723249344590365,0.724285573602222,0,0,1.5844155844155845,1.1884512908284866,PRDX1
1483,KEGG_2021_Human,Cardiac muscle contraction,1/87,0.4925414037678645,0.724285573602222,0,0,1.4919208698278466,1.0565436778339263,CACNA1C
1484,KEGG_2021_Human,Gap junction,1/88,0.4964913811934125,0.724285573602222,0,0,1.4746977160770265,1.0325673473680734,PLCB3
1485,KEGG_2021_Human,Pathways of neurodegeneration,4/475,0.5041827801208734,0.724285573602222,0,0,1.0896359724975746,0.7462006032672096,CHRM3;PLCB3;CACNA1C;SLC25A4
1486,KEGG_2021_Human,Hypertrophic cardiomyopathy,1/90,0.5042999228922834,0.724285573602222,0,0,1.4414125200642054,0.9867680968127808,CACNA1C
1487,KEGG_2021_Human,Small cell lung cancer,1/92,0.5119881366366351,0.724285573602222,0,0,1.4095904095904097,0.9436556911618096,E2F1
1488,KEGG_2021_Human,Th1 and Th2 cell differentiation,1/92,0.5119881366366351,0.724285573602222,0,0,1.4095904095904097,0.9436556911618096,TYK2
1489,KEGG_2021_Human,PI3K-Akt signaling pathway,3/354,0.5192679133772774,0.724285573602222,0,0,1.0961538461538465,0.7183483296322304,GNG5;PKN3;TNR
1490,KEGG_2021_Human,TGF-beta signaling pathway,1/94,0.5195578646566036,0.724285573602222,0,0,1.379136992040218,0.9030273054750364,TGIF2
1491,KEGG_2021_Human,Dilated cardiomyopathy,1/96,0.5270109213468184,0.724285573602222,0,0,1.3499658236500345,0.8646990183859043,CACNA1C
1492,KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.5306942574187079,0.724285573602222,0,0,1.3358360389610389,0.8463445838597365,PLCB3
1493,KEGG_2021_Human,Prostate cancer,1/97,0.5306942574187079,0.724285573602222,0,0,1.3358360389610389,0.8463445838597365,E2F1
1494,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,1/98,0.5343490934947801,0.724285573602222,0,0,1.3219975900388272,0.8285037165324352,PLCB3
1495,KEGG_2021_Human,Ras signaling pathway,2/232,0.5388702068170566,0.724285573602222,0,0,1.1148053424268258,0.6892624499465704,GNG5;RASAL2
1496,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.5415741406288901,0.724285573602222,0,0,1.295159386068477,0.7942892672270463,PLCB3
1497,KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.5415741406288901,0.724285573602222,0,0,1.295159386068477,0.7942892672270463,ANAPC13
1498,KEGG_2021_Human,Melanogenesis,1/101,0.5451447847938456,0.724285573602222,0,0,1.2821428571428573,0.7778810197667608,PLCB3
1499,KEGG_2021_Human,Chagas disease,1/102,0.5486877954904755,0.724285573602222,0,0,1.2693840812652697,0.7619169205092237,PLCB3
1500,KEGG_2021_Human,Protein digestion and absorption,1/103,0.5522033851102792,0.724285573602222,0,0,1.2568754774637128,0.7463814872250639,SLC1A1
1501,KEGG_2021_Human,Chemical carcinogenesis,2/239,0.5549720628900142,0.724285573602222,0,0,1.081492512616861,0.63682335133225,E2F1;CACNA1C
1502,KEGG_2021_Human,Th17 cell differentiation,1/107,0.5659957260383035,0.7263611817491562,0,0,1.2092011761823085,0.6882395243362479,TYK2
1503,KEGG_2021_Human,Glucagon signaling pathway,1/107,0.5659957260383035,0.7263611817491562,0,0,1.2092011761823085,0.6882395243362479,PLCB3
1504,KEGG_2021_Human,Toxoplasmosis,1/112,0.582644009595311,0.7415469213031232,0,0,1.1544401544401544,0.6236042096528597,TYK2
1505,KEGG_2021_Human,Sphingolipid signaling pathway,1/119,0.6048907884981283,0.7611997181779632,0,0,1.0855712084525644,0.5457246277445359,PLCB3
1506,KEGG_2021_Human,AMPK signaling pathway,1/120,0.6079712034798018,0.7611997181779632,0,0,1.076394194041253,0.5356436325568794,CAB39L
1507,KEGG_2021_Human,Platelet activation,1/124,0.6200560688358586,0.7686264032802911,0,0,1.0411783338612608,0.4976263654976579,PLCB3
1508,KEGG_2021_Human,Prion disease,2/273,0.6274730536461381,0.7686264032802911,0,0,0.9441670887297108,0.4400333688852824,CACNA1C;SLC25A4
1509,KEGG_2021_Human,Osteoclast differentiation,1/127,0.62887614813842,0.7686264032802911,0,0,1.0162337662337662,0.4713505052570561,TYK2
1510,KEGG_2021_Human,Estrogen signaling pathway,1/137,0.6568329687783446,0.7936425485763523,0,0,0.941033231474408,0.3955402880352903,PLCB3
1511,KEGG_2021_Human,Measles,1/139,0.6621679608930106,0.7936425485763523,0,0,0.9273009599096556,0.3822668736214677,TYK2
1512,KEGG_2021_Human,Ubiquitin mediated proteolysis,1/140,0.6648044725087627,0.7936425485763523,0,0,0.920583014108194,0.3758393459193833,ANAPC13
1513,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.6725919704563945,0.7967627957714212,0,0,0.9009968904335102,0.3573501591451499,NEUROG1
1514,KEGG_2021_Human,Breast cancer,1/147,0.6826963506241392,0.7975741535546977,0,0,0.87613413983277,0.3344248695253931,E2F1
1515,KEGG_2021_Human,Gastric cancer,1/149,0.6876317347448913,0.7975741535546977,0,0,0.8642067392067392,0.3236470257461311,E2F1
1516,KEGG_2021_Human,Huntington disease,2/306,0.6888140417063299,0.7975741535546977,0,0,0.8402562779497764,0.3132340461760044,PLCB3;SLC25A4
1517,KEGG_2021_Human,MicroRNAs in cancer,2/310,0.6956607582229721,0.7994907221368486,0,0,0.8291740938799762,0.3009016019939308,E2F1;TNR
1518,KEGG_2021_Human,JAK-STAT signaling pathway,1/162,0.7179039001836697,0.8189422268761862,0,0,0.7939017504234895,0.2631145709101377,TYK2
1519,KEGG_2021_Human,Wnt signaling pathway,1/166,0.7266181085188693,0.8226006495185593,0,0,0.7744982290436836,0.2473392911792392,PLCB3
1520,KEGG_2021_Human,Tight junction,1/169,0.7329777618405983,0.8226006495185593,0,0,0.760551948051948,0.2362577933392269,SLC9A3R1
1521,KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.7371356469711764,0.8226006495185593,0,0,0.751527883880825,0.2292034922834323,UGGT2
1522,KEGG_2021_Human,Neuroactive ligand-receptor interaction,2/341,0.7446080587014462,0.8249614463310987,0,0,0.7521545491352883,0.2218083417680617,CHRM3;GRIK4
1523,KEGG_2021_Human,Tuberculosis,1/180,0.7550641533482444,0.8305705686830689,0,0,0.7134150765435682,0.2004357935391753,ATP6V0A1
1524,KEGG_2021_Human,Transcriptional misregulation in cancer,1/192,0.7770924291982806,0.8401177927411153,0,0,0.6681852179234378,0.1685136253158941,HHEX
1525,KEGG_2021_Human,Pathways in cancer,3/531,0.783350993873783,0.8401177927411153,0,0,0.7220768540669856,0.1763126937123545,PLCB3;GNG5;E2F1
1526,KEGG_2021_Human,Pathogenic Escherichia coli infection,1/197,0.7856791887014877,0.8401177927411153,0,0,0.650974025974026,0.1570193139979243,SLC9A3R1
1527,KEGG_2021_Human,Focal adhesion,1/201,0.7923113059444477,0.8401177927411153,0,0,0.6378246753246753,0.1484861593096634,TNR
1528,KEGG_2021_Human,Viral carcinogenesis,1/203,0.7955504898858875,0.8401177927411153,0,0,0.6314452873858815,0.1444247747467937,HDAC3
1529,KEGG_2021_Human,Proteoglycans in cancer,1/205,0.7987394747864027,0.8401177927411153,0,0,0.6251909854851031,0.1404931998963959,ANK1
1530,KEGG_2021_Human,Rap1 signaling pathway,1/210,0.8064973598992963,0.8401177927411153,0,0,0.610078916299012,0.1312003108373764,PLCB3
1531,KEGG_2021_Human,Human immunodeficiency virus 1 infection,1/212,0.8095166582177842,0.8401177927411153,0,0,0.6042346279313104,0.1276856094024045,GNG5
1532,KEGG_2021_Human,Lipid and atherosclerosis,1/215,0.8139580579127228,0.8401177927411153,0,0,0.5956730185702148,0.1226171704035203,PLCB3
1533,KEGG_2021_Human,Regulation of actin cytoskeleton,1/218,0.8182965513712163,0.8401177927411153,0,0,0.5873481357352325,0.1177812011425311,CHRM3
1534,KEGG_2021_Human,Shigellosis,1/246,0.8542384884092359,0.8689277003616857,0,0,0.5194805194805194,0.0818414876608536,PLCB3
1535,KEGG_2021_Human,Parkinson disease,1/249,0.8576429250323132,0.8689277003616857,0,0,0.5131179304566401,0.0787982056685745,SLC25A4
1536,KEGG_2021_Human,MAPK signaling pathway,1/294,0.9001761401257923,0.9060596443096208,0,0,0.4333141261468906,0.0455694036205143,CACNA1C
1537,KEGG_2021_Human,Herpes simplex virus 1 infection,1/498,0.9802297440421386,0.9802297440421386,0,0,0.2527894640570697,0.0050477763851064,TYK2
